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Abstract 
The tetraheme cytochrome C3 from Desulfovibrio vulgaris Miyazaki F is involved in 
sulphate reduction. It contains four c-type hemes covalently bound to a single 
polypeptide of only 107 amino acids. The protein surface is highly positively charged 
at physiological pH with a prevalence of lysine residues. All four hemes are bis-
histidine ligated and their reduction potentials are very low. With a cyclic heme 
arrangement and their partial exposure to solvent, cytochrome C3 can transfer 
electrons in all directions. The purpose of this work was to develop novel methods of 
controlling the crosslinking selectivity of proteins constructing biological "nanowires" 
with cytochrome C3 modules. The crosslinking functional groups are bismaleimide 
derivatives and the cysteine thiol. Construction strategies involve electrostatic 
selection by controlling the surface charge distribution to regulate protein 
crosslinking, and the use of protein-peptide recognition (i.e. Calmoduim and its 
binding peptide) to block/protect the crosslinking sites. Another aim of this project is 
to exploit the electrochemical properties of cytochrome c3 by covalently attaching it to 
cytochrome P450 BM3 heme domain and electrodes to form unique bioelectronic 
components, which could facilitate electron transfer between enzymes and electrodes. 
In order to utilize the cytochrome c3 for protein conjugation, three cysteine mutants 
(K40C, S107C, and K40C:S107C) were constructed, successfully expressed in 
Shewanella oneidensis MR-1, purified and characterized by fluorescent labelling and 
thiol counting. Protein crosslinking was performed with a bismaleimide crosslinker, 
1 ,8-bis-Maleimidodiethyleneglycol (BM(PEO) 2) on the cysteine mutants to produce 
cytochrome c3 dimers and polymers. The homodimer formation showed that S107C 
was more efficient in forming homodimers than K40C probably because it is at the 
flexible and exposed C terminus of the protein. The K40C and SI07C heterodimer 
(yield: 25 %) was generated upon the production of a bismaleimide-modified 
S1 07C intermediate. The two-step reaction shows that protein ligation can be 
performed in a controllable multi-step way. Two methods were used for polymer 
production: disulfide crosslinking and bismaleimide crosslinking. The polymers 
generated through disulfide crosslinking were cleavable whereas bismaleimide 
crosslinked polymers are stable in a reducing environment. Both gave a high degree 
of polymerization yielding up to the 1 2mer at least for disulfide crosslinking and up to 
V 
the 8mer at least for bismaleimide crosslinking. The chemical nature of heme groups 
in the cytochrome C3 modules remained unchanged before and after polymerization. 
OTTLE potential titration shows that the polymerisation of the cytochrome C3 
modules leads to a reduction potential shift towards the negative from - 304 mV (wild 
type) to -336 mV (disulfide-linked cytochrome C3 polymers) and -388 mV 
(bismaleimide-linked cytochrome C3 polymers). A possible reason is that the 
interaction among hemes in the cytochrome C3 modules makes the polymer more 
difficult to reduce. 
The affinity tags: Calinodulin Binding Peptide (CBP) and Strep Tag II, were are 
exploited to control the protein ligation. The cytochrome c3 mutants tagged with CBP 
did not bind to the Calmodulin (CaM) affinity resin during purification. Possible 
reasons might be that the linker between protein and CBP was not long enough or that 
the CBP was partly proteolysed during expression. A K40C cytochrome C3 with a 
"New Strep Tag" containing a cysteine (nstK40C) was constructed, expressed and 
purified. Strep-Tactin was used to block the cysteine in New Strep Tag of nstK40C 
cytochromes C3 allowing the cysteine 40 to react, in order to control the ligation 
process. A controlled protein ligation strategy was successfully developed and a short 
wire was generated using three different cytochrome C3 modules in spite of low yield. 
Cytochrome C3 was crosslinked to P450 close to its active site heme. The heme of 
P450 had a similar environment to the heme of wild type P450. P450 heme domain 
could not be reduced directly by the electrode due to its buried active site and it was 
slowly reduced by cytochrome C3 
(S-' 10 hours). However, there was no electron 
transfer observed under the same condition for the conjugate of cytochrome C3 and 
P450 BM3 heme domain. Probably the cytochrome c3 was not crosslinked to the right 
position of P450 BM3 close enough to the P450 BM3 heme. 
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Abbreviations and units 
A. Amino Acids 
Amino acid Three letter code One letter code 
Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic acid Asp D 
Cysteine Cys C 
Glutamic acid Glu E 
Glutamine Gin Q 
Glycine Gly G 
Histidine His H 
Isoleucine lie I 
Leucine Leu L 
Lysine Lys K 
Methionine Met M 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr T 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine Val V 
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Standard units 
M meter °C degree Celsius 
g gram K degree Kelvin 
S second 1 litre 
V volt M molar 
A Angstrom Da Daltons 
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CBP: Calmodulin binding peptide 
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CYP: Cytochrome P450 
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DTT: Dithiothreitol 
EDC: 1 -Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
EDTA: Ethylene diamine tetraacetic acid 
EGTA: Ethylene glycol tetraacetic acid 
F5M: Fluorescin-5-maleimide 
FAD: Flavin adenine dinucleotide 
FMN: Flavin mononucleotide 
FNR: FAD-dependent ferredoxin reductase 
FPLC: Fast protein liquid chromatography 
Frd: Fumarate reductase 
GST: Glutathione S-transferase 
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HMC: High-molecular-weight cytochrome c 
MBP: Maltose binding peptide 
MOPS: 3-(N-morpholino)-propanesulfonic acid 
MV: Methyl viologen 
NADH: Nicotinamide adenine dinucleotide 
NADPH: Nicotmamide adenine dmucleotide phosphate 
NilE: Normal hydrogen electrode 
NHS: N-Hydroxysuccinimide 
OTTLE: Optically transparent thin layer electrode 
PAGE: Polyacrylamide gel electrophoresis 
PEG: Polyethylene glycol 
PCR: Polymerase chain reaction 
PDB: Protein data bank 
2-PDS: 2,2'-Dipyridyl disulfide 
PMSF: Phenylmethylsulphonyl fluoride 
SBP: Streptavidin binding peptide 
SDS: Sodium dodecyl sulphate 
SHE: Standard hydrogen electrode 
TCEP: Tns(2-carboxyethyl) phosphme hydrochloride 
TMBZ: 3,3 '5,5 '-tetramethylbenzidine 
TNB: Thio-2-nitrobenzoic acid 
Tris: 2-Amino-2-hydroxymethyl-propane- 1,3-diol 
TSS: Transformation and storage solution 




Acknowledgments 	 IV 
Abstract 	 V 
Abbreviations and units 	 VII 
Chapter 1: Introduction I 
1.1 Electron Transfer in Biology 2 
1.2 Electron Tunnelling 3 
1.3 Marcus Theory 4 
1.4 Biological Electron Transfer Models 8 
1.5 Electical Wiring of Redox Enzymes 9 
1.6 Biological Redox Centres, Electron Relay Units 10 
1.6.1 Herne 11 
1.6.2 Iron-Sulfur Centres 12 
1.6.3 Flavin 13 
1.6.4 Ubiqumone and Menaqumone 15 
1.7 Cytochromes 16 
1.7.1 Cytochromes c 16 
1.7.1.1 Tetraheme cytochrome C3 from Desulfovibrio vulgaris Miyazaki F 17 
1.7.2 Cytochrome P450 18 
1.8 Bioconjugation Techniques 24 
1.8.1 Bioconjugate-active groups 25 
1.8.2 Crosslinkers for bioconjugation 33 
1.9 Protein Tag 34 
1.9.1 Calmodulin and Calmodulin Binding Peptide (CBP) 37 
1.9.2 Streptavidin and Streptavidin Binding Peptide (SBP) 38 
1.10 Aims of Project 39 
x 
Chapter 2: Materials and methods 
	
45 
2.1 Bacterial plasmids and strains 46 
2.2 Growth media and antibiotics 47 
2.3 Genetic manipulation 49 
2.3.1 Primers and plasmids 49 
2.3.2 Point mutagenesis for production of 
K40C, S1O7C, K40C:SI07C cytochromes C3 52 
2.3.3 Overlap PCR for tagging calmodulin binding 
peptide (CBP) to K40C : Si 07C cytochromes C3 58 
2.3.4 Overlap PCR for tagging Strep Tag II to 
K40C:S 107C cytochromes C3 65 
2.3.5 Point mutagenesis for production of K40C and 
wild type cytochromes C3 with New Strep Tags 68 
2.3.6 Long oligonuleotide insertion for the attachment of 
His6 tags to K40Cand wild type cytochromes C3 70 
2.3.7 Point mutagenesis for production of K40C 
cytochromes C3 with a Strep Tag II 72 
2.3.8 Site-directed mutagenesis for production of P450 
BM3 heme domain mutants 72 
2.4 Transformation of plasmids into Shewanella oneidensis MR-1 75 
2.4.1 Chemical transformation of plasmids into 
Shewanella oneidensis MR-i 75 
2.4.2 Electrical transformation of plasmids into 
Shewanella oneidensis MR-i 76 
2.4.2.1 Preparation of electro-competent cells of 
Shewanella oneidensis 76 
2.4.2.2 Electrotransformation of plasmids into 
Shewanella oneidensis competent cells 77 
2.5 Protein Expression 77 
2.5.1 The expression of all cytochrome C3 mutants 
in Shewane/la oneidensis MR-i 77 
Xl 
2.5.2 The expression of cytochrome P450 
BM3 heme domain mutants 78 
2.6 Protein Purification 78 
2.6.1 The purification of cytochrome C3 cysteines mutants 78 
2.6.2 The purification of cytochrome C3 mutants with 
Calmodulin binding peptide (CBP) 80 
2.6.3 The purification of cytochrome C3 mutants with 
Strep Tag II or New Strep Tag 82 
2.6.4 The purification of cytochrome P450 BM3 heme domain mutants 83 
2.7 Determination of Protein purity and 
Concentration 85 
2.7.1 Sodium dodecyl sulphate polyacrylamide 
gel electrophoresis (SDS-PAGE) 85 
2.7.2 UV/Vis spectrophotometry 87 
2.8 Thiol Counting 88 
2.9 Fluorescent Labelling of Cysteine on the protein 90 
2.10 Substrate binding to the P450 BM3 heme domain mutant 91 
2.11 Chemical Crosslinking 92 
2.11.1 Homodimers of K40C and Si 07C cytochrome C3 92 
2.11.2 Heterodimer of K40C and Si 07C cytochrome C3 93 
2.11.3 Polymers of K40C: Si 07C cytochrome C3 93 
2.11 .3.1 Polymers formed by disulfide bonding 93 
2.11.3.2 Polymers formed by bismaleimide crosslinking 94 
2.11.4 Heterotrimer of cytochrome C3 modules 94 
2.11.5 Heterodimer of cytochrome C3 and the heme domain of P450 BM3 96 
2.12 Analysis of crosslinking products by 
Fast Protein Liquid Chromatography (FPLC) 96 
2.13 OTTLE Potentiometric Titrations 97 
2.14 OTTLE-driven electron transfer 101 
Chapter 3: Untagged cytochrome c3 cysteine mutants 103 
XII 
3.1 Introduction 104 
3.2 Basic characterization of untagged 
cytochrome c3 cysteine mutants 106 
3.2.1 Protein purities and UV-Vis absorption spectra 106 
3.2.2 Fluorescent labelling of the cysteine thiol 107 
3.2.3 Thiol counting 108 
3.3 Crosslinking of untagged cytochrome c3cysteine mutants 110 
3.3.1 Homodimers of cytochome C3 modules: 
K40C-K40C and S1O7C-S1O7C 110 
3.3.2 Heterodimer formation 112 
3.3.3 Polymerising cytochrome C3 modules 114 
3.4 Conclusions 121 
Chapter 4: Using affinity tags to control protein conjugation 123 
4.1 Introduction 124 
4.2 Calmodulin binding peptide (CBP) tagged cytochrome C3 124 
4.3 Tagging cytochrome C3 with Strep Tag II 126 
4.4 Tagging cytochrome C3 with New Strep Tag 128 
4.5 Conclusions 135 
Chapter 5: The conjugation of cytochrome c3 and 
P450 BM3 heme domain 136 
5.1 Introduction 137 
5.2 Protein purification and basic characterization 139 
5.3 Substrate binding of the mutants of P450 BM3 heme domain 143 
5.4 Conjugation of the P450 BM3 and cytochrome C3 mutants 144 
5.5 OTTLE driven electron transfer between 
cytochrome C3 and P450 heme domain mutant 149 
5.6 Conclusions 153 
Chapter 6: Conclusions and future work 	 155 
Chapter 7: References 	 159 
Appendices 	 168 
XIII 
Cvtochmnie c3 modules as electron transfer nanowires 
Chapter 1 
Introduction 
1.1 Electron Transfer in Biology 
Electron transfers without chemical bond formation or breakage are fundamentally 
important in biological systems, such as the systems of respiration, and 
photosynthesis (Fig. 1.1). Both systems involve redox centres, strategically placed 
between initial donor and final acceptor, transporting electrons to the required site 
forming 'biological currents'. Most redox centres contain transition metals, although 
flavins, quinones and other organic species also facilitate electron transfers. 
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Figure 1.1: photoreaction center of the purple bacterium Rhodopseudomonas viridis, 
(PDB entry: JPRC). Panel a: the system has four components: three subunits, H, M, 
and L (cyan, yellow, and purple, respectively), and a fourth protein, cytochrome c 
(green) associated with complex at the membrane surface. Panel b: shown as stick-
and-ball models are the prosthetic groups that participate in the photochemical 
events. Shown at the top of the figure are four heme groups (red) of c-type cytochrome 
associated with the reaction center. Bound to the L and M chains are two pairs of 
bacteriochiorophyll molecules (green); one of the pairs (the "special pair," (Chl) 2) is 
the site of thefirst photochemical changes after light absorption. Also incorporated in 
the system is a pair of bactriopheophytin molecules (blue); two quinones, 
menaquinone (QA)  and ubiquinone (QB)  (yellow and orange), and a single nonheme 
Fe (red) located in the center between the quinones. The excited special pair passes 
an electron to bacteriopheophytin, from which the electron moves rapidly to the 
tightly bound menaquinone, QA.  This quinone passes electrons much more slowly to 
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the diffusible ubiquinone, QB,  through the nonheme Fe. Meanwhile, the "electron 
hole" in the special pair is filled by an electron from a heme of cytochrome c. 
The rate of electron transfer decreases exponentially with the distance between redox 
centres. However, it has been shown that biological electron transfer is productive 
within 14 A, which is still fast enough to enable substrate binding and chemical bond 
formation or breakage without being the rate-limiting step in a catalytic cycle [1]. 
Naturally, most of the distances between redox centers are limited to less than about 
14 A and chains of redox centers are exploited to relay electrons over a long distance. 
1.2 Electron Tunnelling 
In the quantum mechanics, the behavior of an electron is described as a wave 
function. All wave equations exhibit evanescent wave coupling effects in the right 
conditions regardless of the existence of the energy barrier. It means that, if the wave 
of an electron on the donor can reach the acceptor penetrating far enough through the 
energy barrier, the electron will transfer from the donor to the acceptor. Electrons 
penetrating the narrow potential energy well between the donor and the acceptor, is 
defined as "electron tunnelling" [2]. In contrast with the classical transition state 
theory, thermal energy (generated by the collision of the reactants) is required to 
overcome the energetic barrier. 
The coupling of donor and acceptor in an electron transfer reaction is only dependent 
upon the distance between them: 
-r 
(Eq. 1.1) 
where HAB  represents the electronic coupling factor between the reactants (A and B) 
and r the distance between them. 
The electron is potentially able to oscillate in the donor and acceptor coupling system. 
The resonance vibration depends on the distance (r) and on the relative energy of the 
wells of the donor/acceptor couple. In a biological system, donor and acceptor will 
have different energy states, enough to break the resonance state and allow the 
electron transfer to progress to completion. The whole system must satisfy both the 
Franck-Condon and energy conservation principles [3,4]. The Franck-Condon 
3 
principle is the approximation that an electronic transition is most likely to occur 
without changes in the positions of the nuclei in the molecular entity and its 
environment. 
1.3 Marcus Theory and Electron Transfer Rate 
Marcus and co-workers, taking the Franck-Condon and energy conservation 
principles into consideration, developed a convenient model to describe the electron 
transfer reactions both in classical and quantum mechanistic terms [5,6]. 
Considering a simple example of an electron transfer reaction, 
e 
Reactant (R) 	Product (P) 
the energy configurations (E) of both reactant and product can be represented by a 
parabola plotted against the reaction coordinate (r) (Fig. 1.2). Both the profiles of 
reactant and product indicate ground states with minimum energy configuration. To 
transfer the electron, the reactant needs to be activated to the transition state, the 
intersection of the two parabolic curves, where the nuclear configurations are 
isoenergetic (ER = Ep). Then, the energy of the reaction system goes along the curve 
of product to the lowest point, forming the stable product. The difference between the 
ground states of reactant and product is defined as the total Gibbs free energy change 
(AG) of the electron-transfer reaction,, representing the driving force for the reaction. 
The activation energy (AG+)  describes the energy required to push the reactant to the 
energy level at the intersection of the two potential energy surfaces. The 
reorganization energy (X) is also introduced as the energy required for all geometrical 
adjustments (nuclear configuration change) from reactant to product without 
transferring an electron. 
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Figure 1.2: plot of the potential energy (E) against nuclear coordinates (r). The blue 
parabola curve shows the energy configuration of the reactant while the black curve 
shows the energy configuration of the product. A, the reorganization energy, AG*,  the 
activation energy; AG, the free energy 
Marcus theory provides a relationship between the activation energy (AG'), the 





In quantum theory interpretation of electron transfer, the energy potential curves are 
simple harmonic oscillators, where only some energy levels are permitted: these 
levels correspond to the frequency of the oscillator (E=hw). In this case the transfer 
depends upon the overlap of the harmonic oscillator wave functions of the two 
reactants. 
In the adiabatic case, the rate of electron transfer reaction is related to the activation 
energy (AG') according to the equation: 
5 
kET =K exp (AG+/ kBT) 
	
(Eq. 1.3) 
where kET represents the observed electron-transfer rate, K is the electron-transfer rate 
when AGO is zero (maximum rate of electron transfer), kB is the Boltzmann constant 
and T is the absolute temperature. 
Combining Eqs. 1.2 & 1.3, it would give 




a.X>AG 	b.A=AG 	c. A 
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Nuclear coordinates (r) 
Figure 1.3: plots of the nuclear potential energy vs. nuclear coordinates. The blue 
parabola curve shows the energy state of the reactant while the black curve shows 
energy state of the product. Three groups of parabola curves represent: (a) normal 
case of electron transfer; (b) activationless case of electron transfer; (c) inverted case 
of electron transfer. A, the reorganization energy; AG, the free energy 






Normal region (Fig 1.3a): when AG + X > 0, which means ?. > —AG; 
Activationless region (Fig 1.3b): when AG + X = 0, which means X = —AG, 
and kEr = K. The reaction reaches the maximum rate without activation 
energy; 
Inverted region (Fig 1.3c): when AG + ?. < 0, which means ?. <—AG 
The driving force (AG) varies in reverse direction of the change of electron 
transfer rate. 
The relationship of the logarithm of electron-transfer rate (in kir)  and reaction driving 
force (AG) is illustrated in Fig. 1.4. As the driving force (AG) increases, kET keeps 
going up until it reaches a summit (- AG = ?.), and then comes down (-AG >?.). 
X 	 AG 
Figure 1.4: plot of In kET against reaction's driving force (AG). 
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In the quantized view the dependence upon temperature (T) of the electron-transfer 
rate in Eq. 1.4 is not allowed and T is replaced by the quantum energy of the 
oscillator, E = hw. 
Other factors that affect electron transfer are not only the distance between the donor-
acceptor pair, but also the intervening medium, that contributes to propagating the 
electron transfer. The electron-transfer rate is dependent on the intervening medium 
and the distance between the donor and acceptor according to the equation below. 
K oc e 
	
(Eq. 1.5) 
where P is the coefficient that describes the decay through the medium and r is the 
travelling distance of the electron. 
To summarize the above equations, a new equation is given below. 
kET 	e 
-1 / zr exp(-(AG+) 2 / (4 ?.kBT)) 	 (Eq. 1.6) 
The Eq. 1.6 indicates that electron-transfer rates are determined by two major factors: 
the thermodynamic oscillation that bring the reactant and the product to their 
isoenergetic states and the probability of electron tunnelling between isoenergetic 
states. The thermodynamic oscillation depends on the contribution of the macroscopic 
environment to the reaction system. The electron tunnelling probability involves the 
chemical and structural properties of the donor-acceptor pair [7-10]. 
1.4 Biological Electron Transfer Models 
Two major theory models have been developed to explain biological electron transfer 
through redox proteins: 
1) The through-space theory model describes the one step electron transfer in 
terms of direct orbital overlap between the donor and acceptor sites regardless 
the network of chemical bonds. As the result of this mechanism, there is only 
Cvtochrome c3 modules as electron transfer nanowires 
one single P value, averaged over the entire pathway. 
2) The through-bond theory model considers that the electrons are tunnelled 
along the routes composed of covalent bonds or hydrogen bonds between 
donor and acceptor sites. The P values vary with different specific routes. 
In biological systems the value of the decay coefficient () is about 1.4 ± 0.2 A' for 
protein, which is much lower than for a complete vacuum space ( P = 2.8 - 3.5 A 1 ) 
[11-12], indicating that the polypeptide chain clearly facilitates electron transfer 
among the redox centres. This is the common ground of the two theory models, 
although there are many arguments with experimental evidence between them [9, 13-
14]. 
Dutton and co-workers [1,11] proposed average values of reorganization energy 
(?. 0.7 eV, intra-protein electron transfer; 1.0 eV, inter-protein electron transfer) and 
decay coefficient (fE 1.4 A-1 ) and calculate the electron transfer rates of various 
redox proteins with the edge-to-edge distances (r) obtained from their crystal 
structures. They find that electron transfer reactions are productive in biological 
systems when the distances between redox centres are within 14 A. 
Gray and co-workers exploited metal-labelling techniques [7] to study electron 
transfer within biological systems. Upon attaching the ruthenium to proteins, such as 
cytochrome c, cytochrome b562, myoglobins and iron proteins [15], the modified 
proteins were exposed to laser light and the electron transfer between ruthenium and 
redox centers investigated in detail. The light-driven electron transfers at differing 
distances between ruthenium and the redox center indicate that the rate and coupling 
correlate with the length of the tunneling pathways that are comprised of covalent 
bonds, hydrogen-bonds and through-space jumps. 
1.5 Electrical Wiring of Redox Enzymes 
The electrical wiring of redox enzymes is of great interest in bioelectronics and it 
leads to develop biosensors and bioreactores like biofuel cells. However, the direct 
electron tunnelling from redox proteins to electrodes is usually difficult, as the 
insulative polypeptide shells of the enzymes separate their internal redox center from 
9 
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the conductive surfaces [16]. Many redox mediators like quinones and its derivatives 
[17-24], viologens [25-29], hexacyano-metal complexes [30-34], ferrocene-devatives 
[35], are utilised to facilitate the electron transfer between redox proteins and 
electrodes. These electron transfers are controlled by the free diffusion of mediators. 
The immobilizations of redox proteins on the electcrodes are developed to enhance 
the electronic communication of them. Small organic molecules can be used to anchor 
and electronically connect redox proteins to electordes [16, 36-38]. Whiner and his 
co-workers reconstitute redox enzymes on the electron relay units' monolayers on the 
electrodes. The electron relay units include pyrroloquinoline-quinone [ 39], 
nanopaticles [40] and nanotubes [41]. The electron relay units and well-defined 
alignment and orientation of redox proteins towards electrodes hugely improve their 
electronic interactions. Self-assembled films [42-43] and electron-conducting redox 
hydrogels [44] are also involved in the entrapment or attachment of biomolecules onto 
the electrodes' surfaces. They electrically connect enzymes' reaction centers to 
electrodes regardless of the spatial orientation of enzymes at the electrode surface and 
also connect multiple enzyme layers. In addition, metallized peptides [45] and small 
electron transportation proteins like cytochrome c [46] and flavodoxin [47-49] can be 
employed to wire redox enzymes, which enable the electrons to hop through the small 
peptides or proteins. 
1.6 Biological Redox Centres, Electron Relay Units 
Since the distance of productive biological electron transfer is within 14 A, nature has 
evolved a large number of redox centers strategically placed over long distances in the 
biological systems to relay electrons from initial donor to final acceptor. Commonly, 
there are two groups of redox active species used as electron transfer cofactors in a 
protein matrix. Inorganic metal complexes like heme groups and iron-sulfur clusters 
contain metal centers with multiple redox states, and they can shorten the electron 
transfer distances (r ee  < reenter-to-center). Organic molecules such as flavins and 
quinones have delocalized it-bonding systems. 
10 
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1.6.1 Heme 
Hemes consist of a porphyrin macrocycle with an iron atom coordinating four ring 
nitrogen atoms in the centre. They have several common representations (Fig. 1.5). 
FW 
hemo 	 heme!' 
Figure 1.5: hemes commonh'fou,zd in biological systems 
Heme-a is found in cytochrome c oxidase. Compared with that of Heme-b, the 
structure of heme-a shows that a methyl side chain of the porphyrin ring is changed 
into a formyl group, and one of the vinyl side chains is replaced by an isoprenoid 
chain. 
Heme-b, also termed protoheme IX, is the most abundant heme, found in hemoglobin, 
myoglobin, b-type cytochromes and the cytochromes P-450. Heme-b is not covalently 
bound to the protein in which it is contained. 
Heme-c is the prosthetic group of c-type cytochromes. These are usually electron 
transfer proteins. Heme-c is covalently linked to the protein via two thioether linkages 
between cysteine residues on the protein and vinyl groups at positions 2 and 4 of the 
porphyrin ring, which therefore differs from heme-b. 
According to the coordination chemistry of iron, it is able to form two additional 
coordinating bonds, on either side of the heme plane. These two coordinating sites are 
called the fifth and sixth coordination positions. The iron centres in the electron 
transfer hemoproteins, which require minimal structural change, are commonly hexa- 
11 	 1 IL/ 
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coordinate and low spin. In contrast, hemoproteins that are involved in catalytic 
reactions or oxygen transportation require an available coordination site at the heme 
iron. Therefore the iron centres are usually penta-coordinate and high spin. 
Three oxidation states of iron can be found in biological systems. Those are the 
ferrous (+2) oxidation state, the ferric (+3) oxidation state, and ferryl (+4) as 
postulated in the cytochromes P450. The coordination and oxidation state of the iron 
play essential roles in the hemoproteins. 
1.6.2 Iron-Sulfur Centres 
Besides hetne groups, iron-sulfur (Fe-S) clusters are another category of iron-
containing cofactors found in the redox active proteins. The coordination chemistry of 
iron atoms in the Fe-S clusters is mainly in tetrahedral arrangements, different from 
that in the hemes. Three common kinds of Fe-S clusters are discussed below. 
The simplest Fe-S cluster is the rubredoxin center, where the sulfur atoms provided by 
four cysteine residues are tetrahedrally coordinated to only a single iron atom (Fig. 
1.6a). [2Fe-2S] clusters, are constituted by two iron ions bridged by two sulfur atoms 
and coordinated by the suifflydryl groups of four cysteines (in Fe 2S2 ferredoxins, Fig. 
1.6b) or by the sulihydryl groups of two cysteines and the imidazole groups of two 
histidines (in Rieske proteins). The oxidized state of an [2Fe-2S] cluster is Fe(III)-
Fe(llI), whereas the reduced state is Fe(III)-Fe(II). The "saturated" Fe-S cluster is the 
[4Fe-4S] motif found in Fe 4S4 ferredoxins. Four iron and sulfur atoms spatially 
occupy the corners of a cube and four cysteine resides are tetrahedrally coordinated to 
the [4Fe-4S] cube (Fig. 1.6c). The oxidation states range from 3Fe(Ill)-Fe(I1), 
2Fe(III)-2Fe(1I) to Fe(1I1)-3Fe(II). 
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/CYS 
\\S, 	
S - Cys 
Cys - 	
Cys 	 S - Cys 
C ys 
a. FC(S( ). S )4 	 b. 1FC , S](Scys)4 
S 	F'1IItS-Cvs 
c. [Fe4 S 4](Sc5 )4 
Figure 1.6: common examples of iron sulphur clusters in biological systems. 
1.6.3 Flavin 
Flavins are a group of organic compounds containing an isoalloxazine ring. In 
biological systems, flavin-containing species are always found as riboflavin, Flavin 
Adenine Dinucleotide (FAD) or Flavin MonoNucleotide (FMN) (Fig. 1.7). 
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Figure 1.7: the structures of the oxidized Jbrms of FAD (entire molecule) and FMN 
(orange portion of molecule). 
The isoalloxazine ring is the redox active motif and it utilises two oxidation states 
during electron transportation. The oxidation states are commonly known as 
flavoquinone (fully oxidized), flavosemiquinone (half-reduced) and 
flavohydroquinone (fully reduced) (Fig. 1.8). 
p 
I 	 I 	I 
- IIIIIzIIIiI:I1y - 
II 	It 
Figure 1.8: three different redox states of isoalloxazine motif: fully oxidized 
(quinone), one-electron reduced (flavosemiquinone) and two-electron reduced 
(hydroquinone). 







Cytochrome c 3 modules as electron transfer nanowires 
1.6.4 Ubiquinone and Menaquinone 
Ubiquinone and menaquinone are both hydrophobic benzoquinone derivatives with 
large isoprenoid tails. Ubiquinone (Fig. 1.9A), also termed coenzyme Q, is an oil-
soluble vitamin-like substance primarily present in the mitochondria of most 
eukaryotic cells. It is an essential component of the aerobic respiratory chain that 
generates energy in the form of Adenosine TriPhosphate (ATP). Menaquinone (Fig. 
1.9C), commonly known as vitamin K2, is produced by bacteria in the intestines and 
plays an important role in blood coagulation. Upon accepting a single electron, 
quinone, the core of ubiquinone/menaquinone, is reduced to semiquinone. 
Semiquinone is able to convert to quinol by one electron's further reduction. 
C 	 I) 
Figure 1.9: structures of the quinone/quinol groups. Panel A: Ubiquinone; Panel B: 
Ubiquinol; Panel C: Menaquinone; Panel D: Menaquinol. Usually n = 10 for 
ubiquinone/ubiquinol whereas n = 6for menaquinone/menaquinol. 
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1.7 Cytochromes 
1.7.1 Cytochromes c 
Cytochromes c are proteins that link one or more heme c moieties via two thioether 
linkages between cysteine residues on the protein and vinyl groups on the porphyrin 
ring. The characteristic heme-attachment sequence motif is either -Cys-Xaa-Xaa-Cys-
His- or -Cys-Xaa-Xaa-Xaa-Xaa-Cys-His- (where Xaa is any amino acid). 
Cytochromes c are crudely divided into six classes, depending on the number of 
hemes, the properties of the axial iron ligands, and the redox potential [50-51]. 
Class I includes the classical soluble cytochromes c of mitochondria, the main role of 
which is to transfer electrons between coenzyme Q-cytochrorne c oxidoreductase and 
cytochrome c oxidase. The heme-attachment site is towards the N-terminus. Usually 
the fifth ligand of a c-type heme is a histidine residue and the sixth ligand is a 
methionine residue about forty residues further on towards the C-terminus. Most class 
I cytochromes c are similar in their three-dimensional structures. 
Class II includes the high spin cytochromes c' and various low-spin cytochromes with 
histidine residues as the fifth ligands of c-type hemes. The heme-attachment site is 
close to the C-terminus. In the low-spin proteins the sixth ligand is likely to be a 
methionine residue close to the N-terminus, and in the high-spin proteins there is no 
ligand in the sixth coordination position. The three-dimensional structures of class II 
cytochrome c is completely different from the others with the proteins folding as a 
cluster of four a-helices. 
Class HI comprises the low redox potential multiheme cytochromes: cytochrome c3 , 
cytochrome c7 and high-molecular-weight cytochrome c (HMC), with only around 
thirty amino acids per heme. All the c-type hemes are bis-histidine ligated. 
Class IV consists of complex proteins that have other prosthetic groups as well as 
heme c, such as flavocytochromes c. 
Class V includes several recently characterized cytochromes c sharing similarities in 
the heme arranement. Such an arrangement is thought to be relevant for the type of 
electron-transfer processes, in which all of the proteins belonging to this group are 
involved. These cytochromes c includes cytochrome cj and cytochrome f which 
function as electron carriers in photosynthetic process, hydroxylamine oxidoreductase 
((HAO) which contains eight covalently bound hemes [52]), and the tetraheme C554 
from Nitrosomonas europaea, pentaheme cytochrome C552 from Sulfurospirillum 
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deleyianum; and the flavocytochrome c3 fumarate reductase from Shewanella species 
[53]. 
Several cytochromes c cannot be assigned to any of the above groups. They are the 
decaheme cytochromes c from Shewanella oneidensis [54], and the diheme 
cytochromes c from Pseudomonas aeruginosa [55], Rhodobacter sphaeroides [56] 
and Rhodobacrer adriaticum [57]. 
1.7.1.1 Tetraheme cytochrome C3 from Desulfovibrio vulgaris Miyazaki F 
The tetraheme cytochrome c3 (cyt c3), which is found in the bacterium Desulfovibrio 
vulgaris Miyazaki F, is involved in sulfate-reduction [58]. This cyt C3 contains four 
hemes covalently bound to a single polypeptide of only 107 amino acids (Fig. 1.10), 
with a size of 14 kDa. In the fifth and sixth coordination positions, the ligands of the 
four hemes are histidines. 
Figure 1.10: three dimensional c?ystal structure of globular cytochrome c3from 
Desulfovibrio vulgaris Miyazaki F (hemes in red, ligating histidines in magenta and protein 
backbone in green, alpha helix in orange, and beta sheets in blue, PDB entry: IJOO) 
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The hemes of cyt C3 have a much greater exposure to solvent than does the single 
heme group of the mitochondrial cytochromes c [59]. The macroscopic reduction 
potentials range from -240 to -357 mV versus the normal hydrogen electrode (NHE) 
[60]. Compared with the reduction potentials of '/202/H20 (+0.815 V) and bacterial 
ferredoxins (-0.432 V) [61], the reduction potentials of the four cyt c3 heme groups 
are very low. The surface of this cyt C3 is highly positively charged. Cytochrome C3 
can interact with an electrode without the presence of any electron transfer mediators 
[62]. The oxidation/reduction of cyt C3 solution by the electrode is reversible and 
diffusion controlled [63]. Even in solid state, cyt c3 demonstrates good electrical 
conductivity [64]. 
An overexpression system for Desuljovibrio vulgaris Miyazaki F cyt C3 was generated 
using Shewanella oneidensis MR-i [65], which is a facultative anaerobe that can be 
grown easily and rapidly, and produce plentiful multiherne cytochromes. This system 
was the basis for much of the work presented in this thesis. 
1.7.2 Cytochrome P450 
The cytochromes P450 (CYP or P450) are a huge and diverse superfamily of heme-
containing proteins present in bacteria, fungi, insects, plants, animals, and humans. 
These colored P450s show very high affinity for carbon monoxide (CO) in their 
reduced states, forming characteristic Soret peaks at 450 nrn. It is also the reason the 
family of proteins are named P450 (Pigment at 450 rim). Usually, P450s all contain a 
b-type heme axially coordinated by the side chain of a conserved cysteine residue, 
leaving another axial coordination position free for catalysis. 
Commonly the typical catalysis reaction of P450s is monooxygenation, which can be 
illustrated simply below: 
RH + 02 + 2H + 2e- 	ROH + H20 
The monooxygenation catalysed by P450s is the insertion of an oxygen atom derived 
from molecular oxygen into an organic substrate (RH), while consuming two 
electrons from an electron transport chain and two protons from the environment. The 
substrates of P450s have a broad range, from small molecules (nitric oxide) [66], long 
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chain fatty acids (arachidonate) [67], to macro rings (epithilone) [68]. The 
oxygenation of organic substrates increases their hydrophilicity, making them much 
more easily excreted by the biological systems. 
P450s activate molecular oxygen (triplet state) in order for it to react with an organic 
substrate (singlet state). Molecular oxygen binding to iron produces highly reactive 
species like the peroxy-ferric (Fe(IH)-00 2 ), hydroperoxy-ferric (Fe(III)-00H) and 
ferryl (Fe(IV)=O) complexes [69]. A schematic showing the P450 catalytic cycle is 
shown in Fig. 1.11. 
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Figure 1.11.' P450 catalytic cycle depicting 1. substrate binding, 2: first electron transfer, 3: 
Oxygen binding, 4: second-electron transfer, 5: formation of oxy-ferryl  species, 617: rebound 
19 
Cvtochrome C? modules as electron transfi'r nanowires 
mechanism for oxygen insertion and 8: product dissociation. The 1, 2 and 4 electron 
uncoupling pathways to superoxide, peroxide and water are shown as dotted lines. 
The catalytic centers (hemes) of P450s are not stand-alone and they need the support 
of electron transfer cofactors to achieve the goal of catalysis. Hence the heme 
domains of P450s and their supporting parts form multi-component electron transfer 
chains, generally called P450 containing systems. The systems mainly can be 
classified into two groups: 
Class I P450s (Fig. 1.12A), commonly found in bacteria [70], are composed of 
three proteins: FAD-dependent ferredoxin reductase (FNR), ferredoxin 
(containing an 2Fe-2S cluster), and a P450. The FNR acquires two electrons 
from NADH and transfers them sequentially to the P450 via a 2Fe-2S cluster 
(ferredoxin). 
Class II P450s (Fig. 1.12B), are associated with the endoplasmic reticulum in 
eukaryotes, and consist of two enzymes: an FAD and FMIN-containing 
reductase and a P450 [71-72]. Compared with class I P450s, the 2Fe-2S 
cluster is replaced by an FMN cofactor and the FAD and FMIN are organised 
together by a single polypeptide. The cytochrome P450 reductase (CPR) 
facilitates electron transfer from NADPH to the P450 heme. 
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Fig 1.12: representation of the diverse classes of cytochromes P450. P450s or its 
heme domains are represented in red and other proteins or components in yellow 
(FAD-containing proteins/domains), green (FMN-containing proteins/domains) 
and blue (iron-sulfur -containing proteins/domains) . (A): class I system comprised 
of FNR, ferredoxin and P450. (B): class 11 system comprised of FAD/FAIN 
reductase and P450. (C): class III system formed by fused FAD/FMN reductase 
and P450. (D) and (E): other unique combinations of redox cofactors such as in 
P450 Rhf and P450 cm. 
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This classification system is suitable for most of the P450s. However, there are some 
examples excluded from the above system. The most famous one is flavocytochrome 
P450 BM3 from Bacillus megarerium (Fig. 1.12C, Fig. 1.13) [73]. It is a large soluble 
protein with only a single polypeptide involving FAD, FMIN, and heme together. 
From a structural point of view, P450 BM3 can be considered the fusion of an 
FAD/FMN domain and a heme domain from a class II P450 model. Flavocytochrome 
P450 BM3 has been studied intensively because of its easy expression in E.coli and as 
an ideal model for P450 systems without the recognition/binding of other components 
complicating the system. 
if 
40or- 
Figure 1.13: three dimensional crystal structure of cytochrome P450 BM3 from Bacillus 
megaterium (hemes in red, ligated cysteine in yellow and protein backbone in wheat, alpha 
helix in cyan, and beta sheets in magenta, PDB entry: 21J2) 
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Other examples with unusual redox cofactor arrangements include P450 Rhf (fusion 
of FM1N-2Fe2S-heme, Fig. 1.1 2D) [74-75], P450 cm (separated FAD, FMN and heme 
domains, Fig. I. 12E) [76-77] and P450 nor [78] gaining electrons directly from the 
environment without the any support of cofactors. 
In some cases, cytochromes P450 also receive electrons from cytochrome b5 [79] 
(Fig. 1.14), a 16.7-kDa electron transfer protein found in the endoplasmic reticulum of 
liver cells and in erythrocytes [80]. 
NADH 
cytochrome b5 - 	
Icytoc0me b51 red uctase 
NAD / 	'S 







cytochrorne P450 - 	 P450 IC reductase NADP R-OH 
Figure 1.14: electron transfer between cytochrome P450, cytochrome b5 and their reductases 
The presence of cytochrome b5 either stimulates, inhibits or has no effect on P450 
catalysis. The interaction between P450 and cytochrome b5 depends on the the P450 
isoform, the specific substrate and experimental condictions [81]. Some 
experiemental evidences showed that binding of cytochrome b5 to P450 causes 
structural influences [82-84]. In the presence of cytochrome b5, cytochrome P450 17 
can catalyse hydroxylation of pregnenolone to dehydroepiandrosterone; without 
cytochrome b5, the hydroxylation product of pregnenolone by P450 17 is cortisol. The 
cytochrome b5 regulation of hydroxylation of pregnenolone by cytochrome P450 17 
does not require electron transfer [83]. It is believed that cytochrome b5 induces a 
conformational change at the active site of P450 17 [85] 
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1.8 Bioconjugation Techniques 
Bioconjugation involves the covalent linking of two or more biomolecules to form a 
novel complex having the combined properties of its individual components [86]. 
Hence either natural proteins or synthetic polypeptides with unusual amino acids can 
be chemically crosslinked together to derive new conjugates that not only retain the 
original individual activities but also add newly designed properties. 
According to the targets of bioconjugation, the crosslinking methods can be crudely 
classified into three types: protein crosslinking, carbohydrate and glycan conjugation, 
and polynucleotide crosslinking [86]. The crosslinking of two proteins can be simply 
achieved by adding a homobifunctional reagent. The reagent will react with one of 
the proteins first forming a coupling-active intermediate, and then the activated 
protein will produce conjugates with another protein (ideal products) or create 
homodimers (side products). If there is more than one conjugation site on the protein, 
there is large probability of producing undesired polymeric conjugates that sometimes 
precipitate from the reaction solution. The progress of conjugation is necessary to 
control and crosslinking sites should be selected with high specificity. The 
carbohydrate and glycan conjugation strategies always involve a multi-step reaction 
sequence. The first step is to process the adjacent hydroxyl groups in the sugar 
residues of polysaccharides through mild sodium periodate oxidation to produce 
aldehyde groups. The aldehyde group is highly active towards amine or hydrazide 
containing compounds, forming a stable covalent linkage. If the second molecule has 
an amine or hydrazide group, the direct mixing of the oxidized intermediate and the 
second molecule in a reducing environment can produce the conjugate. Otherwise, it 
is necessary to introduce an amine or hydrazide group onto the second molecule 
before conjugation. The weakness of the carbohydrate conjugation is that the 
periodate oxidation always destroys the three-dimensional structures of 
polysaccharides. The polynucleotide crosslinking method is quite different from that 
with any other biomolecules. Without any interference from base pairing, conjugates 
can be formed at the 3'-end or 5'-end upon modification. 
1.8.1 Bioconj ugate-active groups 
Generally the reactive groups for bioconjugation involve natural amino acid residues 
like primary amines, sulffiydryl, carboxyl, hydroxyl, together with synthetic 
aldehyde/ketone, photochemically active groups, etc [86]. In relation to the aim of the 
project, the introduction of reactive groups will focus on the natural amino acid 
residues. 
1. 	Primary amine (-NH2) 
The amine group is up to now the most common reactive group for bioconjugation. 
Amine-involved conjugation could happen with most proteins due to the abundance 
of lysines and arginines within polypeptides. The reaction types for amine coupling 
are mainly acylation and alkylation. The coupling process is very fast and efficient at 
a suitable pH, where amine shows high nucleophilic activity, and produces a stable 
product like amide or secondary amine. Several amine-coupling reactions occur with 
commercially available regents such as N-hydroxysuccinimide (NHS) ester-amine 
reaction, imidoester-amine reaction and carbodiimide-amine reaction that are utilised 
in large number of bioconjugations. 
(1) 	N-hydroxysucciniinide (NHS) ester [87-88] 
An NHS (N-hydroxysuccinimide) ester can be created by the addition of NHS to the 
carboxylate in presence of a carbodiirnide. The NHS ester can react with a primary 
amine at physiological pH yielding an amide bond in the product. Hydroxyl group, 
sulfhydryl group, and imidazolyl ring of histidine will competitively react with the 
NHS ester. Their conjugates are unstable and easily hydrolyzed. 
0. 
c NOH 
Q NII: 	J"" J~" 
Scheme 1.1: the conjugation ofprimarv amine and N-/ivdroxvsuccinimide (NHS) ester 
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Imidoester [89-92] 
Imidoester crosslinks to a primary amine to form an amidine bond. The resulting 
amidine is protonated at physiological pH and bears a positive charge. Like NHS 
esters, imidoesters have high specificity for amine. 
Nil, 
II 3C-oII 
Q— NH , \ __"I/ 	
NH,- 
Scheme 1.2: the conjugation ofprimarv amine and imidoester 
Carbodiirnide [93-95] 
The carbodiimide is considered to be a zero-length crosslinker between carboxylate 
and primary amine. Zero length means that there are not any additional inter -
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Scheme 1.3: the conjugation of nucleophilic regents (primary amine, water, sulfo-
NHS ester) and carbodiimide activated carboxylate. 
In the progress of coupling, EDC reacts with a carboxyl group on biomolecule A 
forming a short-lived 0-acylisourea intermediate. This intermediate has a very high 
reactivity towards nucieophilic reagents. It can react with another biomolecule B 
containing a primary amine yielding a heterodimer, or is hydrolysed back to the 
27 
Cvtochroine c, ,i/uIc 'c '!c(trF? t,,,ivfc'r 'ian'nipre.c 
biomolecule A, or coupled to a soluble sulfo-NHS to become a stable amine-reactive 
NHS ester that may crosslink to biomolecule B. 
2. 	Sulfhydryl (-SH) 
As the functional group of the amino acid cysteine, the sulfhydryl or thiol group, 
plays an important role in biological systems. In the presence of oxidants, two 
cysteines' thiol groups, which are near each other, can form a disulfide bond that 
helps proteins maintain their tertiary structure or connect the heavy chain and light 
chain together in antibodies. In this project, thiol groups link the heme groups to the 
polypeptide chain in cytochromes c or coordinate to the b-type hemes in P450s. 
The suithydryl group is the second crosslinking target widely used for bioconjugation. 
At pH > 7, the thiol group deprotonates (J)Ka 8.3) and forms thiolate (-S), which 
behaves as a strong nucleophilic regent. Although the coupling activity of the 
sulfhydryl group is comparable to primary amine, thiol groups are less common in a 
large number of biomolecules. Therefore, thiol groups must be introduced to 
biomolecules before conjugation, either by chemical conversion or mutagenesis. 
The reaction types involving thiol coupling are alkylation and disulfide interchange. 
Typical coupling reactions include the haloactyl derivative-thiol reaction, maleimide-
thiol reaction, vinylsulfone-thiol reaction, and thiol-disulfide interchange. 
(1) 	Haloacetyl derivative [96] 
The representive reaction is the conjugation between iodoacetyl derivatives and thiol 
containing biomolecules, since the other haloactyl derivatives are not so reactive 
towards thiol group at physiological pH. 
However, selectivity of iodoacetyl derivatives during conjugation is poor. In addition 
to the thiol group of cysteine, they will react with the imidazole group of histidine, the 
thioether of methionine, the primary amine of lysine and the N-termini of proteins. It 
limits the application of iodoacetyl derivatives in many areas. 
HI 
(D-Hii 
Scheme 1. 4: the conjugation of thiol and iodoacetyl derivative 
(2) 	Maleimide 
Maleimides are the products of the reaction between maleic anhydride and ammonia 
or primary amine. The functional site for coupling is the double bond, which is easily 
attacked by strong nucleophilic reagents like thioates or amines. At pH 6.5 - 7.5, the 
maleimide group can react specifically with thiol groups, forming a stable thioether 
linkage [97-100]. At pH 7.0, maleimides react with thiols 1,000-fold faster than with 
amines [101]. This is the most suitable conditon for specific thiol-maleimide coupling. 
However, at pH >8.5, the primary amine-maleimide coupling becomes the main 
reaction [102]. Maleimides do not react with weak nucleophilic reagents contributed 
by the residues of tyrosines, histidmes or methionines. 
S-11 
Scheme 1.5: the conjugation of thiol and maleimide 
Unfortunately, the maleimide group always faces the problem of hydrolysis, 
especially at pH> 8.0 [103]. The hydrolysis breaks the five-member ring and makes 
the maleimide group unreactive to the coupling reagent. 
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Vinylsulfone [104] 
A vinylsulfone group can crosslink to nuleophilic groups like thiol, amine, and even 
hydroxyl groups. At pH 7.2 9.2, the vinylsulfone group mainly reacts with the thiol 
group to give a stable thioester. Unlike the maleimide group, the vinylsulfone group 
does not give stereoisomers upon addition of a thiol. 
o 0 
Scheme 1.6: the conjugation of thiol and vinylsulfone 
At pH > 9.5, the primary amine reacts with the vinylsulfone group competitively, 
although the thiol-vinylsulfone coupling is still the fastest reaction in the same system. 
Compared with the maleimide group, the conjugation of the vinylsulfone group is less 
efficient and slow, but the vinylsulfone group is resistant to hydrolysis. 
Thiol-disulfide interchange 
Thiol-disulfide interchange is the attack of thiolate on a sulfur atom in a disulfide 
bond resulting the breakage of the old disulfide bond and the formation of a new one. 
The common disulfides used are DTNB (5,5'-DiThiobis(2-NitroBenzoic acid)) [105-
106] and 2-PDS (2,2'-diPyridyl DiSulfide) [107]. They are both classical thiol-
counting reagents due to the formation of chromophores after the breakage of their 
disulfide bond. Either the original or newly formed disulfide bond is easily cleaved 
by thiol-reducing reagents, e.g. TCEP (Tris(2-CarboxyEthyl)Phosphine), DTT 
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Scheme 1.7: thiol-disuijIde interchange. The yellow chromophore is 5-Thio-2-
NitroBenzoic acid (TNB) or 2-pyridinethione 
3. 	Carboxylate (-000) 
Carboxylate groups show low nucleophilicity, even when the pH is much higher than 
7 in aqueous solutions. This is due to the delocalization of electrons within the 
carboxylate group conjugation system. Carboxylates are therefore not very reactive 
for the conjugation. In order to crosslink at the carboxylate site, this functional group 
must be activated first. The common activation regents are carbonyldiimidazoles and 
carbodiimides (see the coupling reactions of primary amine). 
(1) 	Carbonyldiimidazole [108] 
Carbonyldiimidazole, abbreviated as CDI, can react with carboxylate groups forming 
intermediate N-acylimidazoles. These intermediates are very reactive towards amines 
or hydroxyls, yielding stable amides or esters. The intermediate can also react with 
another carboxylate group in alkaline solution. 
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Scheme 1.8: the conjugation of CDI activated carboxylate and primary amine 
4. 	Hydroxyl (-OH) 
The hydroxyl group is more reactive than the carboxylate group. However, in many 
conjugation applications, they are modified to increase their reactivity and specificity. 
(1) 	Carbonyldiimidazole 
Similarly, carbonyldiimidazole can react with the hydroxyl group. The intermediate is 
an imidazole carbamate. This intermediate is active towards nucleophilic regents as 
well, like amines. And the coupling product is a stable N-alkyl carbamate. 
() 
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Scheme 1.9: the conjugation of CDI activated hydroxyl group and primary amine 
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(2) 	N,N '-Disuccinimidyl carbonate/N-hydroxysuccinimidyl chioroformate 
In terms of hydroxyl group, the goal of NN'-disuccmimidyl carbonate or N-
hydroxysuccinimidyl chioroformate is to produce a succinimidyl carbonate. The 
succinimidyl carbonate is highly active toward nucleophilic reagents and usually 
crosslinks to primary amines creating a carbamate with good stability. 
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Scheme 1.10: the conjugation of N,N'-disuccinimidyl carbonate or N- 
hydroxysuccinimidyl chioroformate activated hydroxyl group and primary amine 
1.8.2 Crosslinkers for bioconjugation 
The selection of crosslinkers is based on their coupling reactivities to particular 
functional groups and the best crosslinker for a specific bioconjugation must be 
determined empirically. Generally, several important points should be under 
consideration while choosing the most suitable crosslinker. 
1. Chemical reactivity and specificity 
Crosslinking normally involves two or more functional groups and they commonly 
include primary amines, sulfliydryls, carboxylates and hydroxyls. The reactivity and 
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specificity towards these functional groups are very important for the conjugation 
process. 
The length of spacer arm 
The selection of the length of spacer arm depends on the specific applications. Some 
applications require the components in conjugates to be separated by a certain 
distance without affecting their respective tertiary structures. Some applications need 
short spacer arms to keep the components closer. Different lengths of spacer may act 
as molecular rulers in some systems. 
Water solubility and cell membrane permeability 
The classification of crosslinkers is on the basis of the solubilities of the reactants in 
aqueous solution or organic solvents. In bioconjugation the solubility of a crosslinker 
must be considered carefully because if too much organic solvent is used for 
dissolving the crosslinker, the enzymes in aqueous solution could precipitate or 
denature. 
Homobifunctional / heterobifunctional crosslinkers 
Homobifunctional crosslinkers connect reactants at the same functional groups and 
they are usually used in one-step conjugation. Heterobifunctional crosslinkers are 
utilised in controlled multi-step conjugation, and react with different functional 
groups. 
Cleavability 
In certain applications, the crosslinked conjugates are designed to allow cleavage after 
use. Normally the cleavable domains of crosslinkers locate in the middle of the spacer 
arm and they are disulfide groups (cleaved by thiol), diol groups (cleaved by 
periodate), ester groups (cleaved by hydroxylamine), or sulfone groups (cleaved by 
base). 
1.9 Protein Tag 
To produce highly pure and well-characterized recombinant proteins is a major task 
for the protein chemists working in scientific laboratories. Many different peptides, 
domains and proteins (called affinity tags) have been developed for purification of 
over-expressed recombinant proteins. Generally these tag systems have the following 
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common features: (a) one-step purification for target proteins; (b) a minimal effect on 
target proteins' tertiary structures and biological activities; (c) easy and specific 
removal from the recombinant proteins; (d) simple and accurate assay of the 
recombinant protein during purification; (e) applicability to a number of different 
proteins [109]. Nevertheless, there is no a single tag suitable for all proteins and it is 
difficult to decide on the best affinity tag for a specific protein of interest. This 
depends on the target protein itself (e.g. stability, hydrophobicity), the expression 
system, and the application of the purified protein. Table 1.1 below lists most 
frequently used and interesting tag-protein fusion systems. 
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Table 1.1: the most commonly used protein tags 
Affinity Tag Residues Sequence Matrix 
Arginine Tag 5-6 RRRRR Cation-exchange resin 
Histidine Tag 2-10 HHHHHH Ni2 -NTA 
Anti-FLAG monoclonal 
FLAG Tag 8 DYKDDDDK 
antibody 
Strep Tag II 8 WSHPQFEK Strep-Tactin 
c-mys Tag 11 EQKLISEEDL Monoclonal antibody 
S Tag 15 KETAAAKFERQHMDS S-fragment of RNaseA 
Calmodulin binding 
26 KRRWKKNFIAVSAANRFKKISSSGAL Calmodulin 
peptide(CBP) 
Cellulose binding 
27-189 Domains Cellulose 
domain 
Streptavidin binding 
38 MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREP Streptavidin 
peptide(SBP) 




211 Protein Glutathione 
transferase(GST) 
Maltose binding 
396 Protein Cross-linked amylose 
protein(MBP) 
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Small peptide tags such as Arginine Tag [110-ill], Histidine Tag [112-115], FLAG 
Tag [116-122], c-myc Tag [123-125], S Tag [126-128], and Strep Tag II [129-131], 
are very commonly used. These tags have nearly no effects on the expression, 
structure and biological activity of most proteins. And usually there is no need to 
remove the tag after purification. Large tag systems like Glutathione S-transferase 
(GST) [132] and Maltose binding protein (MBP) [133-135], can increase the yield or 
enhance the solubility of recombinant proteins besides introducing one-step 
purification in some cases. The disadvantage is that the tag must be removed for 
several applications e.g. crystallization or antibody production. 
1.9.1 Cat modutin and Catmodulin Binding Peptide (CBP) 
Calmodulin is a small, acidic, Ca 2,1 	protein constituted of 148 amino acids 
with a mass of 16706 Daltons. The apo-Catmodulin is dumb-bell-shaped. Two 
globular domains, also called lobes, are connected by a flexible a-helical linker. 
There are two helix-loop-helix Ca 2+  binding sites which are commonly called EF 
hands in each globular domain. In the presence of Ca 2 , Calmodulin undergoes a 
major conformational change and "wraps-around" its target peptide or protein 






Calmodulin with 4 Ca2 
	
Complex of Calmodulin 
and CBP 
Figure 1.15: Calmodulin and Calmodulin Binding Peptide (CBP). Calmodulin is in 
green; Calcium ions are in red; CBP is in yellow 
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1.9.2 Streptavidin and Streptavidin Binding Peptide (SBP) 
Streptavidm is a tetrameric protein, obtained from the bacterium Streptomyces 
avidinii, which binds extraordinarily tightly to the small molecule, biotin (K1 10 
M). Compared with most biomolecules, streptavidin is extremely stable and survives 
tough environments, such as 8 M urea or guanidine, 0.5 M NaOH, or 50 % 
formamide. Common proteases, including pepsin, papain, subtilisin, thermolysin, 
and elastase, do not cleave streptavidin. Even in the presence of SDS, streptavidin 
keeps its integrity and disassociates into monomers only at high temperature (> 
60°C). Strep-Tactin is a streptavidin derivative, which is mainly used as the column 
material for affinity purification of proteins with the Strep-Tactin association peptide. 
Strep tag II is a small peptide with only 8 amino acids (WSHPQFEK) and it is 
found that it displays a very high affinity towards Strep-Tactin (Fig 1.16) [129-13 1]. 
Strep tag II is widely used for affinity purification as a tag placed either at the C-
terminus or N-terminus. Generally, it does not interfere with protein folding or 
bioactivity, does not react with heavy metal ions, has no ion exchange properties and 
does not induce protein aggregation. There is no need to remove it after purification 
in most case. 





derivative and Strep Tag II 
Figure 1.16: Streptavidin derivative and Strep Tag H. Streptavidin derivative is in 
cyan and Strep Tag Ills in magenta stick representation. 
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1.10 Aims of this Thesis 
The aims of project include: 
Constructing cytochrome C3 mutants for use in conjugation studies; 
Characterizing the constructed cytochrome c3 mutants by gel 
electrophoresis, UV-Vis spectroscopy, fluorescent labelling, and thiol 
counting; 
Constructing simple dimers of cytochrome C3 mutants; 
Constructing polymers of cytochrome C3 mutants ("biological nanowires") 
and characterizing them with gel electrophoresis, UV-Vis spectroscopy, and 
OTTLE (Optically Transparent Thin Layer Electrode) potentiometry; 
Developing a controllable conjugation strategy through constructing a well-
defined conjugate of cytochrome C3 mutants; 
Constructing P450 BM3 mutants for use in conjugation studies; 
Characterizing the constructed cytochrome C3 mutants by gel electrophoresis 
and UV-Vis spectroscopy, and substrate binding; 
Constructing a conjugate of P450 BM3 mutant and cytochrome C3 mutant, 
characterizing them with gel electrophoresis, UV-Vis spectroscopy, and size 
exclusion chromatography, and investigating the electron transfer between 
P450 BM3 mutant and cytochrome C3 mutant by an OTTLE. 
How can multiple redox proteins be coupled together in a controlled way to generate 
a "nanowire"? The keys are to have very selective chemical ligating reactions and 
effective protecting/deprotecting strategies. 
For native proteins the most selective chemical ligation site is a cysteine thiol group. 
These can be placed anywhere on the protein surface by mutagenesis. It's easy to 
link two proteins together by using either a disulfide bond directly or a synthetic 
linker. The best synthetic linkers are bis-maleimide cross-linking reagents (Fig. 
1.17), which can react with cysteine thiol groups specifically, and the cross-linking 
products are stable at physiological pH. Moreover, the lengths of these linkers can be 
changed due to different spacers between two maleimides. 
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Figure 1.17: bis-maleimide cross-linking reagents 
In making a hetero-dimer (A-B), homo-dimers (A-A and B-B) will be a problem. So 
A should be treated with a linking agent first, prior to reaction with B. 
0 	0 	 0 	0 
0 	 - 0 
Scheme 1.11: two-step conjugation to produce A-B heterodimer, hereby A, B 
represents two different cysteine mutants of cytochrome c3, respectively 
Linking 3 proteins together in a controlled way is much more difficult. To make an 
A-B-C module, B requires two exposed cysteine thiols to form the bridge. In order to 
connect A to B without forming A-B-A, one of the cysteine sites must be protected. 
Strategies for this are detailed below: 
(1) Electrostatic control 
Electrostatics could be used to control reactivity. By generating a dipole (Fig. 1.18) 
across a c3 molecule near the cysteine site through mutagenesis, connection will be 
favoured in one orientation. 
___ 
 
rcyt  c- 511 I — ___> [IS r- Cyt 3 —SI-I 	 I I IS— cytc1 
Figure 1.18: a cyt c3 dipole controls the ligation 
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(2) Affinity tags 
The choices for affinity tag strategies include calmodulm (CaM) / calmodulin 
binding peptide (CBP) and Strep-Tactin / Strep Tag IL 
As an example, calmodulin binding peptide (CBP) is tagged at the N- or C-terminus 
of a protein near the cysteine site (Fig. 1.19). While binding to the CBP, CaM can 
physically obstruct the cysteine thiol group to achieve the aim of protection (Fig 
1.20). It is easy to remove CaM by decreasing the calcium concentration using 
EGTA. 
Li 
Figure 1.19: the CBP is tagged at the C-terminus of cytochrome c3 double cysteine 
mutants. The big circle with 4 diamonds represents the cytochrome c3 and 4 hemes; the 
small circles in magenta and cyan represent cysteine thiol groups at different  sites on 






Figure 1.20: CaM binds to the CBP and the thiol group in (or near) the tag is involved 
by CaM so that it becomes unreactive towards conjugation. 
A postulated procedure to create a well-organized cytochrome C3 heterotrimer is 












Figure 1.21: a postulated multi-step procedure to produce a cytochrome C3 
heterotrimer. A, B represent different cysteine mutants of cytochrome c3;the 
magenta star represent the bismaleimide crosslinker. 




Figure 1.22: three dimensional crystal structure of cytochrome P450 BM3 from Bacillus 
megaterium (hemes in red, ligated cysteine in yellow and protein backbone in wheat, alpha 
helix in cyan, and beta sheets in magenta, PDB entry: 21J2) 
Physiologically, it needs electron transfer cofactors (FAD and FMN) to gain 
electrons to achieve catalysis. This aim is to connect cytochrome c3 near to the active 
site of the P450 BM3 and utilize the electrode to provide the electrons to the P450 










cytochrome P450 heme domain 




Materials and methods 
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2.1 Bacterial pJasmids and strains 
Table 2.1. bacterial plasm k/v 
Bacterial plasmids 	 Main purpose use  
Cloning vector for Desulfovibrio vulgaris Miyazaki F 
pKF 19k 	
cytochrome C3 and its mutants; 
Compatible with the expression system of Shewanella 
oneidensis MR-1 [65] 
pUC 118 	
Cloning vector for the heme domain of cytochrome P450 
BM3 [140] 
pET-i id 	Cloning vector for Calmodulin Binding Peptide (CBP) [141] 
Table 2.2: bacterial strains 
—Bacterial strains flu purpose o use I Source 
Escherichia co/i Cloning strain for wild type Desulfiwibrio ' Lab stock 
DH5cz vulgaris Miyazaki F cytochrome c3 
Escherichia coli Cloning strain for mutants of Desulfovibrio Lab stock 
JM109 vulgaris Miyazaki F cytochrome C3 
Cloning and Expression strain for the heme Lab stock 
Escherichia co/i TG 
domain of cytochrome P450 BM3 
Expression strain for Desulfovibrio vulgaris Lab stock 
Shewanella 




2.2 	Growth media and antibiotics 
Table 2.3: LB Broth (per litre) 




I 	Bacto Yeast extract 	I 	 5 g 	 I 
Deionised water (millipore) was added to 1 litre and the solution was sterilized by 
autoclaving at 121 °C for 20 minutes before use. 
The following filter-sterilized supplements were added prior to use: 
Table 2.4.2: additives of SOC broth (per litre) 




KC1(0.25M) 10 ml 
MgCl2 (1 M) 10 ml 
M9SO4 (1M) 10 ml 
Glucose (2 M) 10 ml 
47  
cvtochrome C3 modules as electron transfer nanowires 





Bacto Yeast extract 24 g 
Glycerol 4 ml 
KI-12PO4 23.12g 
K2HPO4 125.41 g 
Deionised water (millipore) was added to 1 litre and the solution was sterilized by 
autoclaving at 121 °C for 20 minutes before use. 




I 	 log 
Bacto Yeast extract 5 g 
NaC1 5g 
Agar 14g 
Deionised water (millipore) was added to I litre and autoclaved for 20 minutes at 
121 °C. It was allowed to cool before addition of antibiotics. 
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Table 2.7.- antibiotics 






Rifampicin 10 10 
Ampicillin 100 100 
Carbenicillin 25 25 
The stock solution of kanamycin, ampicillin, or carbenicillin was prepared in 
deionised water (millipore), passed through a 0.22 j.tM syringe-driven filter and 
stored at -20 °C. The stock solution of rifampicin was prepared in methanol without 
being filtered and stored at -20 °C. 
2.3 	Genetic manipulation 
2.3.1 Primers and plasmids 
Table 2.8: Plasmids and cloning primers (see separated page) 
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Table 2.8: summarization ofplasmids and cloning primers in the project 
Name of plasmid Forward and reverse primes for PCR (5' -> 3') Description 
pKFC3k N / A 
encoding wild type Desu!fovibrio vulgaris Miyazaki F 
cytochrome c3 , obtained from Japan 
pSL 1 
CACCCGGTCAACGGCTGTGAAGACTACCAGAAG 














encoding K40C:SI07C cytochrome c3 and a calmoduin 







encoding K40C:SI07C cytochrome c3 and a calmodulin 






encoding K40C:SI07C cytochrome c3 and a calmodulin 







encoding K40C:S107C cytochrome c3 and a Strep Tag 






encoding S1O7C cytochrome c3 and a Strep Tag H with 




CCAAGTGCCATAGCAGCGCTTGGTGCCACCCGCAG encoding K40C cytochrome c3 and a New Strep Tag 




encoding wild type cytochrome c3 and a New Strep Tag 
with a short linker, senne and alanine CTGCGGGTGGCACCAAGCGCTGCTATGGCACTTGG 
pSL11 
TCCAAGTGCCATAGCGGATCGCATCACCATCACCATCACTAAGAATTCACTGGC encoding K40C cytochrome c3 and a His 6 Tag with a 
short linker, glycine and serine GCCAGTGAATTCTTAGTGATGGTGATGGTGATGCGATCCGCTATGGCACTTGGA 
pSL12 
TCCAAGTGCCATAGCGGATCGCATCACCATCACCATCACTAAGAATTCACTGGC encoding wild type cytochrome c3 and a His6 Tag with a 
short linker, glycine and serine GCCAGTGAATTCTTAGTGATGGTGATGGTGATGCGATCCGCTATGGCACTTGGA 
pSL13 
AGCGCTTGQAGCCACCCG encoding K40C cytochrome C3 and a Strep Tag H with a 
short linker, serine and alanine CGGGTGGCTCCAAGCGCT 
pBM20 N/A 
encoding heme domain of wild type P450 BM3, 
obtained from lab stock 
pSLa 
CAATTGGTCTTAGCGGCTTTAAC 
encoding C156S heme domain of P450 BM3 
GTTAAAGCCGCTAAGACCAATTG 
pSLb 
CAGTCTGCTAAAAAAGTACGCCATCACCATCACCATCACTAATAGGATCCTCTAGAGTCG encoding C1 56S heme domain of P450 BM3 and a His6 
Tag (C62P450) CGACTCTAGAGGATCCTATTAGTGATGGTGATGGTGATGGCGTACTTTTrTAJCAGACTcI 
pSLc 
CTAATTAAAGAAGCAAGCGATGAATCACGC 
encoding C62S:C156S:Q387C heme domain of P450 





encoding Calmodulin Binding Peptide (CBP), 




2.3.2 Point mutagenesis for production of K40C, S107C, K40C:S107C 
cytochromes c3 (pSL1, pSL2, and pSL3, in collaboration with Dr. 
Caroline Miles) 
Small scale plasmid DNA extraction with QiAprep spin miniprep kit 
(Qiagen) 
5 ml of LB broth supplemented with 50 jig / ml of kanarnycin, was 
inoculated from the stock of pKFC3kIDH5u in the -80 °C freezer using a 
sterile inoculating loop and grown at 37 °C in an incubator at 225 rpm 
overnight. The cells were harvested by centrifugation at 5,000 rpm for 3 
minutes. The pellet was resuspended in 250 jil of Buffer P1 and the 
mixture was transferred to a sterilized 1.5-ml eppendorf. 250 jil of Buffer 
P2 was added to the mixture and mixed throughly by inverting the 
eppendorf 4-6 times. 350 j.tl of Buffer N3 was added and mixed 
immediately and throughly by inverting the eppendorf 4-6 times again. 
The cloudy mixture was spinned at 13,000 rpm for 10 minutes and the 
supernatant was transferred carefully to the QlAprep spin column. The 
column was spinned at 13,000 rpm for 1 minute and the flow-though was 
discarded. At this moment, plasmid DNA was bound to the resin of the 
column. 500 jil of Buffer PB and 750 of Buffer PE, respectively, were 
applied to wash the spin column and the residual buffers were discarded 
by centrifugation at 13,000 rpm for 1 minute. DNA was eluted into a 
clean sterilized eppendorf upon addition of 50 jil of Buffer EB and 
centrifugation at 13,000 rpm for 1 minute. The extracted DNA was used 
immediately or stored in -20 °C freezer. 
(The kit includes buffers P1, P2, N3, PB, PE, EB, and QiAprep spin 
columns.) 
Detection of DNA by Agarose gel electrophoresis 
52 
Cvtochrome c 3 modules as electron transfer nanowires 
Table 2.9: TAE buffer (50x stock solution) per litre 
Table 2.10: gel sample loading buffer (6x stock solution) 
Chemicals 	Concentration 
Ficoll 	 15% 
Bromophenol Blue 	0.25% 
Xylene Cyanoll 	0.25% 
Table 2.11: electrophoresis sample preparation 
DNA stock solution 




Sample loading buffer (6x) 2.5 2.5 
Sterilized deionised water 11.5 7.5 
total 15 15 
* New England Biolabs 
Table 2.12: 0.8 % Agarose gel composition for each gel 
The agarose gel was run in I x TAE buffer at 15 - 20 V/cm for 30 - 60 
minutes according to the migration of colored frontier. DNA bands on the 
gel could be monitored and photographed under a UV lamp. 
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(3) Site-directed mutagenesis with QuikChange mutagenesis kit (Stratagene) 
Table 2.13.- PCR (Polymer Chain Reaction) sample preparation for K40C 
(pSLJ) or S107C (pSL2) mutants of cytochrome C3 
tiReagents*5 
pKFC3k 1 (-j 25 ng) 
forward primer 1.25 (- 125 ng) 
reverse primer 1.25 (- 125 ng) 
dNTP mix 0.5 
QuikSol 3 
Buffer (lOx) 5 
sterilized deionised water 38 
Pfu Turbo DNA polymerase 1 
Total 51 
* pKFC3k was the extraction of 5-ml overnight LB broth; Primers were ordered from 
Sigma and made 100 ng/t1 stock solution; other reagents were provided by 
QuikChange mutagenesis kit. 




Usage / Rl 
forward primers for K40C and S 107C 1.25+1.25 
reverse primers for K40C and Si 07C 1.25+1.25 
dNTP mix 05 
QuikSoi 3 
Buffer (I Ox) 5 
sterilized deionised water 35.5 
Pfu Turbo DNA polymerase I 
total 51 
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Table 2.15: PCR program for K40C (pSLJ), S107C (pSL2), or 
K40C.S107C (pSL3) mutant of cvtochrome C3 
Temperature / °C Incubation time / s Cycles 
II - 
DpnI, restriction enzyme provided in the kit, was added to the PCR 
product directly. The reaction mixture was incubated at 37 °C for 80 
minutes to digest the parental double strand DNA. 
A 100-RI aliquot of XL 10-Gold Ultracompetent Cells (Stratagene) was 
thawed on ice. 4 p1 of the f'-ME mix provided with the kit was added to 
the cells and mixed very gently. The cells were incubated on ice for 10 
minutes and mixed gently every 2 minutes. Then, 2 p1 (single mutant) or 
3 p1 (double mutant) of PCR product was added to the cells. The cells 
were mixed very gently and incubated on ice for another 30 minutes. The 
mixture was incubated at 42 °C for 30 seconds (The duration of the heat 
pulse is critical) and then, chilled on the ice for 2 minutes. 900 p1 of 
NZY broth, preheated at 42°C, was added the mixture and the entire 
mini-culture was shaken at 225 rpm at 37 °C for 1 hour. 250 p1 of the 
mini-culture was spreaded on the LB Agar plate supplemented with 50 .Lg 
I ml kanamycin and incubated at 37°C overnight. 
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Table 2.16.1: NZ)"" broth per liter 
F 	
Chemicals 	 Usage 
NZ amine 	 lOg 
Bacto Yeast extract 	 5 g 
NaCl 	 5g 
Deionised water (millipore) was added to I litre. The solution was adjusted to pH 7.5 
using NaOH and sterilized by autoclaving at 121 °C for 20 minutes before use. 
The following filter-sterilized supplements were added prior to use: 
Table 2.16.2: additives of SOC broth (per litre) 
Clieinicals (aqueous concentration) 
'MgC12 (1 M) 
L'sage 
12.5 ml 
MgSO4 (1 M) 12.5 ml 
Glucose (2 M) 10 ml 
(4) General method for DNA sequencing with BigDye Terminator v3.1 Cycle 
Sequencing Kit (Applied Biosystems) 
A single colony was picked up using a sterile inoculating loop from LB 
Agar plate supplemented with 50 pg / ml kanamycin. Then the colony 
was transferred into 5 ml LB Broth with 50 gg / ml kanamycin, and 
grown at 37 °C overnight in an incubator at 225 rpm. 930 tl of overnight 
culture was pipetted into a clean sterile 1.5-ml eppendorf and 70 tl of 
sterilized DMSO was added to the eppendorf. The mixture was swirled 
very gently and put into a -80 °C freezer for long-term storage. Plasmid 
DNA was extracted from the rest of the overnight culture with QlAprep 
spin miniprep kit (Qiagen) and checked by agarose gel electrophoresis. 
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10 (250 ng) 
primer 2 (- 200 ng) 
Terminator Ready Reaction Mix (kit reagent) 4 
sterilized deionised water 4 
total 20 
Table 2.18: general PCR program for DNA sequencing 
The forward and reverse primers for sequencing pSL1, pSL2, and pSL3 
are 5'-ATGACCATGATTACGCCAAGCTTGC and 5 9 -
GTCACGACGTTGTAAAACGACGGCC, respectively. And there is 
only one primer, not a pair of primers, in a sequencing sample. 10 .t1 of 
PCR product was submitted to School of Biological Science Sequencing 
Service (SBSSS) at the University of Edinburgh. 
(5) DNA sequence analysis 
The sequencing results, returned from SBSSS, were aligned with 
nucleotide sequence in the NCBI (National Center for Biotechnology 
Information) database (access number: D31702), using an online 
sequence alignment tool 'EMBOSS Pairwise Alignment Algorithms' 
from EBI (European Bioinforniatics Institute). The reverse sequence was 
converted to its reverse-complement part with an online tool 'Reverse 
Complement' from Bioinformatics Organization, Inc. 
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2.3.3 Overlap PCR for tagging calmodulin binding peptide (CBP) to 
K40C:S1O7C cytochromes C3 (pSL4, pSL5, pSL6) 




Primer 3/5/7 	Primer 4 
PCR al 
	
j PcR a2 
Hindill 	 EcoRI 
MMMIA- 
Primer 1 	 Primer 4 
PCR b 
Hindill 	 EcoRI 
	
cyt c3 	 CBP 
Figure 2.1: CBP tagging strategy. The Plasmids are in linear 
representation. Nucleotide segment encoding cytochrome C3 is in red; 
nucleotide segment encoding CBP is in green. 
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Table 2.19: primers for CBP tagging* 
Primer I (forward)  ACGCCAAGCTT( i( \T( I ( 
Primer 2(pSL4r)  GCAATGGCACTTGGAGC 
Primer 3(pSL4f)  GTGCCATTGCGGTACCAAGCGACGATG 
Primer 4 (reverse)  (•\ 1( GAATTC \AAGTGC'CCCGGAGG 
Primer 5(pSL5f)  GTGCCATTGCACCAAGCGACGATGGAA 
Primer 6(pSL5r)  GTCGCTTGGTGC A ATG GCACTTGG A GC 
Primer 7(pSL6f)  GTGCCATTGCATGTATCCACGTGGGAA 
Primer 8(pSL6r)  GTGGAATGCAATGGCACTTGGAGC 
* Sequences in pink are restriction-cutting sites o/ hindu! and LcoRl: 
sequences in red are the fragments annealing to cytochrome C3 encoding 
sequences; sequences in green are the fragments annealing to CBP 
encoding sequences. pSL4: K40C:SJ07C cyt c 3-Gly-Thr-CBP, pSL5: 
K40C:SJ07C cyt c 3-Thr-CBP, 
pSL6. K40C:SJ07C cyt c 3-thrombin-CBP 
The cytochrorne c3 encoding sequence and CBP encoding sequence were 
amplified by PCR, respectively (Fig 2.1). The amplified product of PCR al 
contained an intact cytochrome c3 encoding sequence with a Hindlil 
restriction cutting site on the upstream and a short sequence encoding N-
terminus of CBP after cytochrome c3 encoding sequence (-j 500 bp). 
Similarly, the product of PCR a2 contained an intact CBP encoding sequence 
with an EcoRl restriction cutting site on the downstream and a short sequence 
encoding C-terminus of cytochrome c3 immediately before the CBP encoding 
sequence (- 100 bp). The products of PCR al and a2, purified by a 
commercial kit, were combined together and amplified by another PCR b 
yielding a product encoding CBP tagged cytochrome C3 (- 600 bp). This 
product was purified, digested by 
Hindill and EcoRl, ligated to the vector of pKFI 9k, and transformed into E. 
co/i JM1O9. 
(2) PCR for CBP tagging 
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Table 2.20: general PCR aI/a2 sample preparation for pSL4/pSL5/pSL6 
Reagents*l 
pSL3 / pCAL-c 1 (-25 ng) 
forward primer 2 (- 200 ng) 
reverse primer 2 (-. 200 ng) 
dNTP mix (10mM each) 1 
Reaction Buffer (1 Ox) 5 
sterilized deionised water 38.5 
Pfu DNA polymerase 0.5 
total 50 
* pCAL-c (Stratagene); Pfu DNA polymerase and I Ox Reaction Buffer (Promega); 
dNTPs (Roche) 
Table 2.21: general PCR b sample preparation for pSL4/pSL5/pSL6 
}14Reagents  
purified PCR al product I 
purified PCR a2 product 1 
forward primer 2 ( 	200 ng) 
reverse primer 2 (- 200 ng) 
dNTP mix (10 mM each) 1 
Reaction Buffer (I Ox) 5 
sterilized deionised water 37.5 
Pfu DNA polyrnerase 0.5 
total 50 
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Table 2.22.' general PCR program for pSL4/pSL5/pSL6 
95 	 120 	 1 
95 	 60 
65 	 30 	 25 
72 	 360 (120 for PCR a2) 
72 	 420 (300 for PCR a2) 	 1 
4 	 Hold 
The product of PCR a! or a2 was purified though QlAquick PCR 
Purification Kit (Qiagen). 250 .t1 of Buffer PBI was added to the PCR 
solution (50 iii) and mixed throughly. The mixture was transferred to the 
QlAquick spin column and the column was centrifuged at 13,000 rpm for 
1 minute. The flow-through was discarded and PCR product was bound to 
the resin of the column. 750 .t1 of Buffer PE was applied to wash the 
column and the residual buffers were discarded by centrifugation at 
13,000 rpm for 1 minute. DNA was eluted into a clean sterilized 
eppendorf upon addition of 50 !.t1 of Buffer EB and centrifuged at 13,000 
rpm for 1 minute and checked by agarose gel electrophoresis. The 
purified PCR al/a2 product was used immediately or stored in a -20 °C 
freezer. (The kit includes buffers PBI, PE, EB, and QlAquick spin 
columns.) 
After the amplication of PCR b, the product was also purified with the 
same kit and checked by agarose gel electrophoresis. 
(3) Double restriction digestion with HindIIJ and EcoRl 
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Table 2.23: general double restriction digestion sample preparation 
Reagents 
DNA 




Buffer E(lOx) 5 
BSA (1 mg/ml) 0.5 
sterilized deionised water 4.5 
total 50 
The sample was mixed throughly and incubated at 37 °C in a water bath for 3 hours. 
Enzymes and Buffer E were purchased from Promega. 
The purified product of PCR b was digested by both HindJIJ and EcoRl 
and purified though QiAquick PCR Purification Kit (Qiagen). The 
purified digested product (insert) was used immediately or stored in a -20 
°C freezer. 
(3) pKFl 9k vector preparation by gel extraction 
The plasmid pSL3 was digested by Hindill and EcoRl. The big fragment 
of the digestion products (-j 2.2 kbp) could be separated from the reaction 
mixture by agarose gel electrophoresis and purified though QiAquick Gel 
Extraction Kit (Qiagen). 
The double digestion mixture (50 p.tl) together with 10 iii of gel sample 
loading buffer (Table 2.10) was loaded into a 0.8 % agarose gel (Table 
2.12). The gel was run at 15 20 V/cm for 40 minutes. The gel fragment 
containing higher molecular weight (' 2.2 kbp) was cut off by a scalpel 
under a UV lamp. The operation was as quick as possible because the 
DNA could be cleaved upon UV exposure. The gel slice was weighed out 
in a clean sterile eppendorf and 3 volumes of Buffer QG were added to 1 
volume of gel slice (1 mg - I .tl). The eppendorf was incubated at 50 °C 
in a water bath until the gel slice was totally dissolved. 1 gel volume of 
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isopropanol was added to the solution and mixed throughly. The mixture 
was transferred to the QlAquick spin column and the column was 
centrifuged at 13,000 rpm for 1 minute. The flow-though was discarded 
and DNA was bound to the resin of the column. 500 tl of Buffer QG and 
750 tl of Buffer PE, respectively, was applied to wash the column and 
the residual buffers were discarded by centrifugation at 13,000 rpm for 1 
minute. DNA was eluted into a clean sterilized eppendorf upon addition 
of 50 tl of Buffer EB and centrifugation at 13,000 rpm for 1 minute. The 
purified double digestion product (vector) was used immediately or stored 
in a -20 °C freezer. (The kit includes buffers QG, PE, EB, and QlAquick 
spin columns.) 
Ligation 
The purified digested PCR b product (insert, 600 bp) and big fragment 
of digested pSL3 (pKF19k vector, 2.2 kbp) were ligated by T4 ligase 
(Promega) 
Table 2.24: general ligation sample preparation 
ie Reagents 
insert 
Usage / ttl 
7 
Vector I 
Ligation Buffer (I Ox) 1 
T4 Ligase I 
Total 10 
The sample was mixed throughly and incubated at 10 °C overnight. T4 ligase and 
Ligation Buffer were purchased from Promega. 
One-step chemical transformation (4) of pSL4, pSL5, or pSL6 into E. coli 
JM 109 
5 ml of LB broth was inoculated from the stock of E. coli JM 109 in the - 
80 °C freezer using a sterile inoculating loop and grown at 37 °C in an 
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incubator at 225 rpm overnight. A new 5-ml of LB was inoculated with 
200 td of overnight culture and grown until the optical density at 600 rim 
reached approximate 0.3 0.4. The cells were harvested by centrifugation 
at 5,000 rpm for 5 min and resuspended in 500 tl of ice-cold 
transformation and storage solution (TSS). 200-tl aliquots of cells were 
dispensed into pre-chilled eppendorfs. 
Table 2.25. transformation and Storage Solution (TSS) 
Reagents Concentration 
LB broth - 
PEG 8000 10 % (wt / vol) 
DMSO 5 % (vol / vol) 
MgSO4 50 	m 
The solution was adjusted to pH 6.5 using NaOH and sterilized by passing through a 
0.22 .tM syringe-driven filter. TSS could be used immediately or put in a 4 °C fridge 
for short-term storage. 
10 .ti of ligation mixture was added to an aliquot of cells and incubated 
for 30 min at 4 °C. 800 tl of SOC broth was added to the mixture and the 
entire mini-culture was shaken at 225 rpm at 37 °C for 1 hour. The cells 
were peileted at 6,000 rpm for 4 minutes and resuspended in 200 ii of 
SOC broth. Then, the cells were spread on an LB Agar plate 
supplemented with 50 .tg / inl kanamycin and incubated at 37 °C 
overnight. 
(6) DNA sequencing analysis for pSL4, pSL5, and pSL6 
DMSO stocks were made for picked-up colonies. A forward primer, 5'-
ACGCCAAGCTTGCATGC, was found to sequence all cytochrome C3 
mutants. All the sequencing procedures and data analysis followed above-
mentioned protocols. 
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2.3.4 Overlap PCR for tagging Strep Tag II to K40C:S107C cytochromes c3 
(pSL7 and psL8) 




Hindlil 	 EcoRI 
I I r-7 	
jul... 
4 
Primer 1 	 Primer 10 
4 1' 
4 PCR b 
Rindill 	 EcoRI 
cyt c 	 sRP 
Figure 2.2: Strep tagging strategy. The Plasmids are in linear 
representation. Nucleotide segment encoding cytochrome c3 is in red; 
nucleotide segment encoding Strep Tag II is in yellow. 
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Table 2.26. primers for Strep tagging * 
PrimertiFthI 
Primer 1 (forward) 
1i iit 
ACG CCAAGCTTGCA TGC 
Primer 9 (pSL7/8r) CCAAGCGCTGCAATGGCACTTGGAGC 
Primer 10 (reverse)  CATCGAATTCATTTTTCGAAC 
C3ST GTGCCATTGCAGCGCTTGGAGCCACCCGCAGTTCG 
AAAAATGAATTCGATG 
* Sequences in pink are restriction-cutting sites of ulnalli ana coKJ; 
sequences in red are the fragments annealing to cytochrome c3 encoding 
sequences; sequences in yellow are the fragments annealing to Strep Tag 
11 encoding sequences. pSL 7: K40C:SJ 0 7C cyt c 3-Ser-A la-Strep Tag II, 
pSL8: SJO7C cvt c 3-Ser-A la-Strep Tag Ii 
The cytochrome C3 encoding sequence was amplified by PCR (Fig 2.2). The 
amplified product of PCR a contained an intact cytochrome c3 encoding 
sequence with a Hindlil restriction cutting site on the upstream and a short 
sequence encoding the N-terminus of Strep Tag II after the cytochrome c3 
encoding sequence (— 500 bp). The purified product of PCR a and a short 
sequence C3ST (51 bp), which encoded the C-terminus of K40C:S107C 
cytochrome c3 , Strep Tag II, and a EcoRl cutting site, were combined 
together and amplified by another PCR b yielding a product encoding Strep 
tagged cytochrome c3 (-. 550 bp). This product was purified, digested by 
Hindu! and EcoRl, ligated to the pKFl 9k vector, and transformed into E. coli 
1M109. The strategy worked in a similar way to CBP tagging. 
(2) PCR for Strep tagging 
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Table 2.27: general PCR a sample preparation for pSL 71pSL8 
Reagents*  
pSL3 / pSL2 1 (-25 ng) 
primer 1 2 (- 200 ng) 
primer 9 2 (- 200 ng) 
dNTP mix (10 mM each) 1 
Reaction Buffer (I Ox) 5 
sterilized deionised water 38.5 
Pfu DNA polymerase 0.5 
total 50 
Table 2.28: general PCR b sample preparation for pSL7/pSL8 
Reagents 
purified PCR a product 
Usage / ILI 
1 
C3ST 1(-.'10ng) 
forward primer 2 (- 200 ng) 
reverse primer 2 (-j 200 ng) 
dNTP mix (10 mM each) 1 
Reaction Buffer (I Ox) 5 
sterilized deionised water 37.5 
Pfu DNA polymerase 0.5 
total 50 
rOYA 
Table 2.29: general PCR program for pSL 7/pSL8 




The product of PCR a was purified though QlAquick PCR Purification 
Kit and used immediately or stored in a -20 °C freezer. After the 
amplication of PCR b, the product was again purified with the same kit 
and checked by agarose gel electrophoresis. 
All the following steps in the Strep tagging procedure shared the same 
protocols and regents with corresponding steps in CBP tagging procedure. 
Double restriction digestion with Hindlil and EcoRl 
Ligation 
One-step chemical transformation of pSL7 or pSL8 into E. coh 
JM 109 
DNA sequencing analysis for pSL7 and pSL8 
2.3.5 Point mutagenesis for production of K40C and wild type cytochromes c3 
with New Strep Tags (pSL9 and pSL1O) 
Small scale plasmid DNA extraction with QlAprep spin miniprep kit 
(Qiagen) 
pSL9 and pSL1O were produced on the basis of pSL7 and pSL8. Plasmid 
DNA solutions of pSL7 and pSL8 were extracted from 5-ml overnight 
mini-cultures with 50 / ml of kanamycin of pSL7JM109 and 
pSL8JM109, respectively. 
Detection of DNA by Agarose gel electrophoresis 
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The extracted DNA solutions of pSL7 and pSL8 were checked by 0.8 % 
agarose gel electrophoresis. 
(3) Site-directed mutagenesis with QuikChange mutagenesis kit (Stratagene) 
and one-step transformation into E. coli JM 109 
Table 2.30: PCR (Polymer Chain Reaction) sample preparation for pSL9 
and pSLJ 0 
Reagents* 
pSL7 / pSL8 
Usage / RI 
I (- 25 ng) 
forward primer 1.25 (— 125 ng) 
reverse primer 1.25 (— 125 ng) 
dNTP mix 0.5 
QuikSol 3 
Buffer (lOx) 5 
sterilized deionised water 38 
Pfii Turbo DNA polymerase 1 
Total 51 
Table 2.31. PCR program for pSL9 and pSLJ 0 
Temperature / C 
S 






The 	 forward 	 primer 	 (5'- 
CCAAGTGCCATAGCAGCGCTTGGTGCCACCCGCAG), and reverse 
primer (5 '-CTGCGGGTGGCACCAAGCGCTGCTATGGCACTTGG) 
were used to convert the cysteines 107 of strep-tagged cytochrome c3 
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mutants (pSL7 and pSL8) to serines and the serines in the Strep Tag H to 
cysteifles. 
After restriction digestion of the parental template by DpnI, 5 tl of 
reaction solution was transferred into 200 tl of the freshly made E. coli 
JMI09 cells in TSS. After 30-minute incubation on ice, 800 itl of SOC 
broth was added and the mini-culture was grown up at 225 rpm at 37 °C 
for 1 hour. Then, the cells were pelleted, resuspended in 200 tl of SOC 
broth, spread onto an LB agar plate with 50 pg / ml of kanamycin, and 
incubated overnight at 37 °C. 
DNA sequencing and data analysis for pSL9 and pSL 10 
This procedure was identical to the previous procedure with the general 
cytochrome C3 sequencing primer, 5'-ACGCCAAGCTTGCATGC. 
2.3.6 Long oligonuleotide insertion for the attachment of His6 tags to K40C 
and wild type cytochromes c3 (pSL11 and pSL12) 
In this project, it was found that the QiAprep spin miniprep kit (Qiagen) not 
only worked well for point mutagenesis, but also had good performance in 
the long oligo nucleotide insertion to the plasmid DNA, which made the 
tagging a small peptide to a protein easier during genetic manipulation. Here, 
the template plasmid DNAs were pSL1 and pKFC3k. 
Small scale plasmid DNA extraction with QlAprep spin miniprep kit 
(Qiagen) 
Plasmid DNA solutions of pSL1 and pKFC3k were extracted from 5-ml 
overnight mini-cultures with 50 pg / ml of kanamycin of pSL1JXL1O and 
pKFC3kIDH5a, respectively. 
Detection of DNA by Agarose gel electrophoresis 
The extracted DNA solutions of pSL1 and pKFC3k were checked by 0.8 
% agarose gel electrophoresis. 
Site-directed mutagenesis with QuikChange mutagenesis kit (Stratagene) 
and one-step transformation into E. coli JM 109 
Table 2.32: PCR (Polymer Chain Reaction) sample preparation for 
pSL ii and pSL 12 
Reagents*  
pSLI / pKFC3k 1 ( 	25 ng) 
forward primer 1.25 (—.. 125 ng) 
reverse primer 1.25 (-.' 125 ng) 
dNTP mix 0.5 
QuikSol 3 
Buffer (I Ox) 5 
sterilized deionised water 38 
Pfu Turbo DNA polymerase 1 
Total 51 
Table 2.33: PCR program for pSLII and pSL12 
Temperature / °C 
S 





The forward long primer containing a His6 tag was 5'-
TCCAAGTGCCATAGCGGATCGCATCACCATCACCATCACTAAG 
AATTCACTGGC, and the corresponding reverse long primer was 5'-
GCCAGTGAATTCTTAGTGATGGTGATGGTGATGCGATCCGCTA 
TGGCACTTGGA. 
After restriction digestion of the parental template by DpnI, 5 .tl of 
reaction solution was transferred into 200 tl of the freshly made E. co/i 
JM109 cells in TSS. After 30-minute incubation on ice, 800 i.tl of SOC 
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broth was added and the mini-culture was grown up at 225 rpm at 37 °C 
for 1 hour. Then, the cells were pelleted, resuspended in 200 tl of Soc 
broth, spread onto an LB agar plate with 50 tg I ml of kanamycin, and 
incubated overnight at 37 °C. 
(4) DNA sequencing and data analysis for pSLI 1 and pSL12 
This procedure was identical to the previous procedure with the general 
cytochrome C3 sequencing primer, 5'-ACGCcAAGcTTGCATGC. 
2.3.7 Point mutagenesis for production of K40C cytochromes c3 with a Strep 
Tag II (pSL13) 
In order to produce a K40C cytochrome C3 with a Strep Tag II at the C-
terminus, point mutagenesis could be exploited though a template plasmid 
DNA, pSL9. All reagents and programs were identical to section 2.3.5, 
except the forward primer, 5'- AGCGCTTGGAGCCACCCG, and the 
reverse primer, 5'- CGGGTGGCTCCAAGCGCT. 
2.3.8 Site-directed mutagenesis for production of the C156S mutant of P450 
BM3 heme domain (pSLa), the C156SHis6 mutant (pSLb), and the 
C62S:C156S:Q387CHis6 mutant (pSLc) 
According to previous experience, pSLa and pSLc could be produced though 
point mutagenesis while pSLb was created though long nucleotide insertion. 
All the genetic operations were achieved using the QuikChange mutagenesis 
kit (Stratagene). The template DNA was pBM20, which encoded the wild 
type heme domain of P450 BM3 [140]. 
Small scale plasmid DNA extraction with QlAprep spin miniprep kit 
(Qiagen) 
Plasmid DNA solutions of pBM20 was extracted from 5-ml overnight 
mini-cultures with 100 p.g/ ml of ampicillin of pBM20ITGI. 
Detection of DNA by Agarose gel electrophoresis 
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The extracted DNA solution of pBM20 was checked by 0.8 % agarose gel 
electrophoresis. 
(3) Site-directed mutagenesis with QuikChange mutagenesis kit (Stratagene) 
and one-step transformation into E. coli JM1O9 
Table 2.34. PCR (Polymer Chain Reaction) sample preparation for pSL a, 
pSLb, orpSLc 
pBM2O 	pSLa / pSLb 
1jTI 
I 	 1 (- 25 ng) 
forward primer 1.25 (- 125 ng) 
reverse primer 1.25 (-j 125 ng) 
dNTP mix 0.5 
QuikSol 3 
Buffer (lOx) 5 
sterilized deionised water 38 (35.5 *) 
Pfu Turbo DNA polymerase 1 
Total 51 
* Four primers were used in the production of pSLc. Therefore, the water volume 
was adjusted to 35.5 t1. 
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Table 2.35: PCR program for pSLa, pSLb, orpSLc 
Temperature / °C 
S 
Incubation time / s 
Is 
Cycles 
1:11 raI1LI u 
IsIs 
Table 2.36: plasmids and primers for the site-directed mutagenesis of 
heme domain of P450 BM3 
ar' mni n 
M2O 













After restriction digestion of the parental template by DpnI, 5 pd of 
reaction solution was transferred into 200 Rl of the freshly made E. coli 
TGI cells in TSS. After 30-minute incubation on ice, 800 ptl of SOC 
broth was added and the mini-culture was grown up at 225 rpm at 37 °C 
for 1 hour. Then, the cells were pelleted, resuspended in 200 pul of SOC 
broth, spreaded onto LB agar plate with 100 pug / ml of ampicillin, and 
incubated overnight at 37 °C. 
(4) DNA sequencing and data analysis for pSLa, pSLb, or pSLc 
This procedure was identical to the previous procedure with the general 
sequencing primer pair for the mutants of heme domain of P450 BM3, 
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5 1 - 	TCACTCATTAGGCACCCCAG 	(forward) 	and 	5 1 - 
CAGCTGGCGAAAGGGGGATG (reverse). 
2.4 	Transformation of plasmids into Shewanella oneidensis MR-i 
2.4.1 Chemical transformation of plasmids into Shewanella oneidensis MR-i 
Previous experimental procedures indicated that the chemical transformation 
of plasmid DNA into E. coli strains, JM109 and TG1, worked very well. 
Actually, this strategy had been proven to perform efficiently for the one-step 
transformation of DNA into most E. co/i strains [142-143]. This method was 
developed and applied to the transformation of DNA into Shewanella species. 
The cell membrane of Shewanella oneidensis is thicker than that of E. coli, 
although they are both classified as y-proteobacteria. This physiological 
property makes Shewanella oneidensis difficult to be transformed. The 
commonly used transformation methods are electrotransfonnation and 
conjugation. Electrotransformation is highly efficient and quick, but it needs 
expensive equipment and special cuvettes. The conjugation is a time-
consuming way of transformation and it will normally take a couple of days. 
The following transformation protocol, with some modifications to the 
literature method, was fully supported by the experimental evidence. 
5 ml of LB broth with 10 tg / ml rifampicin was inoculated from the stock of 
wild type Shewanella oneidensis MR-I in the -80 °C freezer using a sterile 
inoculating loop and grown at 37 °C in an incubator at 225 rpm overnight. A 
new 5-ml LB broth with the same antibiotics was inoculated with 200 tl 
overnight culture and grown until the optical density at 600 nm reached 
approximate 0.5 0.7. The cells were harvested by centrifugation at 5,000 
rpm for 5 min and resuspended in 500 iii of ice-cold transformation and 
storage solution (TSS). 200-rd aliquots of cells were dispensed into pre-
chilled eppendorfs. 
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5 il of plasmid DNA, extracted from 5-ml overnight culture of E. co/i 
containing pKFC3k or pSLn (n = 1 - 13), was added to an aliquot of cells and 
incubated for 30 min at 4 °C. 800 jil of SOC broth was added to the mixture 
and the entire mini-culture was shaken at 225 rpm at 37 °C for 1 hour. The 
cells were pelleted at 6,000 rpm for 4 minutes and resuspended in 200 tl of 
Soc broth. Then, the cells were spread onto an LB Agar plate supplemented 
with 50 .tg / ml kanamycin and 10 j.tg / ml nfatnpicin, and incubated at 37 °C 
overnight. 
A single colony was picked up for the growth of 5-ml overnight culture with 
antibiotics. A DMSO storage stock was made. The plasmid DNA was 
extracted from the rest of the culture and checked by agarose gel 
electrophoresis. 
2.4.2 Electrical transformation of plasmids into Shewanella oneidensis MR-1 
2.4.2.1 Preparation of electro-competent cells of Shewanella oneidensis 
5 ml of LB broth with 10 tg / ml rifampicin was inoculated from the stock of 
wild type Shewanella oneidensis MR-i in the -80 °C freezer using a sterile 
inoculating loop and grown at 30 °C in an incubator at 225 rpm. A 250-ml 
flask, filled with 100 ml LB Broth, was inoculated with 2-ml overnight 
culture and incubated for approximately 3 hours at 30 °C in an incubator at 
180 rpm until the optical density at 600 run reached approximately 0.5 0.7. 
The flask was placed on ice for 20 minutes. Then the culture was transferred 
into 4 sterile, ice-cold 50-ml Falcon tubes and the cells were harvested by 
centrifugation at 4000g (5000 rpm in a Sorvall GSA rotor), 8 mm, 4 °C. The 
supernatant was discarded, and the cell pellets were gently resuspended in 
200 ml of ice-cold 10 % glycerol. The cells were harvested by centrifugation 
at 4000g, 8 mm, 4 °C, and the supernatant was discarded. The wash of the 
cell pellets was repeated with 100 ml and 40 ml of ice-cold 10 % glycerol. 
Finally the cell pellets were resuspended in 1 ml cold 10 % glycerol. 40-tl 
aliquots of the cell suspension were dispensed into sterile, ice-cold 1.5-ml 
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eppendorfs, dropped into a bath of liquid nitrogen, and stored in a -80 °C 
freezer. 
2.4.2.2 Electrotransformation of plasmids into Shewanella oneidensis competent 
cells 
The competent cells of Shewanella oneidensis MR-i were thawed on ice. A 
1.5-ml eppendorf and 0.2 cm electroporation cuvette were placed on ice as 
well. In a cold 1.5-ml eppendorf, 40 .tl of the competent cell suspension was 
mixed with 2 p.1 of plasmid well and incubated on ice for approximately 1 
minute. The MicroPulser (Bio-Rad) was set to "Ec2", and the mixture of 
competent cells and plasmid was transferred into a cold 0.2 cm 
electroporation cuvette and tapped to the bottom. The slide was placed into 
the chamber and the "Pulse" button was pressed once. The cuvette was 
removed from the chamber and immediately I ml Soc medium was added. 
The cells were resuspended quickly but gently, and then transferred into a 
1.5-ml eppendorf and incubated at 30°C for 1 hour, shaking at 225 rpm. The 
miniculiure was spinned down at 6,000 rpm for 4 minutes. The supernatant 
was discarded and the cell pellet was resuspended gently with 200 p.1 of soc 
medium. And then the mixture was plated out on an LB-agar plate 
supplemented with 50 Vg / ml of kanamycin and 10 p.g / ml of rifampicin, and 
incubated at 30 °C overnight. 
2.5 	Protein Expression 
2.5.1 The expression of all cytochrome c3 mutants in Shewanella oneidensis 
MR-1 
Starter cultures, 5 ml of LB broth supplemented with 50 p.g / ml of 
kanamycin and 10 jig / ml of rifampicin, were inoculated with the stock of 
pKFC3kIMR-i or pSLnIMR-1 (n = 1 - 13) in the -80 °C freezer using a 
sterile inoculating loop and grown at 30 °C in an incubator at 225 rpm 
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overnight. 2-litre flasks, filled with 1000 ml of TB broth supplemented with 
200 .tg / ml of kanamycin and 10 .tg / ml of rifampicin per flask, were 
inoculated with I ml of starter culture and grown for 48 hrs at 30 °C, 150 
rpm. Cells were harvested by centrifugation (16000 g for 12 minutes) and 
stored at -20 °C. 
2.5.2 The expression of cytochrome P450 BM3 heme domain mutants 
Starter cultures, consisting of 5 ml of LB broth supplemented with 100 Vg / 
ml of ampicillin, were inoculated with the stock of pSLxITG 1 (x = a, b, c) in 
the -80 °C freezer using a sterile inoculating loop and grown at 30 °C in an 
incubator at 225 rpm overnight. 2-litre flasks, filled with 1000 ml of TB broth 
supplemented with 25 pg / ml of carbenecillin and 1-ml hemin solution 
(hemin 7mM and NaOH I mM) per flask, were inoculated with I ml of starter 
culture and grown for 48 his at 37 °C, 150 rpm. Cells were harvested by 
centrifugation (16000 g for 12 minutes) and stored at -20 °C. 
2.6 Protein Purification 
2.6.1 The purification of cytochrome C3 cysteines mutants 
Table 2.37: buffers for the purification of cytochrome c 3 cysteines mutants 
_iiiaiiI1TT11'i iIWli (SI 
MOPS 10 mM, pH 7.0 
DTT5mM 
Lysis Buffer I 
Streptomycin 1% (wt/vol) 
PMSF 200 p.M 
MOPS 10 mm 
Buffer Al 
DTT 1 iiiM 
MOPS 10mM 
Buffer B! DTT1mM  
NaC1 500 mM 
MOPS 10 mm 
Buffer C  DTT1mM  
NaCl 200 mM 
Generally, the purification of untagged cytochrome C3 cysteine mutants 
mainly utilized the unusual positive electrostatic surface while most of other 
proteins have negative surfaces. The cytochromes c3 could bind very tightly 
to the cation exchange resin, SP Sephraose because the exchanging functional 
group of SP Sepharose is the sulfopropyl anion (-CH2CH2CH2SO3). Elution 
from the SP Sephrose column followed by gel filtration on Superdex 75 [19]. 
Gel filtration, also called size exclusion, separates proteins according to the 
difference in their sizes. 
Approximately 30 g frozen cell pellets were defrosted, resuspended in 100 ml 
of Lysis Buffer 1, and lysed by sonication (MSE soniprep 150, 10 15 
mirons) for 20s x 10 on ice. Cell debris were removed by centrifugation at 
4000 g (20000 rpm in a Sorvall GSA rotor) for 1 hour at 4 °C. Further 
purification was carried out in the 4 °C cold room. The supernatant was 
loaded onto an SP-Sepharose gravity column (2.6 cm by 10 cm, Sigma) 
previously equilibrated with Buffer Al. Cytochrorne c3 bound to the column 
forming a red band at the top and the column was washed by 10 column 
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volumes of Buffer Al. A gradient from Buffer Al to Buffer B 1 was then used 
to wash out the cytochrome C3, which was eluted at 150 mM NaCl. The 
cytochrome C3 fraction was concentrated to approximately 2.5 ml by 
centrifugation at 3000 rpm (MSE centaur 2) using a concentrator (MWCO 
5,000, Vivascience) and further purified by gel filtration though fast protein 
liquid chromatography (FPLC) using a Hiload Superdex 75 column (2.6 cm 
by 60 cm, Ainersharn) on an AKTApurifier (GE healthcare) equilibrated with 
Buffer Cl. The cytochrome C3 fractions were pooled, and concentrated to 
approximate 2 ml. 200-F'1  aliquots were dispensed into sterile eppendorfs, 
dropped into a bath of liquid nitrogen, and stored in a -80°C freezer. 
2.6.2 The purification of cytochrome c3 mutants with Calmodulin binding 
peptide (CBP) 
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Table 2.38: buffers for the purification of CBP tagged cytochrome c 3 
Nanie of buffer Reauents and concentrations 
Tris 50 mM, pH 8.0 
DTTImM 
NaCl 150 mM 
Mg(AcO)2 1 mM 
Lysis Buffer 
Imidazole 1 mM 
CaCl2 2mM 
Streptomycin 1% (wt/vol) 
PMSF 200 gM 
Iris 50 mM, pH 8.0 
DTT1mM 
NaCl 150 	m 
Buffer A2 
Mg(AcO)2 1 MM 
Imidazole 1 mM 
CaC12 2mM 
Tris 50 mM, pH 8.0 
DTT1mM 
Buffer B2 
NaCl 150 mM 
EGTA 2mM 
Generally the purification of CBP tagged cytochromes C3 mainly utilized the 
tight binding activity of CBP and Calmodulin (CaM) to a CaM agarose resin 
(Stratagene) or a CaM Sepharose resin (Sigma) [83]. 
Approximately 30 g frozen cell pellets were defrosted, resuspended in 100 ml 
of Lysis Buffer II, and lysed by sonication (MSE soniprep 150, 10 - 15 
mirons) for 20s x 10 on ice. Cell debris was removed by centrifugation at 
4000 g (20000 rpm in a Sorvall GSA rotor) for 1 hour at 4 °C. Further 
purification was carried out in the 4 °C cold room. The supernatant was 
loaded onto a Calmodulin (CaM) affinity column (1.6 cm by 5 cm, Stratagene 
or Sigma) previously equilibrated with Buffer A2. CBP tagged cytochrornes 
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C3 were supposed to bind to the top of the CaM afimity column and were 
eluted out with Buffer B2. However, all red proteins in the supernatant 
simply went though the CaM affinity column and none of them were bound 
to the column. All three CBP tagged cytochromes C3 did not show any CaM-
binding. The CBP tagged cytochromes c3 were then purified with the protocol 
in section 2.6.1. The CBP tagged cytochromes C3 were eluted out at 
approximately 400 mM NaCl from SP Sepharose column and then purified 
by gel filtration though FPLC. The CBP tagged cytochrome C3 fractions were 
pooled and concentrated. 200-.tl aliquots were dispensed into sterile 
eppendorfs, dropped into a bath of liquid nitrogen, and stored in a -80°C 
freezer. 
2.6.3 The purification of cytochrome c3 mutants with Strep Tag II or New 
Strep Tag 
Table 2.39: buffers for the purification of Strep tagged cvtochrome C3 
1Fh itI$)  buffer ReagentslF1 LIEconcentrations 
I 	Tris 100 mM, pH 8.0 
Buffer W NaCl 150 mM 
DTT1mM 
Tris 100 mM, pH 8.0 
NaCl 150 mM 
Buffer E 
DTT 1 mM 
Desthiobiotin 2.5mM 
Tris 100 mM, pH 8.0 
NaCI 150 mM 
Buffer R 
DTT1mM 
HABA 2.5 mM 
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Generally the purification of strep tagged cytochromes c3 utilized the tight 
binding activity of Strep Tag II / New Strep Tag to a commercial streptavidin 
derivative resin (IBA) [144]. 
Approximately 30 g frozen cell pellets were defrosted, resuspended in 100 ml 
of Lysis Buffer I, and lysed by sonication (MSE soniprep 150, 10 15 
mirons) for 20s x 10 on ice. Cell debris were removed by centrifugation at 
4000 g (20000 rpm in a Sorvall GSA rotor) for 1 hour at 4 °C. Further 
purification was carried out in the 4 °C cold room. The supernatant was 
loaded onto an SP-Sepharose column (2.6 cm by 10 cm, Sigma) previously 
equilibrated with Buffer Al. Cytochrome C3 bound to the column forming a 
red band at the top and was eluted out with Buffer B 1. The cytochrome C3 
fractions were pooled, adjusted to pH 8.0 with Tns solution (1M, pH 8.0), 
and loaded onto a Strep-Tactin Sepharose column (10 ml, IBA) previously 
equilibrated with Buffer W. The strep column was washed by 10 column-
volume Buffer W and the strep tagged cytochrome C3 was eluted out with 
Buffer E. The red fractions were pooled, and concentrated to approximately 
2.5 ml. 200-tl aliquots were dispensed into sterile eppendorfs, dropped into a 
bath of liquid nitrogen, and stored in a -80°C freezer. 
In case of cytochromes C3 with New Strep Tag, the elution from strep column 
was further purified by gel filtration (Section 2.6.1). The fractions of the 
protein's monomer were collected, concentrated to approximately 2.5 ml. 
200-d aliquots were dispensed into sterile eppendorfs, dropped into a bath of 
liquid nitrogen, and stored in a -80°C freezer. 
The strep column was regenerated with Buffer R and Buffer W. 
2.6.4 The purification of cytochrome P450 BM3 heme domain mutants 
Table 2.40: buffers for the purification of mutants of P450 BM3 heme domain 
'ii 	 buffer Reagents and concentrations  
Tris 50 mM, pH 8.0 
NaCl 300 mM 
TCEP 1 mM 
Lysis Buffer III 
Imidazole 10 mM 
PMSF 200 j.tM 
Egg white lysozyme 1mg / ml 
Tris 50 mM, pH 8.0 
NaCl 300 mM 
Buffer A3 
TCEP 1 1iM 
Imidazole 20 mM 
Tris 50 mM, pH 8.0 
NaCl 300 mM 
Buffer B3 
TCEP 
Imidazole 250 mM 
Tris 50 mM, pH 8.0 
Buffer C3 
TCEP 1 i 1 iM 
Generally the purification of His6 tagged P450 BM3 heme domain utilized 
the tight binding activity of His 6 Tag to Nickel-N itrilotri acetic acid (Ni 2t 
NTA) resin (Qiagen). The excess imidazole introduced by Ni 2 -NTA column 
purification was removed by passing the protein solution though a G-25 
medium, which is a gel filtration column resin separating biomacromolecules 
from small molecules very well. 
Approximate 30 g frozen cell pellets were defrosted, resuspended in 100 ml 
of Lysis Buffer III, and lysed by sonication (MSE soniprep 150, 10 15 
mirons) for 20s x 10 on ice. Cell debris were removed by centrifugation at 
4000 g (20000 rpm in a Sorvall GSA rotor) for 1 hour at 4 °C. Further 
purification was carried out in the 4 °C cold room. The supernatant was 
loaded onto a Ni2 -NTA agarose gravity column (2.6 cm by 10 cm, Qiagen) 
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previously equilibrated with Buffer A3. The heme domain of P450 BM3 
bound to the column forming a red band at the top and the column was 
washed by 10 column volumes of Buffer A3. The heme domain was washed 
out with Buffer B3 directly. The red fraction was concentrated to 
approximate 2.5 ml by centrifugation at 3000 rpm (MSE centaur 2) using a 
concentrator (MWCO 30,000, Vivascience) and further purified by a G-25 
desalting gravity column (2.6 cm by 10 cm, Sigma) equilibrated with Buffer 
C3. The imidazole-free heme domain solution was concentrated to 
approximately 2 ml. 200-pt aliquots were dispensed into sterile eppendorfs, 
dropped into a bath of liquid nitrogen, and stored in a -80°C freezer. 
2.7 Determination of Protein purity and Concentration 
2.7.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
Polyacrylamide gel electrophoresis (PAGE) is an effective method for 
addressing protein purity by the separation of proteins in complex mixtures. 
The principle is that different proteins of different sizes run at different rates 
in an electric field. Small proteins will run faster than large ones, and 
globular-shaped proteins will run more quickly than linear-shaped proteins. 
Sodium dodecyl sulphate (SDS) is used to dissociate the proteins into 
individual chains, which are easy to be separated according to molecular 
weights in polyacrylamide gel electrophoresis. 
Pre-cast NuPAGE Novex 4-12% Bis-Tris gels (Invitrogen) were used to 
determine the purity of the protein throughout the purification procedures. 
Samples were prepared by adding 10 .tl of WAGE LDS sample buffer (4x, 
Invitrogen) to 30 il of protein sample. They were then boiled for 5 minutes 
to denature the protein before being loaded onto the gel. SeeBlue Plus 2 pre-
stained protein standard (Invitrogen) was used to mark the molecular weight. 
The running buffer was prepared by diluting 50 ml of WAGE MES SDS 
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(20x, Invitrogen) stock solution to 1 litre with deionised water (millipore) 
The gel was run for 1 hour at 150 V. 
Coornassie Brilliant Blue (CBB) staining 
Coornassie Brilliant Blue (CBB) staining is widely used for detection of 
proteins in SDS-polyacrylarnide gel electrophoresis. The blue dye can 
attach to polypeptides on the gel and form blue bands displaying the 
existence and abundance of proteins in the gel sample of complex 
mixture. 
Table 2.41: solutions for CBB staining 
Name of solution Reagents and concentrations 
I Coornassie Brilliant Blue 1 % 
CBB staining solution Methanol 40 % 
Acetic acid 10 % 
Methanol 40 % 
CBB destaining solution 
Acetic acid 10% 
The gel was stained with CBB staining solution for approximate 20 minutes. 
The dye was removed with CBB destaining solution until clear protein blue 
bands appeared on the gel. 
Heme staining (3,3',5,5'-tetramethylbenzidine (TMBZ)/H 202 staining) 
The staining method is always used to detect c-type cytochromes, in which 
the c-type hemes are covalently bound to polypeptide and will not lost during 
the sample preparation of gel electrophoresis in tough conditions. 
Table 2.42: solutions for heme staining 
.'F1IiP4]  solutio 
I 	 Methanol 30 % 
heme staining buffer I 
Sodium acetate 70 %, pH 5.2 
Methanol 30 % 
TMBZ solution Sodium acetate 70 %, pH 5.2 
TMIBZ solution (in Methanol, Sigma), I mg/ml 
Isopropanol 30 % 
heme staining buffer II 
Sodium acetate 70 %, pH 5.2 
All the staining steps were performed in a black box without any lights, 
which would degrade TMBZ. The gel was soaked in herne staining buffer I 
for 30 minutes. Then the gel was soaked in TMBZ solution for 30 minutes. 
150 p1 of H202  (AR Grade, 30%, 100 volumes, Fisher) was added to develop 
bands for 15 minutes and the dyes were then poured. Herne staining buffer II 
was used to fix the bands. 
2.7.2 UVfVis spectrophotometry 
UV/Vis spectrophotornetry was performed at room temperature using a 
Shirnadzu UV-1601 UVIVis scanning spectrophotometer with the UV-1601 
software. The characteristic absorbances and extinction coefficients for 
Desulfovibrio cytochrome C3 in both its oxidized and reduced forms are 
shown in Table 2.43. 
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Table 2.43: characteristic absorbances and extinction coefficients for Desu/fovibrio 
cvtochrome c3 in both its oxidized and reducedforms 
For cytochrome c3 of Desulfovibrio vulgaris Miyazaki F, e552 = 116 niM' cm - 
1 in the reduced state or Co = 416 mM cm in the oxidized state was used 
to determine the concentration [145]. 
The concentration of P450 was determined by producing the CO-bound 
reduced P450 BM3 heme domain, calculating out the difference spectra 
[Fe(I1)-CO] - [Fe(H)], using the extinction coefficient of C45o90 = 92 mM 
cm' [146]. 
Generally, the proteins were diluted 200 fold (5 R I protein stock solution in 
995 tl of the appropriate buffer). Spectra of protein samples were taken in the 
oxidised form, the reduced form, and the CO-bound reduced form only for 
P450 BM3 heme domain. The protein was reduced by addition of excess 
sodium dithionite (Na 2S204), and on addition bubbled with CO (Sigma) only 
for P450 BM3 heme domain. The protein concentration could be determined 
using the Beer-Lambert Law (A = ccl, 1 = 1 cm) and the above extinction 
coefficients. 
2.8 Thiol Counting 
The number of cysteine residues on the surface of the protein can be 
determined by reaction with 2,2' —dipyridyl disulphide (2-PDS). 2-PDS reacts 
with the thiol of the cysteine group to yield 2-pyridinethione, the presence of 
which was measured spectrophotometrically (Fig. 2.3) 
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Figure 2.3: the reaction scheme of a 2-PDS with a thiol yielding a 
chromophore, 2-pyridinethione (in yellow) 
The accumulation of the chromophore, 2-pyridmethione, was detected 
spectrophotornetrically at 343 nm (9343 = 8.08 mM' cm') [52]. The 
concentration change of 2-pyridinethione can therefore be used to calculate 
the concentration of thiol groups in the protein and hence the number of 
cysteine residues on the protein. 
Table 2.44: solutions for thiol counting 
.F1l itlu) solution (1Il*L1 uLIII]iN 	iiTT 	i 
2-PDS solution 
I 	
stock solution: 100 mM in methanol 
(oxygen free) working solution: 1 mM in NaOAc buffer 
NaOAc buffer Sodium acetate 500 mM, pH 5.0 
(oxygen free) EDTA 1mM 
Generally, the protein stock solution from -80 °C freezer was defrosted and 
incubated with DTT (stock concentration of 1 M and working concentration 
of 10 mM)for 30 minutes. Then, the sample was delivered into an anaerobic 
glove box (Belle Technology) and the following steps were carried out. The 
protein sample was passed through a gravity G-25 column (1.6 cm x 5cm) 
that had been equilibrated with the NaOAc buffer to remove the DTT. The 
concentration of the protein was determined by UV/Vis Spectroscopy and the 
protein was then diluted to 10 jiM. 
900 p.1 of the protein solution was added to a 1cm pathlength quartz crystal 
cuvette and a background reading of the protein sample was taken. 100 p.1 of 
89 
2-PDS working solution was added to the cuvette and the change in 
absorbance at 343nm was measured immediately and every minute for 30 
minutes. The total absorbance change corrected with baseline and protein 
dilution was converted to the quantity of free cysteines in the cysteine 
mutants of cytochrome c3 . 
2.9 Fluorescent Labelling of Cysteine on the protein 
Fluoresce in- 5 -maleimide (F5M) was used to determine the accessibility of 





Figure 2.4: chemical structure of F5M with a rhodamine-like fluorescent 
group (in yellow) 
F5M is a water-soluble and thiol-reactive fluorescent probe. There is a 
maleimide group that is connected to a rhodamine-like fluorescent group 
(Fig. 2.4). The increased photostability and pH insensitivity of the 
rhodamine-like component is useful in imaging experiments. 
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Table 2.45. solutions for F5M labelling 
Generally, the protein stock solution from -80°C freezer was defrosted and 
incubated with 10 mM DTT (stock concentration of I M and working 
concentration of 10 mM) for 30 minutes. Then, the protein sample was 
passed through a gravity G-25 colunm (1.6 cm x 5 cm) column that had been 
equilibrated with the MOPS buffer to remove the DTT. 
100 tl of F5M stock solution was added to 900 il of protein sample 
(approximate 10 1iM) and the mixture was incubated on ice in the dark for 5 
minutes. The reaction was quenched by adding DTT (1 M) to a final 
concentration of 10 mM for 5 minutes. The mixture was analyzed with SDS-
PAGE for evaluating the result of fluorescent labelling, and the gel was 
photographed under UV light. 
2.10 Substrate binding to the P450 BM3 heme domain mutant 
UVIVis spectra were recorded at room temperature over the range 250 - 800 
nm using a Shimadzu UV-2 101 PC spectrophotometer and quartz cuvette with 
a path length of 1 cm. 
Due to the insoluble nature of sodium laurate and palmitic acidlpalmitate, the 
saturated solutions of them were made by dissolving the substrates in the hot 
Buffer C3 (Section 2.6.4) initially. And then the precipitates were removed 
by centrifugation while the hot solution cooled to the room temperature. The 
clear solution for each substrate was taken as a baseline correction on the 
UV-Vis spectrophotometer. 
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The stock solution of P450 BM3 heme domain mutant from storage was 
defrosted and 10 p1 of the stock was added into 990 il of the substrate-
saturated solution. Then, the absorption spectrum was recorded. 
2.11 Chemical Crosslinking 
The crosslinker was 1 ,8-bis-Maleimidodiethyleneglycol (BM(PEO)2, Pierce). 
BM(PEO)2 can irreversibly crosslink to thiol groups of cysteine. It has a non-
cleavable flexible PEG(polyethylene glycol)/PEO spacer arm, which can 
enhance the aqueous solubility of the crosslinker, causing a reduced tendency 
toward protein aggregation, increased stability of conjugate, and reduced 
immunogenicity. Generally, the conjugation environment was pH 7.0 
maintained by an XL Buffer (MOPS 50mM, pH 7.0; glycerol 5%) and all 
crosslinking reactions were performed at room temperature. 
2.11.1 Homodimers of K40C and S107C cytochrome c3 
The frozen stock of K40C (or Si 07C) cytochrome C3 was defrosted and 
incubated with DTT (stock concentration of 1 M and working concentration 
of 10 mM) for 30 minutes to free the thiols of the surface cysteines. Then, 
the protein stock was passed though a gravity G-25 column (1.6 cm x 5 cm) 
previously equilibrated with XL Buffer to remove excess DTT. The protein 
was diluted to approximate 10 tM. 10 p1 of BM(PEO)2 (0.5 mM in DMSO) 
was added to 990 p1 of the diluted protein solution to a final concentration of 
5 pM and mixed throughly. Every 100-VI solution taken out from the mixture 
was quenched by 1 M DTT at 0, 1, 2, 3, 4, 5, 24 hours. The time-dependent 
crosslinking reaction samples were analyzed by SDS-PAGE. The gel was 
stained by heme staining, photographed, and analyzed by an image 
processing and analysis tool, ImageJ (NIH) (see appendix II). 
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2.11.2 Heterodimer of K40C and S107C cytochrome c3 
The cytochrome C3 modules were reacted at a molar ratio of 1:1. 
Frozen stocks of K40C and S 107C cytochromes C3 were defrosted and 
incubated with DTT (stock concentration of 1 M and working concentration 
of 10 nilvi) for 30 minutes to free the thiols of the surface cysteines. Then, the 
protein stock of SI07C was passed though a gravity G-25 column (1.6 cm  5 
cm) previously equilibrated with XL Buffer to remove excess DTT. The 
eluted S1O7C was diluted to approximately 10 gM. I inl of the diluted S1O7C 
solution was slowly added to 1 ml of BM(PEO) 2 solution (0.1 mM in XL 
Buffer, 1 mM in DMSO stock) with mixing. The reaction mixture was 
incubated for 1 hour and loaded onto a syringe-driven SP FF column (1 nil 
SP Sepharose column, Amersham) previously equilibrated with XL Buffer to 
remove excess BM(PEO)2 by washing the column with 10 ml of XL Buffer. 
All the red proteins were eluted out from the SP FF column with 0.5 M NaCl 
in XL Buffer. The protein stock of K40C was passed though a gravity G-25 
column (1.6 cm x 5 cm) previously equilibrated with XL Buffer to remove 
excess DTT. The eluted K40C was diluted to approximate 10 tM. 1 ml of 
K40C solution was mixed with the SP FF column's red elution and the 
mixture was concentrated by centrifugation to 200 iii and incubated at room 
temperature overnight. The crosslinking reaction was quenched with 1M 
DTT. The samples taken from every steps were analyzed by SDS-
PAGE/heme staining. 
2.11.3 Polymers of K40C:S107C cytochrome c3 
2.11.3.1 	Polymers formed by disulfide bonding 
The frozen stock of K40C:S107C cytochrome c3 was defrosted and incubated 
with DTT (stock concentration of 1 M and working concentration of 10 mM) 
for 30 minutes to free the thiols of the surface cysteines. Then, the protein 
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stock was passed though a gravity G-25 column (1.6 cm x 5 cm) previously 
equilibrated with XL Buffer to remove excess DTT. CuSO4 (1 mM) was 
added to the K40C:SI07C cytochrome C3 solution (- 20 .tM) to a final 
concentration of 20 tM and the reaction mixture was incubated at room 
temperature overnight. EDTA (stock concentration of 10 mM and working 
concentration of 1 mM) was used to quench the metal-induced disulfide bond 
crosslinking. The reaction mixture was analyzed by SDS-PAGE/heme 
staining and FPLC (see 2.12). 
2.11.3.2 	Polymers formed by bismaleimide crosslinking 
The frozen stock of K40C:S 1 07C cytochrome C3 was defrosted and incubated 
with DTT (stock concentration of 1 M and working concentration of 10 mM) 
for 30 minutes to free the thiols of the surface cysteines. Then, the protein 
stock was passed though a syringe-driven SP FF column (1 ml SP Sepharose 
column, Arnersham) previously equilibrated with XL Buffer to remove 
excess DTT. K40C:S107C cytochrome c3 was absorbed on the top of the mini 
SP Sepharose column and the column was washed with 10 ml of XL Buffer 
to remove excess DTT. The column was further washed 50 ml of BM(PEO)2 
(0.1 mM in XL Buffer made from 1 mM DMSO stock solution). Then, all the 
red proteins were eluted out from the SP FF column with 1 M NaCl in XL 
Buffer. The elution was incubated at room temperature overnight and the 
crosslinking reaction was quenched with 1M DTT. The reaction mixture was 
analyzed by SDS-PAGE/heme staining and FPLC. 
2.11.4 Heterotrimer of cytochrome C3 modules 
All three cytochrome C3 modules were reacted at a molar ratio of 1:1:1. 
(1) Preparation of K40C-BM(PEO) 2 or S  07C-BM(PEO) 2 
Frozen stocks of K40C or S107C cytochromes C3 were defrosted and 
incubated with DTT (stock concentration of 1 M and working 
concentration of 10 mM) for 30 minutes to free the thiols of the surface 
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cysteines. Then, the protein stock was passed though a gravity G-25 
column (1.6 cm x 5 cm) previously equilibrated with XL Buffer to 
remove excess DTT. 100 p1 of BM(PEO) 2 solution (10 mM in DMSO) 
was added to the eluted cytochrome C3 solution (-j 2 ml) with gentle 
stirring. The reaction mixture was incubated for 0.5 hour and loaded onto 
a syringe-driven SP FF column (1 ml SP Sepharose column, Amersham) 
previously equilibrated with )(L Buffer to remove excess BM(PEO)2 by 
washing the column with 10 ml of XL Buffer. All the red protein 
fractions containing K40C-BM(PEO) 2 or Si 07C-BM(PEO)2, were eluted 
out from the SP FF column with 0.5 M NaCl in XL Buffer. 
Production of S i 07C-BM(PEO)2-nstK4OC 
Frozen stocks of K40C cytochromes C3 with a New Strep Tag (nstK40C) 
was defrosted and incubated with DTT (stock concentration of 1 M and 
working concentration of 10 mM) for 30 minutes to reduce the thiols of 
the surface cysteines. Then, nstK40C was loaded onto a gravity Strep-
Tactin column (1 ml, IBA) previously equilibrated with DTT-free Buffer 
W (Section 2.6.3). nstK40C was bound to the strep column and the 
column was washed with 10 ml of DTT-free Buffer W. The column was 
drained out and S107C-BM(PEO)2 was added to the nstK40C bound 
resin. The mixture was kept shaking for 0.5 hour and the unreacted 
51 07C-BM(PEO)2 was drained out. The strep column was washed with 5 
nil of DTT-free Buffer W and the red protein fractions were eluted out 
with DTT-free Buffer E (Section 2.6.3). 
Production of Si 07C-BM(PEO) 2-nstK40C- BM(PEO) 2-K40C 
The strep column elution was added to K40C-BM(PEO) 2 . The mixture 
was concentrated to - 500 .tl and incubated at room temperature 
overnight. The crosslinking reaction was quenched with IM DTT. The 
samples taken from every step were analyzed by SDS-PAGE/heme 
staining. 
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2.11.5 Heterodimer of cytochrome c3 and the heme domain of P450 BM3 
The proteins were reacted at a molar ratio of 1:1. 
The frozen stock of K40C cytochrorne C3 with Strep Tag II (stK40C) and 
C62S:C156S:Q387C P450 BM3 heme domain (C387P450) were defrosted 
and incubated with DTT (stock concentration of 1 M and working 
concentration of 10 mM) for 30 minutes to free the thiols of the surface 
cysteines. Then, the protein stock of C387P450 was passed though a gravity 
G-25 column (1.6 cm x 5 cm) previously equilibrated with XL Buffer to 
remove excess DTT. 100 p1 of BM(PEO)2 solution (10 mM in DMSO) was 
added to the eluted C387P450 solution (- 2 ml) with gentle stirring. The 
reaction mixture was incubated for 0.5 hour and loaded onto a syringe-driven 
Q FF column (1 ml Q Sepharose column, strong anion exchange column, 
Amersham) previously equilibrated with XL Buffer to remove excess 
BM(PEO)2 by washing the column with 10 ml of XL Buffer. All the red 
protein, containing C387P450-BM(PEO)2, were eluted out from the Q FF 
column with 0.5 M NaCl in XL Buffer. The protein stock of nstK40C was 
passed though a gravity G-25 column (1.6 cm x 5 cm) previously equilibrated 
with XL Buffer to remove excess DTT. The eluted nstK40C protein was 
mixed with the Q FF red elutent and the mixture was concentrated by 
centrifugation to 200 p1 and incubated at room temperature overnight. The 
cross linking reaction was quenched with IM DTT. The samples taken from 
every step were analyzed by SDS-PAGE/heme staining. 
2.12 Analysis of crosslinking products by Fast Protein Liquid 
Chromatography (FPLC) 
Fast Protein Liquid Chromatography (FPLC) on a AKTApurifier (GE 
healthcare) was utilized to analyse the crosslinking mixture. A size exclusion 
column, Superdex S200 10/30 (Amershain), was attached to the 
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AKTApurifier and the column was equilibrated with Buffer C  (Section 
2.6.1) running at a flow rate of 0.5 ml/min. 500j.i.l of protein was loaded onto 
the column and the size distribution in the crosslinking products was then 
determined by the elution profile. 
2.13 OTTLE Potentiometric Titrations 
OTTLE (Optically Transparent Thin Layer Electrode) potentiometric titration 
is a powerful electrochemical technique to determine the mid-point potentials 
of redox proteins. 
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Figure 2.5: sample loaded 077'LE cell equipped with a three-electrode system and a 
potentiostat 
Generally, the working system (Fig. 2.5) of the technique contains three 
components: OTTLE, mediators (small electro-active molecules), and the 
redox protein. At a certain potential, the electrode interacts rapidly with the 
mediators and then these activated small molecules exchange electrons with 
the redox protein. After a period of equilibration, the portion of redox state 
change can be measured by UV-Vis spectrophotometry. According to the 
Nernst equation (Eq. 2. 1), the mid-point potential of the redox protein can be 
determined. 
RT [red] 
E= Em —lfl 
nF [ox] 
(Equation 2.1) 
where E is the half-cell reduction potential, Em is the standard half-cell 
reduction potential (mid-point potential), R is the universal gas constant, T is 
the absolute temperature, n is the number of electrons transferred in the half-
cell reaction, and F is the Faraday constant. 
OTTLE potentiometnc titrations were carried out at 25 °C using a Cary UV-
Vis spectrophotometer and Autolab PGSTAT 10 potentiostat. All samples for 
OTTLE titration were prepared in a Belle Technology glove box in a nitrogen 
atmosphere, with 02 levels maintained at < 5 ppm. 
Table 2.46: solutions for 077'LE 
ni rio solution Reagents and Econcentrations  
MOPS 50 mM, pH 7.0 
Buffer PT  KC1 500 mM 
glycerol 10 % 
MOPS 50 mM, pH 7.0 
Buffer PT2 
KC1 500 mM 
All buffers were degassed prior to use by bubbling with nitrogen gas for at least 1 
hour and left in the glove box overnight. 
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Table 2.47: mediators for cvtochrome c3 in OTTLE 
	
Flavin Mononucleotide (FMIN) I 	 -200 
I 	Benzyl Viologen (BV) 	1 -310 	 I 
I Methyl Viologen (MV) 	I 	 -430 	 I 
Mediators were introduced into the glove box as powdered samples and dissolved in 
degassed buffer PT I to a concentration of approximate 2 mM and added to the 
protein sample at a concentration of around 2 RM. 
A protein sample was concentrated to around 50 jil with a concentration of at 
least 300 jiM and introduced into the glove box upon degassing under the 
nitrogen atmosphere for at least 1 hour. This sample was added to 250 jil of 
Buffer PT1 with mediators and mixed throughly. Then, the mixture was 
introduced into the thin part of the OTTLE cell (0.3 mm) by a micro-syringe, 
carefully avoiding bubble production. The remainder of the cell was filled 
with Buffer PT2 with care, keeping clear layers of Buffer PT1 and Buffer 
PT2. A three-electrode system, Pt/Rh (95/5) gauze working electrode (wire 
diameter 0.06 mm, mesh size 1024 cm', Engelhardt, UK), platinum wire 
counter electrode and a Ag/AgC1 reference electrode (model MF2052, 
Bioanalytical Systems, IN 47906, USA) was used. Upon setup of electrodes, 
the OTTLE cell was taken out of the glove box and located in the Cary UV-
Vis spectrophotometer so that changes in the spectrum could be observed. 
Then, the potential was applied using an Autolab PGSTAT potentiostat via 
the three-electrode system (Fig. 2.5). An initial potential more positive than 
the approximate reduction potential was applied and lowered in 50 mV steps 
until reduction was achieved. The enzyme samples were allowed to 
equilibrate before the potential was moved on and spectra were recorded at 
each applied potential. Difference spectra were calculated and the maximum 
absorbance changes associated with a change in the redox state were plotted 
against applied potential (vs. SHE). Em values were determined by fitting the 
data to the Nernst equation (Microcal Origin 7.0). 
100 
2.14 OTTLE-driven electron transfer 
OTTLE was also used to investigate the inter-molecular electron transfer 
between cytochrome C3 and P450 BM3 heme domain, and intra-molecule 
electron transfer within the conjugate of cytochrome c3 and P450 BM3 heme 
domain. At a low applied potential supplied by a potentiostat, the cytochrome 
C3 module was reduced by the electrode due to its direct electrochemical 
interaction with electrodes while P450 BM3 heme domain can not interact 
with the electrode due to its buried active site. The reduced cytochrome c3 
module can then transfer electrons to the redox center of P450 BM3 heme 
domain on docking with the concave surface near the active site of P450 
BM3 heme domain. In the presence of CO, the reduction of P450 BM3 heme 
domain can be monitored by the UV-Vis spectrophotometer with the 
increases in absorbance at 450 nni. Here, cytochrome C3 plays a role as an 
electron transfer mediator. And palmitate was also added to favour reduction 
of P450 BM3. 
A saturated solution of palmitate was prepared in Buffer PT 1 (Section 2.13) 
with the previous protocol (Section 2.10), degassed, and transferred into the 
glove box. And a protein sample (1:1 mixture of cyt C3 and P450 BM3 heme 
domain, or their conjugate) was concentrated to around 50 tl with a 
concentration of at least 300 1tM and introduced into the glove box upon 
degassing under a nitrogen atmosphere for at least 1 hour. This sample was 
added to 200 In of palmitate-saturated Buffer PT1 without any mediators and 
mixed throughly. Finally, approximate 50 .tl of CO saturated Buffer PTI 
(200 pM), which was generated by bubbling a sealed Sterilin tube with CO 
(Sigma) for -5 minutes, was added to the reaction mixture. Then, the mixture 
was introduced to the thin part of the OTTLE cell (0.3 mm) by a micro-
syringe, carefully avoiding bubble production. The remainder of the cell was 
filled with Buffer PT2 (Section 2.13) with care, keeping clear layers of Buffer 
PTI and Buffer PT2. A three-electrode system (Section 2.13) was fitted to the 
UTILE cell and the cell was taken out of the glove box and located in the 
Cary UV-Vis. Then, the potential was applied using an Autolab POSTAl 
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potentiostat via the three-electrode system (Fig. 2.5). An initial potential was 
set to -200 mV for 1 hour to get rid of traces of molecular oxygen in the 
sample. Then, the potential was set to -300 mV and absorption spectrum was 
recorded every 5 minutes over a long period of 24 hour. 
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Chapter 3 




The tetraheme cytochrome C3 from the bacterium Desulfovibrio vulgaris Miyazaki F 
is a small, globular, highly soluble c-type cytochrome. The four hemes have 
extremely low reduction potentials, with half exposure to the solvent and a cyclic 
arrangement, which makes them able to transfer electrons in every direction. The 
highly positively charged surface also facilitates the interaction with negatively 
charged redox partners. In addition, this cytochrome has great stability to protease 
digestion and high temperature. Due to its physical, chemical, and electronic 
properties, this tetraheme cytochrome C3 was selected to be a fundamental module in 
the protein conjugation part of this project. 
It was found that the area on the surface near lysine 40 is negatively charged and 
serine 107 (C terminus), which is opposite to lysine 40, is surrounded by positive 
charge (Fig. 3.1). 
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A. Electrostatic surface of K40C cyt c3 	B. Electrostatic surface of SI07C cyt a 3 
C 
Lys 40 -> Cys 40 	 Ser 107 9 Cys 107 
Figure 3.1: the electrostatic surface of cytochrome c3. Panel A: the electrostatic 
surface of the K40C mutant; panel B: the electrostatic surface of the SI07C 
mutant; (the cysteines are highlighted in yellow); panel C. the spatial positions 
of residues 40 and 107 (the cysteine is in yellow). The electrostatic surfaces were 
generated using Pymol [14 7-149]. 
These two ammo acids were chosen as the ligation sites and mutated to cysteines. To 
some extent, the natural dipole may facilitate controllable ligation. The aims in this 
chapter are to construct three cysteine mutants, K40C, SIO7C, and K4OC:SIO7C, 
express them in Shewanella oneidensis, purify and characterise them by thiol 
counting and thiol labelling, produce homodimers and a heterodimer, with a 
bismaleimide crosslinker, I ,8-bis-Maleimidodiethyleneglycol (BM(PEO)2, Pierce), 
and generate high molecular weight polymers by disulfide and bismaleimide 
crosslinking of K40C :S 1 07C. 
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3.2 Basic characterization of untagged cytochrome C3 cysteine mutants 
3.2.1 Protein purifies and UV-Vis absorption spectra 
Wild-type cytochrome C3 and the mutants K40C, S107C and K40C:SI07C were 
successfully over-expressed in Shewanella oneidensis MR-I with yields of I 2 mg 
per litre culture and purified with ion exchange and gel filtration procedures. The 
presence of a single band in SDS-PAGE analysis (Figure 3.2B) indicated that the 
purity was higher than 90%. 
A 	 B 
1 2 3 4 5 6 7 8 9 1011 12 
17 
I 
Figure 3.2: SDS-PAGE/Coomassie Brilliant Blue staining analysis of wild 
type cytochrome c 3 during purification. Panel A: SDS-PAGE analysis of SP 
Sepharose eluted fractions. Lane 1, molecular weight marker; lane 2, soluble 
cells' extract; lane 3, column flow though; lanes 4 - 5, low salt elution; lane 
6, cytochrome C3 fraction. Panel B: SDS-PAGE analysis of gel filtration 
eluted fractions. Lane 1, molecular weight marker; lane 2 - 12, eluted red 
fractions; fractions of lanes 9 and 10 were collected. The pattern of SDS-
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Figure 3.3: UV-Vis spectra of wild type cytochrome C3 from Desulfovibrio 
vulgaris Miyazaki F. The red curve represented the oxidised form of 
cyzochrome C3 while the reduced form is in black All cytochrome c 3 mutants, 
including tagged mutants in later chapters, had the similar UV- Vis spectra. 
The UV-Vis spectra of cytochrome c3 of Desulfovibrio vulgaris Miyazaki F and all 
its mutants had two peaks (at 410 nm, 530 nm) in the fern-form (oxidised) and three 
peaks (at 419 tim, 523 nm, and 552 tim) in the ferro-form (reduced). The ratio of 
Abs552 (ferro-form) and Abs280 (fern-form), of all the cytochromes c3 were about 3 
(the highest ratio for this cytochrome c3), which meant the proteins were highly 
purified and had high heme content [16]. 
3.2.2 Fluorescent labelling of the cysteine thiol 
Fluorescein-5-maleimide (F5M) was used to determine the accessibility of free thiols 
in the cysteine mutants of Desulfovibrio vulgaris Miyazaki F cytochrome C3 (K40C, 
Si 07C and K40C:S I 07C) to the maleimide group. F5M has a maleimide group that 
is connected to a rhodamine-like fluorescent group (Fig. 2.4, 2.9). 
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The thiols of all three mutants: K40C, SI07C, and K40C:S107C, were shown to be 
accessible to maleimide-type reagents since they reacted with fiuorescein-5-
maleimide forming strong fluorescent bands on a gel (Fig. 3.4). However, there were 
small bands shown below the cytochrome c3 bands (Fig. 3.413). It was likely to be a 
small free-cysteine-containing protein co-purified with the cytochrome C3 mutant. It 
could be seen on the SDS-PAGE/CBB stained gel (Fig. 3.213, - 6 kDa) and 
chromatography analysis (Fig. 3.12, 20 mL). 
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Figure 3.4. fluorescent labelling of cysteine mutants of Desulfovibrio 
vulgaris Miyazaki F cytochrome c 3. Coomassie Brilliant Blue Stained 
analysis of the SDS-PAGE gel (panel A): lane 1, molecular mass marker; 
lane 2, 3, K40C without / with F5M; lane 4, 5, S107C without / with F5M; 
lane 6, 7, K40C:SJ07C without / with F5M Fluorescent lights on the same 
SDS-PAGE gel under UV light (panel B): 17 kDa Myoglobin is the marker 
(lane 1); big cytochrome C3 bands and small unknown protein bands appear 
(lane 3, 5, 7) 
3.2.3 Thiol counting 
The number of free cysteine residues within the cytochrome c3 was determined using 
the reagent of 2,2'-pyridyl disulfide (2-PDS). 2-PDS reacts specifically with free 
thiols yielding a chromophore, 2-pyridinethione (Fig. 2.3, 2.8). The accumulation of 
2-pyridinethione is usually monitored spectrophotometrically at 343 nm (C343 = 8.08 
108 
mM cm') to give quantification of the number of free cysteine groups within the 
protein. 
The thiol counting was carried out on the three cysteine mutants (Fig. 3.5). The 
absorbance change at 343 nm was monitored over 30 minutes. There were fast initial 
phases followed by slow phases in all three cases. The initial mixing phase could not 
be recorded due to the rapid reaction and it could be corrected by the spectrum of 
protein before adding 2-PDS. The absorbance change was recalculated to show thiol 
equivalents. The mean of thiol numbers obtained from 16 30 minutes (where the 
reaction was almost finished) was used to represent the overall thiol number of each 
mutant and the standard deviation of them represented the errors. 
Thiol counting for cysteine mutants 
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Figure 3.5: time-dependent traces of the absorbance change at 343 nm 
during the counting analysis of three cysteine mutants of Desulfovibrio 
vulgaris Miyazaki F cytochrome c 3 
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Experimentally, for two single cysteine mutants, K40C and S107C, the number of 
free cysteines was 0.80 ± 0.06 and 1.00 ± 0.02, respectively. And the double 
mutant, K40C:SI07C had 2.04 ± 0.04 equivalent free cysteines. 
Generally, the results of fluorescent labelling in the qualitative view and 2-PDS 
counting in the quantitative view indicated that the cystemes at positions 40 and 107 
of cytochrome C3 were non-coordinated and could be accessed by small molecules. 
3.3 Crosslinking of untagged cytochrome C3 cysteine mutants 
In order to determine whether cysteines 40 and 107 were exposed enough for protein 
conjugation, homodimers of K40C and Si 07C cytochrome c3 were produced and 
dimer formation was analyzed with time dependence. A heterodimer of K40C and 
S107C cytochrome C3 was also made in a two-step crosslinking reaction, which laid 
the basis for developing the multi-step crosslinking (Section 4.4). Furthermore, high 
molecular weight polymers were also produced by disulfide crosslinking and by 
bismaleimide crosslinking of K40C:SI07C cytochrome C3. This demonstrated the 
possibility of the formation of cytochrome C3 "nanowires". 
3.3.1 Homodimers of cytochome c3 modules: K40C-K40C and S107C-S107C 
The production of homodimers was achieved by simply mixing the single cysteme 
mutant with a half-equivalent of bismaleimide (BM(PEO) 2 , Section 2.11. 1). There 
was no colour change in the reaction mixture and the solution retained clear during 
the crosslinking process. The reaction was quenched by concentrated DTT at 
different times allowing the time dependence of homodimer formation to be studied 
by SDS-PAGE (Fig. 3.6). The gels were analysed by ImageJ (see appendix II), which 
is a free image processing and analysis tool from NTH [150]. 
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10 pM K40C or S107C self-crosslinking with 5 pM BM(PEO) 2 
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Figure 3.6: time dependent homodimer formation. In both SDS-PA GE gels, 
the top bands were homodimer (K40C-K40C or SI07C-SJ07C) and the 
bottom bands were cytochrome C3 monomer. The portion of S107-SI07C in 
the cross/inking mixture against time was in the blue plot, while that of 
K40C-K40C was plotted in red. 
The analysis of crosslinking results showed that the crosslinking reaction was almost 
finished in 2 hours and the yields were 60 % for the S1 07C dimer and 30 % for 
the K40C dimer respectively. S107C was more efficient in forming homodimers than 
K40C. The C terminus of protein (SI07C) was much more flexible and exposed to 
the solvent than K40C, which is located in the middle of the polypeptide sequence. 
There was still a little monomeric mutant left uncrosslinked in the reaction mixture, 
even after 24 hours. It might be due to hydrolysis of the maleimide group (Fig. 3.7), 








Figure 3.7: hydrolysis of the maleimide group. Half life is approximately 24 
hours at pH 7.0 [48]. 
There were small bands between monomer and dimer shown on the gel of Si 07C 
homodimer formation (Fig. 3.6). They were considered as the conjugates of small 
free-cysteine-containing protein (Section 3.2.2) and SIO7C. 
3.3.2 Heterodimer formation 
For the production of the heterodimer of K40C-S107C cytochrome c3 , S107C was 
treated with 10-fold excess bismaleimide crosslinker and the maleimide-modified 
S107C (S107-BM(PEO)2) was purified using a small SP Sepharose column. Then, 
S107-BM(PEO)2 was mixed with the equivalent K40C (Fig. 3.8, Section 2.11.2). 
There was no colour change in the reaction mixture and the solution retained clear in 
each step. 
Figure 3.8: reaction scheme for the production of the K40C-SJ07C heterodimer 
Small amounts of solution were taken from each step of the cross linking reaction and 
were prepared as gel samples to be analysed by SDS-PAGE/heme staining (Fig. 3.9). 
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Figure 3.9: SDS-PA GE/heme staining analysis of the two-step cross/inking 
reaction for producing K40C-SI07C heterodimer. Lane M molecular weight 
marker; lane 1: SIO7C, lane 2: SJO7C-BM(PEO)2: lane 3: K40C; lane 4: 
SI 07C-K40C heterodimer 
According to the SDS-PAGE result, most SIO7C was converted into SIO7C-
BM(PEO)2 with a little Si 07C homodimer side-product (lane 2, Fig. 3.9). Upon the 
addition of K40C, the amount of dimer sharply increased (lane 4, Fig. 3.9), which 
meant that the heterodimer of K40C and Si 07C was successfully synthesized in this 
two-step crosslinkmg reaction with a yield of 25 %. The middle bands between 
monomer and dimer (lane 2, 4, Fig. 3.9) were considered as the conjugates of small 
free-cysteine-containing protein and S1 07C (Section 3.3.1). Although this 
heterodimer was not separated from the reaction mixture for further analysis, the 
two-step reaction indicated that the crucial intermediate product, the bismaleimide-
modified cytochrome c3 module, could be synthesized, purified, and reacted with the 
other reactant. In addition, the synthesis of K40C-SI07C laid the basis for 
developing a controllable multi-step crosslinking method (4.4). 
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3.3.3 Polymerising cytochrome c3 modules 
The polymerization of cytochrome C3 modules was achieved by crosslinking the 
double cysteine mutant of K40C:S107C, through disulfide bonding (cleavable) or 
bismaleimide linking (non-cleavable). Since the ligation sites were opposite to each 
other on the surface of cytochrome C3, the created protein polymers could be one-
dimensional long chains. The chains should have properties as bioelectronic 
"nanowires". 
When two cysteine thiol groups are close enough to each other, a disulfide bond is 
formed spontaneously in an oxidising environment. That's the reason DTT was used 
in the purification of cytochrome c3 cysteines mutants to prevent protein aggregate 
formation. Transition metal ions, like Cu 2 and Nil" can catalysize disulfide bond 
formation, even in trace amounts. Here, disulfide-linked polymers were produced in 
the presence of small amount of CuSO4. The polymerization process was also 
initiated by adding the bismaleimide crosslinker (BM(PEO) 2) to an equimolar 
amount of K40C:S107C. There was no colour change in the reaction mixture and the 
solution remained clear during the crosslinking process. Both kinds of cytochrome C3 
polymer were investigated by UV-Vis spectrometry, SDS-PAGE, size exclusion 
chromatography and OTTLE potentiometric titration. 
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Figure 3.10: UV-Vis spectra of disulfide-linked cytochrome c 3 polymers 
with the oxidised form in red and the reduced form in black The UV- Vis 
spectra of bismaleimide-linked cytochrome C3 polymers had similar 
characteristic peaks in both forms. 
The UV-Vis spectra of cytochrome C3 polymers were similar to those of wild type 
cytochrome c3, with two peaks at 410 nm, 530 nm in the oxidised form and three 
peaks at 419 nm, 523 nm, and 552 nm in the reduced form (Fig. 3.10). It showed that 
the conjugation of cytochrome C3 modules, through either the short linkage of 
disulfide bond or long soft polyethylene glycol group, did not affect the chemical 
nature of the heme groups. It implied that the components of the protein conjugates 
retained their properties after crosslinking. 
(2) SDS-PAGE/heme staining analysis of cytochrome C3 polymers 
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Figure 3.11: SDS-PA GE/heme stained gels of cytochrome c 3 polymers. 
Panel A: lane M, molecular weight marker; lane 1, disulfide-linked 
cytochrome C3 polymers; lane 2, cleavage of disulfide-linked cytochrome 
C3 polymers by DTI'. Panel B: lane 3, unreacted K40C:S107C cytochrome 
C3; lane 4, bismaleimide-linked cytochrome C3 polymers 
In the disulfide-crosslinking reaction mixture (lane 1, Fig. 3.11), most of the 
K40C:SI07C cytochrome C3 modules formed a large portion of high molecular 
weight polymers (at least 12 mer), although a little monomer was left unreacted in 
the mixture. The disulfide driven crosslinking reaction was reversible and the 
polymers could be cleaved by concentrated DTT, which was added into the gel 
sample to 1 M before boiling. The cleavage product was mainly K40C:SI07C 
cytochrome C3 monomer (lane 2, Fig. 3.11). The bismaleimide-crosslinking reaction 
also showed high degree polymerization (at least 8 mer) but was not as efficient as 
disulfide-crosslinking reaction. The portion of bismaleimide-linked high molecular 
weight polymers in the reaction mixture was not as much as that of disulfide-linked 
polymers (lane 4, Fig. 3.11). And the crosslinking progress was not reversible 
because there was already concentrated DTI' (1 M) in the gel sample. Possible 









crosslinker and the two-step reaction mechanism being more complex than the one-
step reaction progress of disulfide crosslinking. Although disulfide crosslinking is 
efficient, the fact that they are cleaved in a reducing environment limits their 
application. 
(3) Size exclusion chromatography analysis of the cytochrome c3 polymers 
Size exclusion chromatography (gel filtration chromatography) separates proteins 
based on their size. Usually proteins with large size will go through the gel filtration 
column faster than proteins with small size. Besides being a common tool for protein 
purification, size exclusion chromatography was applied here to analysize the 
crosslinking reaction mixture. 
The elution profile of cytochrome c3 polymers on Superdex S200 
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Figure 3.12: Elution profile of cytochrome C3 polymers on the size 
exclusion column, Superdex S200, flow rate 0.5 ml/min. The blue curve 
represents the elution of bismaleimide-linked polymers; the black curve 
represents the elution of disulfide-linked polymers; the red curve 
represents the elution of DTT cleaved disulfide-linked polymers (mainly 
K40C:SI 07C); the green vertical line highlights the position of the 
monomeric cytochrome c 3 module (16.4 ml). 
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There was a large portion of high molecular weight polymers in the disulfide-
crosslinking reaction (Fig.3. 12, black curve). The bismaleimide driven 
polymerization was not so efficient and had less high molecular weight polymers 
(Fig.3. 12, blue curve). The results of size exclusion chromatography analysis were 
consistent with that of SDS-PAGE/heme staining analysis. 
(4) OTTLE potentiometric titration analysis of cytochrome C3 polymers 
The results of UV-Vis spectroscopy showed that heme groups in the cytochrome C3 
modules retained their chemical properties before and after polymerization. 
However, the conjugation of cytochrome C3 modules may modify the microscopic 
electronic environments of the hemes. OTTLE potentiometric titration analysis was 
used to study the change in the reduction potentials of the hemes before and after 
polymerization. And the protein samples remained soluble during the potentiometric 
titration. Difference spectra were calculated and the maximum absorbance (410 nm) 
changes associated with a change in the redox state were plotted against applied 
potential (vs. SHE). One-electron form Nernst equation (Eq. 2.1) was transformed to 
equation 3.1 (note that [Ox]+[Red] = 1) and equation 3.1 was extended to four-
electron form (Eq. 3.2). Em values of four hemes were determined by fitting the data 
to the equation 3.2 using Microcal Origin 7.5. 
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(Eq. 3.2) 
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Figure 3.13: potentiometric titration data and 4-electron Nernst fits for 
wild type cytochrome C3 (black solid square), disulfide-linked polymers 
(red solid circle), and bismaleimide-linked polymers (blue solid triangle) 
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Table 3.1: macroscopic reduction potentials of wild type cyiochrome c3 
and two crosslinked polymers 
E 1 /mV E2 ImV E3/mV E4ImV E*/ mV 
wild type cytochrome C3 
-242 -296 -313 -358 -302 
(literature value [151]) 
wild type cytochrome C3 261l -261 -261 § -433 •-304 
(this work) ±11 
disulfide-linked polymers -247 -321 321 1  456 -336 
±10 ±9 
bismaleimide-linked polymers -261 -355 428 -507 -388 
±8 ±9 ±10 ±11 
* -= E1 + E2 + E3 + 
4 
§ Errors could not be determined due to interdependency. 
Although the individual macroscopic reduction potentials were different from the 
literature values (Table 3.1), the overall mid-point reduction potential of wild type 
cytochrome c3 (E = -304 mV) was very close to the literature value (E = -302 mV). 
Generally, the reduction of the three species occurred over a range of -100 mV - 
600 mV (Fig. 3.13). However, the electrochemical behaviours of the three species 
were a little different. Wild type cytochrome c3 had the least negative mid-point 
reduction potential (E) whilst those of the two polymers were shifted towards the 
negative. Actually, disulfide bonds are reduced at potentials < 300 mV and the real 
active species in the potential titration is likely to be the K40C:S 107 cytochrome C3 
monomer. The bismaleimide-linked polymers had the lowest overall mid-point 
potential (E = -388 mV). A possible reason is that the interaction among hemes in 
the cytochrome c3 modules makes the polymer more difficult to reduce. 
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3.4 Conclusions 
Three cysteine mutants of cytochrome C3, K40C, S107C, and K40C:S107C, were 
genetically constructed, successfully expressed in Shewanella oneidensis MR-I, and 
purified. Fluorescent labelling showed that the thiols were accessible towards the 
maleimide group and the 2-PDS counting of cysteine thiol groups confirmed the 
number of free thiols in the mutants. 
Protein crosslinking was performed with a bismaleimide crosslinker, 1,8-bis-
Maleimidodiethyleneglycol (BM(PEO)2) on the cysteine mutants and the heme 
environment remained unchanged during reaction. The following crosslinking 
products were successfully produced: 
K40C and Si 07C cytochrome C3 homodimers 
S 107C was more efficient in forming homodimers than K40C probably because it is 
the flexible and exposed C terminus of the protein. The yields in two hours were 60 
% for the Si 07C dimer and - 30 % for the K40C dimer respectively. The incomplete 
dimerization might be due to the hydrolysis of the maleimide group and two-step 
crosslinking mechanism. The trace amount of thiol containing protein also affected 
the production of homodimers in conjugating with the monomeric cytochrome c3 
mutant. 
K40C and Si 07C cytochrome c3 heterodimer 
In order to make a heterodimer, a bismaleimide-modified S107C intermediate was 
prepared, purified, and reacted with K40C with a yield of 25 %. The two-step 
reaction shows that protein ligation can be performed in a controllable multi-step 
way. However, the maleimide group hydrolysis during reaction and the impurity in 
the protein sample were still the problems limiting the production of the heterodimer. 
Disulfide-linked and bismaleimide-linked cytochrome c3 polymers 
Cytochrome C3 polymers are long chains of heme proteins. It is possible that electron 
transfer could occur along the length forming bioelectronic nanowires. Two methods 
were used for the polymer production: disulfide crosslinking and bismaleimide 
crosslinking. The polymers generated through disulfide crosslinking were cleavable 
whereas bismaleimide crosslinked polymers were stable in the reducing environment. 
Polymerization was conducted by adding Cu 2 /bismaleimide directly. Both gave high 
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degree polymerization yielded up to 1 2mer at least for disulfide crosslinking and up 
to 8mer at least for bismaleimide crosslinking. The UV-Vis spectroscopy of both 
polymers showed that the chemical nature of heme groups in cytochrome C3 
remained unchanged before and after polymerization. OTTLE potential titration 
shows that the polymerisation of the cytochrome c3 modules leads reduction 
potentials shift towards the negative from - 304 mV (wild type) to -336 mV 
(disulfide-linked cytochrome C3 polymers) and -388 mV (bismaleimide-linked 
cytochrome c3 polymers). A possible reason is that the interaction among hemes in 
the cytochrome C3 modules makes the polymer more difficult to reduce. 
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Chapter 4 
Using affinity tags 
to control protein conjugation 
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4.1 	Introduction 
Many different peptides, domains and proteins, have been developed as affinity tags 
for one-step purification of recombinant proteins. Generally, the tags should have 
only a minimal effect on the target proteins' tertiary structure and biological activity. 
In some applications, it is required to specifically remove the tag from the 
recombinant protein. There is not a single tag suitable for all proteins and it is 
difficult to decide on the best affinity tag for a specific protein of interest. 
In this project, the affinity tag not only aided the purification of recombinant proteins 
but was also used as "protective groups" in the controllable crosslinking strategy 
(Figs. 1.20 - 1.22). Two common commercially available affinity tag systems were 
applied: Calmodulin binding peptide (CBP) / Calmodulin (1.9.1) and Strep Tag II! 
Streptavidin (1.9.2). 
The initial aims in this chapter were to construct a series of CBP tagged 
K40C:S107C cytochromes C3, express them in Shewanella oneidensis, purify them 
with the Calmodulin affinity column, and characterize them by thiol counting, and 
produce a cytochrome C3 heterotrimer by controlled crosslinking. Upon failure of the 
CBP tagged cytochromes C3 to bind to the Calmodulin affinity resin, the Strep Tag II 
/ Streptavidin derivative tag system was exploited. Furthermore, a new strep tag 
based on Strep Tag 11 was developed specifically for protein crosslinking. 
4.2 	Calmodulin binding peptide (CBP) tagged cytochrome c3 
Calmodulin (CaM) is a small, Calcium-binding protein constituting of 148 amino 
acids. The apo-Calmodulin is dumb-bell-shaped. In the presence of Ca 2 , Calmodulin 
undergoes a major conformational change and wraps around its target peptide or 
protein (Fig. 1.13). The commonly used CaM binding peptide (CBP) affinity tag is a 
28 amino acid long sequence with a size of about 3 kDa (Table 1.1). 
In order to achieve maximum blocking effect on the cysteine 107, the length of the 
linker between protein and CBP should be as short as possible. Therefore, three 
CBP-tagged cytochromes C3 with different linkers were constructed mainly by 
overlap PCR (2.3.3). They were K40C:S107C-Gly-Thr-CBP, K40C:S107C-Thr-
CBP, and K40C:5107C-ihrombin-CBP (thrombin = a 
thrombin-cleavable linker). They were all expressed in Shewanella oneidensis for 
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purification on CaM affinity column. Unfortunately, no red proteins bound the 
column. Two CaM affinity columns from different companies, Stratagene and 
Sigma, were tested using three CBP tagged cytochromes C3 and the results were 
negative. 






Figure 4.1: SDS-PAGE/heme staining analysis of the eluted fractions of the SP 
Sepharose column for purification of CBP lagged cytochromes C3. All the three 
tagged cytochromes c 3 had similar patterns of SDS-PAGE/heme staining gels. Lane 
M molecular weight marker; lane 1: 150 mM NaCl elution; lane 2:400 mM NaCl 
elution. 
The CBP tagged cytochromes C3 were then purified by SP Sepharose column 
chromatography (cation exchange). They were eluted out from SP Sepharose column 
at about 400 mM NaCl concentration, which is higher than the elution conditions of 
untagged cytochromes C3 (150 mM, Fig. 4.1). A possible reason is that the total 
charge of CBP is mainly positive (Arg + Lys = 8). 
The UV-Vis spectra of the purified CBP-tagged cytochromes C3 were identical to that 
of the wild type (Fig. 3.3). Therefore, the attachment of a short peptide to the C 
terminus did not affect the coordination environments of the heme groups. 
Possible reasons for CBP-tagged cytochromes C3 without CaM binding activity might 
be that the linker was not long enough or that the CBP was partly proteolysed during 
expression. The problems might be solved by genetically lengthening the linker or 
co-expressing CBP-tagged proteins with Calmodulin in Shewanella oneidensis. 
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However, the long linker might not block the cysteine 107 very well and the 
expression of Calmodulin in Shewanella oneidensis had not been tested yet. Hence, 
the work was moved onto the following affinity system. 
4.3 	Tagging cytochrome C3 with Strep Tag II 
After the failure of the CBP/CaM affinity system, another affinity tag, Strep Tag II, 
was utilized. Strep Tag II is a small peptide with only 8 amino acids and its 
associated protein is Strep-Tactin, a streptavidm derivative. Due to the size and 
neutral charge of Strep Tag II, it is less likely to affect the folding and biological 
activity of proteins. Streptavidin, a small tetrameric protein, has high physical and 
chemical stability and can survive various protease digestions. The special properties 
of Strep Tag II and Strep Tactin make them very popular in affinity purification. 
The strep-tagged K40C:SI07C cytochrome C3 was constructed by overlap PCR 
(Section 2.3.4), expressed in Shewanella oneidensis, and purified by a Strep-Tactin 
Sepharose column chromatography (IBA). The strep-tagged K40C:S107C 
cytochrome C3 was successfully bound to the Strep-Tactin Sepharose column and 
formed a red band on the top of the column. The red band was eluted by 
desthiobiotin buffer E (Section 2.6.3) and was analysized by SDS-PAGE/heme 
staining (Fig. 4.2). Interestingly, the bands of strep tagged cytochrome C3 on the 
SDS-PAGE gel could not be developed by Coomassie Brilliant Blue (CBB) staining. 
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Figure 4.2: SDS-PAGE/heme staining analysis of the fractions of the Strep-Tactin 
Sepharose column. Lane M: molecular weight marker; lane 1. cell extract; lane 2: 
SP Sepharose column flow through; lane 3: 500mM NaCl elution of SP Sep harose; 
lane 4: Strep-Tactin column flow through; lane 5 10: eluted fractions of stKS 
cytochrome C3 
Besides the monomeric strep tagged K40C:SI07C cytochrome C3 (stKS), there were 
oligomers of stKS formed. The oligomers were covalently linked since the gel 
sample was prepared in presence of I M DTT. The reason of the oligomer formation 
remains unclear. Ferguson and co-workers [152] showed that a cysteine, within or 
next to the c-type heme binding motif in the sequence of cytochromes c (CXXCH or 
CXXXXCH, where X is any amino acid), could be activated during the cytochrome c 
maturation progress. Cysteine 107 in the stKS was just next to the heme binding 




Figure 4.3: protein sequence ofstKS near the C-terminus. The cytochrome C3 portion 
is highlighted in red; Strep Tag II is highlighted in yellow after the linker ofserine 
and alanine. Cysteine 107 is in italic and -Cys-Lys-Gly-Ser-Lys-Cys-His is a typical 
cytochrome c binding motf(CXXXCH). 
Therefore, cysteine 107 might be activated during expression and connected to 
another cytochrome C3 module forming covalent linked oligomers. However, the 
untagged Si 07C mutant of cytochrome C3 did not encounter this problem, although 
the carboxyl group of the C-terminal cysteine might affect the process. 
The UV-Vis spectra of the stKS remained the same as those of wild type cytochrome 
C3 (Fig. 3.3). 
4.4 	Tagging cytochrome C3 with New Strep Tag 
To counteract the self oligomerization of strep-tagged K40C:S107C cytochrome C3, a 
mutation was introduced the Strep Tag II, where the second amino acid, serine, was 
changed to cysteine; and the cysteine 107 was changed back to serine (Fig. 4.4). 
K40C:S107C cytochrome c-, with Strep Tag H 
Ser-Ala-Trp-$er-His-Pro-Gin-Phe-GIu-Lys 
'CyslO7-)Ser 	Ser -)Cys 
Ser-Ala-Trp-Cys-His-Pro-Gin-Phe-GIuLyS 
K40C cytochrome c. with New Strep Tag 
Figure 4.4: muzagenesis of K4OC:SJO7C cytochrome C3 with Strep Tag II (stKS) into 
K40C cytochrome c 3 with New Strep Tag (nstK40C). The cytochrome C3 portion is 
highlighted in red; Strep Tag II and New Strep Tag are highlighted in yellow after 
the linker of serine and alanine. The mutation sites are in italic and underlined 
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The mutated Strep Tag H is now named New Strep Tag. The physical similarity of 
serine and cysteine should minimise the disruption of the Strep-Tactin binding 
activity. The cysteine in the new strep tag was also more exposed than the cysteine at 
the C terminus of cytochrome C3 module. Upon interaction with Strep-Tactin, the 
cysteine in the New Strep Tag would be inside the Strep-Tactin binding pocket and 
crosslinking reaction at this site should be fully blocked (Fig. 1.21). 
(1) 	Purification of nstK40C cytochrome C3 
The nstK40C cytochrome C3 was constructed by point mutagenesis of the plasmid 
encoding stKS cytochrome C3 (Section 2.3.5). It was expressed in Shewanella 
oneidensis, and purified by Strep-Tactin Sepharose column chromatography (IBA). 
The nstK40C cytochrome C3 was bound to the Strep-Tactin Sepharose column and 
formed a red band on the top of the column. The red band was eluted by the 
desthiobiotin buffer E (Section 2.6.3) and was analysized by the SDS-PAGE/heme 
staining (Fig. 4.5). The bands of nstK40C cytochrome c3 on the SDS-PAGE gel also 
could not be developed by Coomassie Brilliant Blue (CBB) staining. 
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Figure 4.5: SDS-PAGE/heme staining analysis of the fractions of the Strep-Tactin 
Sepharose column. Lane M - molecular weight marker; lane 1: column flow though; 
lane 2 7: eluted fractions of nstK40C cytochrome C3 
The gel analysis showed that there were no high molecular weight oligomers formed 
at this time. Most nstK40C was monomeric with minor dimer and trace trimer bands. 
It also supported the hypothesis that the cysteine at position 107 next to the heme 
binding motif might involved in stKS cytochrome c3 oligomerization. 
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Figure 4.6: size exclusion chromatograghy (Superdex S200) to separate the 
monomeric nstK40C cytochrome c 3, fractions 13 and 14 were collected. 
The nstK40C cytochrome C3 was further purified by size exclusion chromatograghy 
to separate the monomeric protein. The elution from the Strep-Tactin column was 
concentrated to about 0.5 ml and loaded on to a Superdex S200 column at a flow rate 
of 0.5 ml/ min on the AKTApunfier (Section 2.12). The biggest peak on the elution 
curve (Fig. 4.6) was nstK40C monomer at approximately 16.5 ml elution volume. 
The peaks of monomer and dimer overlapped together. The nstK40C monomer 
fractions were collected. 
The UV-Vis spectra of nstK40C were the same as those of the wild type cytochrome 
C3 (Fig. 3.3) and were used to determine the concentration. 
(2) 	Thiol counting of nstK40C cytochrome c3 
The previous studies of thiol counting on the untagged cytochrome C3 (Section 3.2.3) 
indicated that there were free cysteines at positions 40 and 107 on cytochrome C3 
mutants. The cysteine on the soft New Strep Tag might be expected to be more 
solvent exposed. The number of free thiols within nstK40C cytochrome C3 was 
determined using the reagent of 2,2'-pyridyl disulfide (2-PDS) as described earlier. 
2-PDS reacts specifically with free thiols to yield a chromophore, 2-pyridinethione 
(Fig. 2.3, 2.8). The accumulation of 2-pyridinethione is usually monitored 
spectrophotometrically at 343 nm = 8.08 mM cm - ) to give quantification of 
the number of free cysteine groups within the protein. The data were processed using 
the previous method. 
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Figure 4.7: time-dependent traces of the absorbance change at 343 nm during the 
counting analysis of nstK40C cytochrome c 3 
According to the results (Fig. 4.7), the number of free thiols was estimated to be 1.52 
± 0.06, but should be 2 theoretically. The error may be due to the existence of small 
amount of nstK40C dimer (also refer to lane 5 in Fig. 4.8). Size exclusion 
chromatography can not totally separate monomer and dimer because their peaks 
overlap with each other. 
(3) 	Production of cytochrome C3 heterotrimer (controlled protein crosslinking) 
The production of homodimers of K40C and S1 07C cytochromes C3 showed that the 
cysteines at position 40 and 107 were reactive in protein crosslinking, and the time-
dependence studies of homodimer formation also showed that their rate of reaction is 
fast (Section 3.3.1). K40C-S107C heterodimer was generated by two-step 
crosslinking (Section 3.3.2). The reactive cytochrome c3-bismaleimide (1:1) 
intermediate made during the reaction process implied a way of developing multi-
step crosslin.king. Furthermore, the high molecular weight soluble polymers linked 
by disulfide bonds or bismaleimides of K40C:S107C cytochrome C3 indicated the 
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possibility of the formation of the long chain cytochrome C3 "nanowires" without any 
precipitation (3.3.3). 
On the basis of the previous work, a controllable protein crosslinking strategy was 
developed and production of a short well-defined wire of cytochrome C3 modules 
was attempted (Fig. 1.22). All three cytochrome C3 modules were reacted at a molar 
ratio of 1:1:1 (Section 2.11.4). Firstly, the K40C-bismaleimide and S1O7C-
bismaleimide intermediates were produced by the reaction of the mutant 
cytochromes c3 with 10 fold excess bismaleimide crosslinker, BM(PEO)2. Then, the 
excess BM(PEO)2 was removed by cation exchange column chromatography. 
Secondly, nstK40C cytochrome C3 was bound to the Strep-Tactin column, where the 
cysteine in the New Strep Tag should be buried in the Strep-Tactin binding pocket 
and cysteine 40 exposed to the environment. SIO7C-BM(PEO) 2 was loaded onto the 
Strep-Tactin column to produce SI07C-BM(PEO) 2-nstK40C. After the unreacted 
Si 07C-BM(PEO)2 had been washed away and the SI 07C-BM(PEO) 2-nstK4OC was 
eluted from the Strep-Tactin column. Finally, K40C-BM(PEO)2 was added to the 
Strep-Tactin elution to make S107C-BM(PEO) 2-nstK40C-BM(PEO)2-K40C. There 
were no precipitates formed throughout the entire reaction progress. SDS-PAGE gel 
samples were taken from each reaction step and the gel was analysized by heme 
staining analysis (Fig.4.8). 
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Figure 48: SDS-PAGE/heme staining analysis of cytochrome C3 heterotrimer 
production. Lane M. molecular weight marker; lane 1: S1O7C; lane 2: S1O7C- 
BM(PEO)2; lane 3: K40C; lane 4: K40C-BM(PEO)2; lane 5: nstK40C; lane 6:: 
Si 07C-BM(PEO)2-nsiK40C mixture; lane 7: SI 07C-BM(PEO)2-nstK40C- 
BM(PEO) 2-K40C mixture 
There was a little homodimer formed during the production of Si 07C-BM(PEO)2 
(lane 2, fig. 4.8) and a side product (middle band in lane 2), the molecular weight of 
which was between 14 kDa (monomer) and 28 kDa (dimer). It is probably the 
crosslinking product of a small ( 6 kDa) non-heme protein with an exposed cysteme 
and S107C (Section 3.3.1). This side product only appeared when the sample of 
S107 was very concentrated, due to its trace existence in the purified Si 07C. 
Although nstK40C was purified by size exclusion chromatography, there was still 
certain amount of homodimer in the reaction sample of nstK40C (lane 5, Fig 4.8). 
Upon the addition of Si 07C-BM(PEO)2 to nstK40C, the amount of dimer increased 
with a yield of-- 20 % (the dimer band was more intensive in lane 6, Fig 4.8). In the 
last step of the reaction, K40C- BM(PEO) 2 was added to the SI 07C-BM(PEO)2-
nstK4OC and the heterotrimer of cytochrome C3 was generated with a yield of— 12 % 





The creation of a heterotrimer of cytochrome C3 validated the feasibility of controlled 
protein crosslinking. However, it was difficult to get pure heterotrimer. The main 
reason is probably the low yield of the bismaleimide crosslinking reaction, especially 
the crosslinking on the Strep-Tactin column, due to the hydrolysis of the maleimide 
group and the multi-step reaction mechanism. Also the size difference among the 
monomer, dimer, and trimers too small to allow total separation by size exclusion 
chromatography. Because the peaks of them would overlap with each other. 
4.5 	Conclusions 
Three CBP-tagged cytochrome C3 mutants were constructed and expressed in 
Shewanella oneidensis but did not bind to the Calmodulin (CaM) affinity resin 
during purification. Possible reasons might be that the linker between protein and 
CBP was not long enough or that the CBP was partly proteolysed during expression. 
A strep-tagged K40C:S I 07C cytochromes c3 was constructed and expressed in 
Shewanella oneidensis. This mutant bound to the Strep-Tactin affinity resin but 
formed oligomers. The cysteme 107 residue next to the heme binding motif may 
have caused this protein seif-oligomerisation. In order to prevent oligomerization, a 
K40C cytochromes c3 with New Strep Tag containing a cysteine (nstK40C) was 
constructed, expressed and purified. 
Strep-Tactin was used to block the cysteine in New Strep Tag of nstK40C 
cytochromes C3 allowing the cysteine 40 reactive in order to control the ligation 
process. nstK40C was reacted with bismaleimide-modified S107C to produce a 
heterodimer ( yield: 20%) while bound to the Strep-Tactin column. This dimer was 
purified and reacted with bismaleimide-modified K40C to generate a heterotrimer 
(yield: 12 %). The results validated the feasibility of multi-step controlled protein 
crosslinking. The yield of the wire was low. It was likely due to the hydrolysis of 
bismaleimide crosslinker and the multi-step reaction mechanism. It was also difficult 
to get the pure form of the final product because peaks of components in the reaction 
mixture would overlap with each other in the size exclusion chromatography 
separation. However, a controlled protein ligation strategy was successfully 
developed and a short well-defined wire was generated using three different 
cytochrome C3 modules. 
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Chapter 5 
The conjugation of 
cytochrome c 3 and 
P450 BM3 heme domain 
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5.1 	Introduction 
The cytochromes P450 (CYP or P450) are a huge superfamily of heme containing 
proteins from various biological species, including humans. The reduced P450s have 
extremely high affinity towards carbon monoxide (CO), forming characteristic Soret 
peaks at 450 nm in the UV-Vis absorption spectra. That's why they are named P450 
(Pigment at 450 rim). Usually, P450s all contain a b-type heme axially coordinated 
by the thiol group of a conserved cysteine residue, leaving another axial coordination 
position free for substrate binding. 
Monooxygenation, illustrated simply below, is the typical catalytic reaction of P450s, 
which have a broad range of substrates. 
RH + 02 + 2H + 2e- 	ROH + H 20 
In addition to the above chemical reagents, P450s need the support of their 
associated redox partners to supply two electrons to drive every catalytic cycle. The 
redox partners are commonly small polypeptides containing redox active species like 
FAD, FMN, and [2Fe-2S] clusters. 
Flavocytochrome P450 BM3 from Bacillus rnegaterium (Fig 1.13) is a well-studied 
P450. It is a large soluble protein with only a single polypeptide including a heme 
domain (cytochrome P450 oxygenase domain) and a flavin domain (cytochrome 
P450 reductase domain) binding FAD and FMN. Hence, flavocytochrome P450 
BM3 is an ideal model for P450 systems consisting of a single component enzyme. 
The b-type heme of P450 BM3 is deeply buried in the protein (Fig. 1.22) and it 
naturally accepts electrons from the flavin domain. The aim of the chapter is to attach 
a stable electro-active protein, e.g. cytochrome c3 , to P450 BM3 near the active site 
and to study the conjugate with an electrode driving catalytic reactions. This strategy 





Figure 5.1: potential cross/inking sites in P450 BM3 heme domain (PDB:21J2). 
Panel a: cartoon view; panel b: molecular surface view. Cysteines are represented in 
yellow; glutamine is represented in blue; the possible docking area of cytochrome C3 
on the P450 BM3 heme domain surface is highlighted by the red dashed circle 
There is a concave pocket located near the active site of P450 BM3 heme domain 
(Fig. 5.1). It might be a suitable binding area for the globular cytochrome C3. Hence, 
the residues in the pockes were good candidate s as crosslinking sites. There are three 
native cysteines in the P450 BM3 heme domain at positions 62, 156, and the 
conserved cysteine 400, the fifth ligand of heme (Fig. 5.1a). Cysteine 156 is buried in 
the protein and can not be accessed by other molecules. Cysteine 62 is half exposed 
to solvent in the concave pocket, and might be a possible site for protein 
crosslinking. In addition, the most exposed amino acid in the pocket, glutamine 387 
(Fig. 5. 1), was considered as an alternative crosslinking site in case of failure of 
crosslinking at cysteine 62. Therefore, two mutants of P450 BM3 heme domain were 
constructed, C156S (C62P450) and C62S:C156S:Q387C (C387P450). A short six-
histidine tag was attached to the C terminus of the mutants facilitating their 
purification. 
The cytochrome C3 module used for conjugation with P450 BM3 heme domain was 
K40C cytochrome c3 with Strep Tag II. Hence, the conjugate of them could be easily 
separated using two affinity columns, Strep-Tactin Sepharose column (IBA) and 
Ni2 '-NTA Agarose column (Qiagen). In fact, S107C cytochrome C3 had better 
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performance in the crosslinking reaction than K40C (Section 3.3.1). However, after 
conjugation to P450, strep-tagged SI07C might not be purified by the Strep-Tactin 
resin because Strep Tag H might be blocked by P450. It would make the crosslinking 
product separation difficult. 
P450 BM3 mutants were expressed, characterized with UV-Vis spectroscopy and 
substrate binding, crosslinked with a cytochrome C3 module near the active site. The 
electrochemistry of the conjugate was studied using an OTTLE and UV-Vis 
spectroscopy combinatory technique (Fig. 1.23). 
5.2 	Protein purification and basic characterization 
(1) 	SDS-PAGE and UV-Vis spectroscopic analysis of P450 BM3 heme domain 
mutants 
Two mutants of P450 BM3 heme domain were over expressed in E. co/i TG 1, and 
purified by Ni2 -NTA Agarose column chromatography. Both mutants were 
successfully bound to the Ni 2 -NTA column and formed a red tight band on the top 
of the column. After several washes of binding buffer, the red band was eluted with 
250 mM Imidazole buffer. The purification progress was analysized by SDS-
PAGE/CBB staining (Fig. 5.2). During the preparation of the gel samples, the b-type 
heme of P450 BM3 was dissociated and hence the gel could not be developed by 
heme staining. 
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Figure 5.2: SDS-PAGE/CBB staining analysis of the fractions of the Ni 2tNTA 
Agarose column. Lane M: molecular weight marker; lane 1: cell extract; lane 2: 
.2+ 	 .2+ 	 .2+ Ni -NTA column flow through; lane 3: Ni -NTA column wash; lane 4: Ni -NTA 
column elution of the target protein. Both mutants of P450 BM3 heme domain had 
the same pattern of SDS-PA GE gel. 
The single band on the SDS-PAGE/CBB stained gel (lane 4, fig.5. 1), showed good 
correlation with the expected molecular mass of P450 BM3 heme domain at 
approximate 55 kDa, indicated that the mutant had a high purity. 
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Figure 53: UV- Vis spectra of C62P450. The red curve represents the oxidised form 
of the mutant [Fe(III)]; the blue curve represented the CO bound reduced form 
[Fe(II)-COJ. The insert plot showed the different spectrum of the CO bound reduced 
form and the reduced form ([Fe(II)-CO]- [Fe(II)]). 
Both mutants had the identical UV-Vis spectra since the mutation sites were far away 
from the active centre (Fig. 5.3). Typically, there were four peaks (363, 420, 535 and 
565 rum) in the fern-form (oxidised). Upon binding CO to the ferro-form P450 heme 
domain, a "famous" Soret peak at 450 rim appeared. The concentration of mutants 
could be determined by the difference spectrum of the CO bound ferro-form and the 
ferro-form with the extinction coefficient E45490 = 92 mM' cm' [90]. 
(2) 	SDS-PAGE and UV-Vis spectroscopic analysis of K40C cytochrome c3 with 
Strep Tag II (stK40C) 
This strep-tagged cytochrome c3 was constructed on the basis of the plasmid (pSL9) 
encoding K40C cytochrome c3 with New Strep Tag (Section 2.3.7), expressed in 
Shewanella oneidensis MR-1, and purified on a Strep-Tactin column. 
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Figure 5.4: SDS-PAGE/heme staining analysis ofthe fractions of the 
Strep-Tactin Sepharose column. Lane M: molecular weight marker; lane 1: cell 
extract; lane 2: SP Sepharose column flow through; lane 3: 500mM NaCl elution of 
SP Sepharose; lane 4: Strep-Tactin column flow though; lane 5 - 10: eluted 
fractions of stK40C cytochrome c 3 
The SDS-PAGE/heme stained gel (Fig. 5.4) showed a similar pattern to previous gels 
(Figs. 4.2 & 4.5). More importantly, compared with the purification result of stKS 
(Sectoin 4.3), this strep-tagged cytochrome c3 massively reduced the self 
oligomerization of the protein, with only a minor dimer band observed (lane 7, fig. 
5.4). It supported the previous hypothesis (4.3) that the cysteine 107 next to the heme 
binding motif could be activated towards self oligomerization of the cytochrome c3 
modules. 
Again, the UV-Vis spectra of stK40C cytochrome c3 were identical to those of wild 
type cytochrome C3 (Fig. 3.3). 
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53 	Substrate binding of the mutants of P450 BM3 heme domain 
In order to check the active site functionality of the mutants, they were treated with 
the common substrates of P450 BM3, laurate and palmitate. Upon binding, the 
substrates of P450 BM3 heme domain displace the water ligand at the sixth 
coordination position leading to a change in geometry and a low- to high-spin shift of 







Figure 5.5: substrate binding to P450 BM3 heme domain. The heme group is 
represented by a purple rectangle and a red ball. 
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Figure 5.6: UV- Vis spectra showing substrate binding to C38 7P450. Substrate free 
P450 was represented in black curve; laurate bound P450 was represented in red 
curve; palmitate bound P450 was represented in blue curve. 
Both mutants gave similar UV-Vis spectra (Fig. 5.6) and exhibited high spin-state 
conversion in the presence of excess palmitate. However, laurate resulted in a 
considerably lower proportion of high-spin protein. This is the same as observed for 
the wild-type enzyme, as laurate is not long enough to be an ideal substrate. 
5.4 	Conjugation of the P450 BM3 and cytochrome c3 mutants 
(1) 	Crosslinking capability of P450 BM3 heme domain mutants 
Two mutants of the P450 BM3 heme domain were made: C62P450 and C387P450. 
The native cysteine 62 is close to the active and has half exposure to solvent (Fig. 
5.1), which might limit its activity in the crosslinking reaction. Cysteine 387 should 
have much higher exposure than cysteine 62 so that it should be more reactive. 
According to the previous study (Section 3.3.1), SI07C cytochrome C3 had better 
performance in the crosslinking reaction than K40C. Hence, it was used to test the 
crosslinking capability of the two mutants of the P450 BM3 heme domain (C62P450 
and C387P450). 
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The small scale crosslinking reaction between the P450 mutants and Si 07C followed 
the procedure described in section 2.11.1, in which K40C was replaced by C62P450 
or C387P450 in overnight reactions. The gel samples were taken from the reactants 
and crosslinking mixtures and analysized by SDS-PAGE/heme staining (Fig. 5.7). 
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Figure 5.7: SDS-PAGE/heme staining analysis of the crosslinking reactions of P450 
BM3 heme domain mutants (C62P450 & C387P450) and S107C cytochrome C3. 
Lane M: molecular weight marker; lane 1: S107C; lane 2; C62P450; lane 3: 
C387P450; lane 4: S107C+C62P450; lane 5: S107C+C387P450 
The bands of P450 BM3 heme domain mutants could not be developed by the heme 
staining due to the dissociation of heme during the sample preparation (lane 2 & 3, 
fig. 5.7). However, it did not affect the analysis of crosslinking reaction. The band of 
the P450-SI 07C conjugate could be highlighted without the interference of the side 
products (P450 monomers and homodimers) in the high molecular weight area. Only 
the cytochrome C3 modules (monomer, homodimer, and heterodimer) appeared on 
this heme staining gel. The band (> 62 kDa) in lane 5 of figure 5.7 indicated the 
mutant C387P450 performed well in conjugation with cytochrome C3 whereas the 
mutant C62P450 could not be crosslinked. 
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(2) 	The conjugation of C387P450 and stK40C 
The two reactants, C387P450 and stK40C, were selected to make a heterodimer on a 
large scale. To get a good control of the reaction, the crosslinking progress 
underwent two steps. Firstly, C387P450 was reacted with 10 fold excess BM(PEO)2 
to produce C387P450-BM(PEO)2. Secondly, C387P450-BM(PEO)2 was purified by 
anion exchange chromatography. It then was mixed with an equivalent of stK40C 
cytochrome C3 producing C387P450-BM(PEO)2-stK40C with a yield of— 28 %. The 
reaction mixture was purified via a Strep-Tactin Sepharose column and a Ni 2 -NTA 
Agarose column. Proteins remained soluble throughout the reaction and each step of 
reaction was analysized by SDS-PAGEi1ieme staining (Fig. 5.8). The purified 
conjugate was studied by the size exclusion chromatography (Fig. 5.9) and UV-Vis 
spectroscopy (Fig. 5.10). 
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Figure 5.8: SDS-PAGE/heme staining analysis of the cross/inking reactions of P450 
BM3 heme domain mutants (C387P450) and stK40C cytochrome C3. Lane M: 
molecular weight marker; lane 1: C387P450; lane 2; C387P450-BM(PEO)2; lane 3: 
stK40C; lane 4: C387P450-BM(PEO)2-stK40C; lane 5: the reaction product after 




Although the crosslinking process was a two-step controlled reaction, there were still 
a few side products. Apart from the homodimer formed by stK40C, a minor band 
(lane 4, fig. 5.8) appeared with a higher molecular weight than the target conjugate 
(C387P450-BM(PEO) 2-stK40C). Probably an additional cytochrome C3 module was 
attached to C387P450-BM(PEO)2-stK40C. After purification on the two affinity 
columns, there were still some cytochrome C3 modules (monomer and homodimer) in 
the product (lane 5, fig. 5.8). 
The purified conjugate was further analysized by size exclusion chromatography 
with a Superdex S200 column (Fig. 5.9). 
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Figure 5.9: the elution profile of Superdex S200 for the analysis of the purified 
conjugate of C387P450 and stK40C. The blue curve represents the elution of 
stK40C; the black curve represents the elution of C387P450; the red curve 
represents the elution of purified conjugate. The stK40C and C387P450 monomers 
are highlighted by green and magenta vertical lines, respectively; the C387P450 
dimer is highlighted by the orange vertical line. 
The unreacted proteins, C387P450 and stK40C, were passed through the Superdex 
S200 column as molecular markers and the elution curves showed that both proteins 
were very pure. There were still small amounts of cytochrome c3 modules (monomer 
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and homodimer) in the product solution. This result was consistent with the analysis 
of SDS-PAGE/heme staining. The situation was more complicated in the high 
molecular weight area. The peak of the the target conjugate (C387P450-BM(PEO)2-
stK40C) was overlapped by the peak of the C387P450 dimer. 
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Figure 5.10: the UV- Vis spectra of C38 7P450-BM(PEO) 2-stK4OC. The black curve 
represented the oxidized form of the conjugate; the red curve represented the 
reduced form; the blue curve represented the CO bound reducedform 
The UV-Vis spectrum of the conjugate seemed like the combined spectra of the 
individual components. There are four hemes in cytochrome c3 and only one heme in 
P450 BM3. Hence, in the oxidised form of the conjugate, the Soret peak of the 
cytochrome C3 module (410 nm) was so intensive that the Soret peak of P450 BM3 
heme domain (420 nm) was covered. The spectrum of the reduced form also only 
showed the characteristic peaks of the cytochrome C3 at 419 nm, 523 nm and 552 rim. 
Upon CO binding to the reduced conjugate, a typical peak at 450 nm belonged to 
P450 component appeared. The peaks of reduced cytochrome c3 at 523 nm and 552 
nm decreased and the Soret peak (419 nm) was shifted to 415.5 rum, which were 
consistent with the literature description of the CO-binding of cytochrome C3 [153]. 
The concentrations of cytochrome c3 module and P450 BM3 heme domain module 
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were figured out with their own extinction coefficients and the ratio of them was 
about 1:2.5 (stK40C : C387P450). 
5.5 OTTLE driven electron transfer between cytochrome C3 and P450 heme 
domain mutant 
OTTLE (Optically Transparent Thin Layer Electrode) was used to investigate the 
electron transfer between cytochrome c3 and P450 BM3 heme domain. The samples 
would be the equimolar mixture of uncrosslinked cytochrome C3 and P450 BM3 
heme domain, and their conjugate. At a low applied potential (-300 mV), the 
cytochrome C3 would be half reduced by OTTLE because its first two microscopic 
reduction potentials are -242 mV and -296 mV [150], lower than -300 mV. P450 
BM3 heme domain can not be directly reduced by the electrode due to its buried 
heme group. The reduced cytochrome C3 module is expected to transfer electrons to 
the active site of P450 BM3 heme domain when it diffuses to the concave pocket 
near the active site of P450 BM3 heme domain. In the presence of CO. the reduction 
of P450 BM3 heme domain can be monitored by the UV-Vis spectrophotometer with 
the increases in absorbance at 450 nm. Here, cytochrome C3 plays a role as an 
electron transfer mediator. Palmitate, a substrate of P450 BM3, is also added to 
favour the reduction of P450 BM3 heme domain. This technique can test the 
possibility of the electron transfer between cytochrome C3 and P450 BM3 heme 
domain. Furthermore, it would show whether cytochrome C3 and P450 BM3 heme 
domain are crosslinked at the right postion for productive electron transfer. 
(1) Inter-molecular electron transfer between the stK40C cytochrome c3 and P450 
BM3 heme domain (C387P450) 
Upon the application of -300 mV to the equimolar mixture of stK40C cytochrome c3 
and P450 BM3 heme domain mutant (C387P450) in the presence of CO and 
palmitate, the UV-Vis spectrum of the sample in the OTTLE cell were recorded 
every 5 minutes over a period of 24 hours. The selected spectra (Fig. 5.11) showed 
that the Soret peak at 410 nm of the mixture was shifted to 415.5 nm and a small 
peak at 552 nm appeared. These were typical changes of cytochrome C3, when 
reduced and bound with CO. The other characteristic increase was at 450 nm 
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indicating that the heme of the P450 BM3 mutant had been reduced and coordinated 
by Co. 
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Figure 5.11: UV-Vis spectra of OTI'LE driven inter-molecular electron transfer 
between stK40C cytochrome C3 and C387P450. The red curve represents the initial 
spectrum of the sample; the magenta curve represents the final spectrum of the 
sample 
The time dependence of the absorbance changes at 450 nm and 552 nm (Fig. 5.12) 
showed that the cytochrome c3 species was reduced by the electrode in - 35 mm 
while P450 BM3 heme domain took 10 hours to fully reduce. The possible reason 
for the asynchronous reduction of the two species (-- 20 fold difference) was that, 
upon reduction of cytochrome c3 module, it took some time to diffuse to the right 
position for transferring electrons into the active centre of P450 BM3 heme domain. 
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Figure 5.12: the absorbance changes during OTTLE driven inter-molecular electron 
transfer between sIK40C cytochrome C3 and P450 BM3 heme domain mutant 
(C387P450). The red curve represents the absorbance change at 450 nm; the black 
curve represents the absorbance change at 552 nm 
As a control, the P450 BM3 heme domain mutant (C387P450) with CO and 
palmitate was also applied with -300 mV potential in the OTTLE cell. No CO-bound 
reduced P450 was observed over the 24-hour experiment (Fig. 5.13). This meant that 
the P450 BM3 heme domain could not directly interact with the electrode. 
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Figure 5.13: the absorbance change at 450 nm of P450 BM3 heme domain mutant 
(C38 7P450) upon the application of -300 mV 
(2) 	Intra-molecular electron transfer between the stK40C cytochrome c 3 and 
P450 BM3 heme domain (C387P450) 
The same experiment was performed on the conjugate of cytochrome C3 and P450 
BM3 heme domain, C387P450-BM(PEO)2-stK40C. Unfortunately, only the 
reduction of the cytochrome C3 component was observed. Taking the baseline shift 
into account, there were almost no changes at 450 rum over a 24-hour period (Fig. 
5.14), even at a lower applied potential (-500 mV). 
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Figure 5.14: UV- Vis spectra of 07TLE driven reduction of the conjugate C387P450-
BM(PEO) 2-stK40C. The red curve represents the initial spectrum of the sample; the 
magenta curve represents the final spectrum of the sample 
The reason for the failure of the electron transfer might be that cytochrome C3 was 
not crosslinked to the right position of P450 BM3 close enough to the P450 BM3 
heme. The movement of the crosslinked cytochrome C3 might have been limited or 
blocked so that it could not access the heme of the P450. 
5.6 	Conclusions 
Cytochrome C3 was used to pass electrons to P450 in a conjugate for immobilization 
on an electrode or for further conjugation. In order to crosslink cytochrome C3 close 
to the heme of P450, two mutants of P450 BM3 heme domain (C62P450 and 
C387P450) with suitable ligation sites were constructed, expressed, and purified. The 
mutant C387P450 was more reactive with cytochrome C3. C387P450 was crosslinked 
to a newly constructed cytochrome C3 mutant (stK40C) with a yield of 28 % and 
the conjugate was purified by two affinity columns. The UV-Vis spectrum of the 
CO-bound reduced conjugate indicated that the heme of P450 had the similar 
environment as the heme of wild type P450. The electron transfer between 
cytochrome C3 and P450 BM3 heme domain was studied by OTTLE. P450 heme 
domain can not be reduced directly by the electrode due to its buried active site and it 
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was slowly reduced by cytochrome C3 (-- 10 hours). However, there was no electron 
transfer observed at the same condition for the conjugate of cytochrome C3 and P450 
BM3 heme domain. Probably cytochrome C3 was not crosslinked to the right position 
of P450 BM3 close enough to the P450 BM3 heme. 
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Chapter 6 
Conclusions and future work 
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In order to utilize the cytochrome C3 for protein conjugation, three cysteine mutants 
(K40C, SI07C, and K40C:SI07C) were constructed, successfully expressed in 
Shewanella oneidensis MR-1, purified and characterized by fluorescent labelling and 
thiol counting. Protein crosslinking was performed with a bismaleimide crosslinker, 
1 ,8-bis-Maleimidodiethyleneglycol (BM(PEO)2) on the cysteine mutants to produce 
cytochrome C3 dimers and polymers. S107C was more efficient in forming 
homodimers than K40C probably because it is the flexible and exposed C terminus 
of the protein. The yields in two hours were 60 % for the S 107C dimer and 30 % 
for the K40C dimer respectively. The incomplete dimerization might be due to the 
hydrolysis of the maleimide group and two-step crosslinking mechanism. A trace 
amount of an impurity thiol containing protein also affected the production of 
homodimers in conjugating with the monomeric cytochrome C3 mutant. The K40C 
and S 1 07C heterodimer (yield: 25 %) was generated upon the production of a 
bismaleimide-modified Si 07C intermediate. This two-step reaction shows that 
protein ligation can be performed in a controllable multi-step way. However, the 
maleimide group does hydrolyse during the reaction and the impurity in the protein 
sample still limited the production of the heterodimer. Two methods were used for 
the polymer production: disulfide crosslinking and bismaleimide crosslinking. The 
polymers generated through disulfide crosslinking were cleavable whereas 
bismaleimide crosslinked polymers were stable in a reducing environment. Both 
gave a high degree of polymerization, yielding up to the 12mer at least for disulfide 
crosslinking and up to the 8mer at least for bismaleimide crosslinking. The UV-Vis 
spectroscopy of both polymers showed that the chemical nature of heme groups in 
cytochrome C3 remained unchanged before and after polymerization. OTTLE 
potential titration shows that the polymerisation of the cytochrome C3 modules leads 
to a reduction potential shift towards the negative from - 304 mV (wild type) to -336 
mV (disulfide-linked cytochrome C3 polymers) and -388 mV (bismaleimide-linked 
cytochrome c3 polymers). A possible reason is that the interaction among hemes in 
the cytochrome c3  modules makes the polymer more difficult to reduce. 
The affinity tags, Calmodulin Binding Peptide (CBP) and Strep Tag H, were used not 
only to aid protein purification but also to control the protein ligation. Three 
cytochrome C3 mutants tagged with CBP were constructed and expressed in 
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Shewanella oneidensis but did not bind to the Calmodulin (CaM) affinity resin 
during purification. Possible reasons might be that the linker between protein and 
CBP was not long enough or that the CBP was partly proteolysed during expression. 
A K40C:SI07C cytochrome C3 tagged with Strep Tag II formed oligomers after 
affinity purification. The cysteine 107 residue next to the heme binding motif may 
have caused this protein self-oligomensation. In order to prevent oligomerization, a 
mutant K40C cytochrome C3 with New Strep Tag containing a cysteine (nstK40C) 
was constructed, expressed and purified. Strep-Tactin was used to block the cysteine 
in New Strep Tag of nstK40C cytochromes C3 allowing the cysteine 40 to be reactive 
in order to control the ligation process. nstK40C was reacted with bismaleimide-
modified Si 07C to produce a heterodimer (yield: 20%) while bound to the Strep-
Tactin column. This dimer was purified and reacted with bismaleimide-modified 
K40C to generate a heterotrimer (yield: -•- 12 %). The yield of the wire was low. It 
was likely due to the hydrolysis of bismaleimide crosslinker and the multi-step 
reaction mechanism. It was also difficult to get the pure form of the final product 
because peaks of components in the reaction mixture would overlap with each other 
in the size exclusion chromatography separation. However, the controlled protein 
ligation strategy was successfully developed and a short well-defined wire was 
generated using three different cytochrome C3 modules. 
Cytochrome C3 was used to pass electrons to P450 in a conjugate for immobilization 
on an electrode or for further conjugation. In order to crosslink cytochrome C3 close 
to the heme of P450, two mutants of P450 BM3 heme domain (C62P450 and 
C387P450) with suitable ligation sites were constructed, expressed, and purified. The 
mutant C387P450 was more reactive with cytochrome C3. C387P450 was crosslinked 
to a newly constructed cytochrome C3 mutant (stK40C) with a yield of — 28 % and 
the conjugate was purified by two affinity columns. The UV-Vis spectrum of the 
CO-bound reduced conjugate indicated that the heme of P450 had a similar 
environment to the heme of wild type P450. The electron transfer between 
cytochrome C3 and P450 BM3 heme domain was studied by OTTLE. The P450 heme 
domain can not be reduced directly by the electrode due to its buried active site, but 
it was slowly reduced by cytochrome C3 (- 10 hours). However, there was no 
electron transfer observed under the same conditions for the conjugate of cytochrome 
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C3 and P450 BM3 heme domain. Probably cytochrome C3 was not crosslinked to the 
right position of P450 BM3 close enough to the P450 BM3 heme. 
It would be interesting to carry out the following work: 
Optimise the crosslinking reaction by varying conditions and stoichiometries to 
increase yield of crosslinking products; 
Produce the conjugates of P450 BM3 heme domain and cytochrome C3 with 
new suitable crosslinking sites; 
Produce the conjugates of P450 BM3 heme domain and other small redox-
active proteins, e.g. ferredoxin; 
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CYTOCIIROME C3 PEPTIDE SEQUENCE 
1 APKAPADGLK MDKTKQPVVF 
21 NHSTHKAVKC GDCHHPVNGK 
41 EDYQKCATAG CHDNMDKKDK 
61 SAKGYYHAMH DKGTKFKSCV 
81 GCHLETAGAD AAKKKELTGC 
101 KGSKCHS 
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P450 BM3 HEME DOMAIN PEPTIDE SEQUENCE 
1 T!KEMPQPKT FGELKNLPLL NTDKPVQALM 
31 KIADELGEIF KFEAPGRVTR YLSSQRLIKE 
61 ACDESRFDKN LSQALKFVRD FAGDGLFTSW 
91 THEKNWKKAH N!LLPSFSQQ AMKGYHAMMV 
121 DIAVQLVQKW ERLNADEHIE VPEDMTRLTL 
151 DT!GLCGFNY RFNSFYRDQP HPFITSMVRA 
181 LDEAMNKLQR ANPDDPAYDE NKRQFQEDIK 
211 VMNDLVDKII ADRKASGEQS DDLLTHMLNG 
241 KDPETGEPLD DENIRYQIIT FLIAGHETTS 
271 GLLSFALYFL VKNPI-IVLQKA AEEAARVLVD 
301 PVPSYKQVKQ LKYVGMVLNE ALRLWPTAPA 
331 FSLYAKEDTV LGGEYPLEKG DELMVUPQL 
361 HRDKTIWGDD VEEFRPERFE NPSAIPQHAF 
391 KPFGNGQRAC IGQQFALHEA TLVLGMMLKH 
421 FDFEDHTNYE LD!KETLTLK PEGFVVKAKS 
451 KKIPLGGIPS PSTEQSAKKV RK 
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APPENDIX II 
Quantification of Gels by ImageJ 
Imagei could be downloaded freely from http://rsbweb.nih.gov/ij/ . It is available for 
Windows, Mac OS X and Linux platforms. After installation (Mac OS X here), 
ImageJ was calibrated by the method provided online 
(http:iirsbweb.nih.gov/ii/docs/examples/calibrationhifldeX.html). 





- 	 31 43 
Open a gel picture by File/Open; 
Invert the color of picture by Edit/Invert, the background will become black; 
Set bands to white color only by Image/Type/8-bit. 
Use the rectangular selection tool to outline the first lane. This should be the left 
most lane if the lanes are vertical or the top lane if the lanes are horizontal. Note that 
lanes are assummed to be vertical unless the width of the initial selection is at least 
twice its height. 
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Select Analyze/Gels/Select First Lane and "Lane 1 selected" will be displayed in 
the status bar. ImageJ will also duplicate the image and outline and label the lane if 
'Outline Lanes' is checked in the Analyze/Gels/Gel Analyzer Options. 
Move the rectangular selection right to the next lane (or down if the lanes are 
horizontal) and select Analyze/Gels/Select Next Lane. "Lane 2 selected" will be 
displayed in the status bar. ImageJ will also outline and label the lane if "Outline 
Lanes" is checked. 
Repeat the previous step for each remaining lane. 
Check the 'Invert Peaks' in the in the Analyze/Gels/Gel Analyzer Options. 
Select Analyze/Gels/Plot Lanes (or press "3") to generate the lane profile plots. 
Use the straight line selections tool to draw base lines and/or drop lines so that 
each peak of interest defines a closed area. To get to all the lanes, it may be 
necessary to scroll the image vertically using the "Hand" tool. (Hold down the space 
bar to temporarily switch to this tool). 
For each peak, measure the size by clicking inside with the wand tool. If 
necessary, scroll the image by holding down the shift key and dragging. 
Select Analyze/Gels/Label Peaks to label each measured peak with its size as a 
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